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Introduction 
Au début du présent manuscrit, il est important d’établir les motivations et les 
principaux objectifs de ce travail de thèse. Nous nous concentrons ainsi sur l’échantillon 
sanguin en tant que riche source d’information, essentielle du point de vue du diagnostic et 
de la recherche. Ceci implique un fort intérêt d’études sur cet échantillon biologique et sur 
les cellules sanguines en particulier. Parmi les différents composants du sang, les 
lymphocytes représentent une fraction cellulaire qui joue une des rôles primordiaux dans le 
fonctionnement de l’organisme humain. Ils sont responsables des mécanismes de défense 
immunitaire qui constituent la barrière de protection contre les différents pathogènes. Les 
acquis en immunologie montrent la complexité des réponses immunitaires générées par les 
lymphocytes et indiquent un réel besoin d’une recherche plus approfondie sur ces divers 
phénomènes. Cette approche doit néanmoins faire face à de nombreux défis comme une 
grande diversité des lymphocytes, leur faible quantité dans un échantillon de sang total 
ainsi qu’une grande sensibilité aux variations des conditions extérieures.  
Afin de découvrir les aspects fondamentaux de l’immunologie, il est 
particulièrement intéressant d’examiner une population de lymphocytes bien définie. C’est 
pourquoi nous avons besoin d’outils de recherche capables de réaliser un tri cellulaire 
efficace. Dans ce domaine, il existe de nombreuses techniques utilisées en routine à 
l’échelle du laboratoire (e.g. FACS®) mais ces procédures sont souvent longues, coûteuses 
et nécessitent une quantité d’échantillon importante. Un développement récent des 
systèmes miniaturisés ouvre de nouvelles voies de fractionnement de cellules vivantes à 
l’échelle micrométrique. L’exemple d’une biopuce est ainsi proposé par ce travail de thèse.  
En effet, ce projet vise à construire une microplateforme capable d’immobiliser 
spécifiquement les cellules sanguines et par la suite d’effectuer leur relargage contrôlé 
depuis la surface. Dans ce cadre, deux stratégies indépendantes seront ici explorées : la 
première basée sur le clivage enzymatique et la deuxième exploitant une approche 
originale de désorption par chauffage localisée. Nous démontrerons ainsi la faisabilité du 
tri cellulaire à partir d’un mélange de lymphocytes primaires. Une technique basée sur la 
résonance plasmonique de surface (Surface Plasmon Resonance ou SPR) assurera la 
détection de phénomènes moléculaires et cellulaires en temps réel et sans marquage.  
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Le travail de thèse décrit par le présent manuscrit est une approche 
pluridisciplinaire qui touche à des domaines à l’interface entre la Chimie, la Biologie et la 
Physique. En vue de cela, la bibliographie nécessaire à la compréhension des résultats sera 
introduite au fur et à mesure. Ainsi, suite à l’introduction générale, le lecteur trouvera trois 
grandes parties (chapitre 2 à 4) qui décrivent les résultats obtenus dans le cadre de ce 
projet. Chapitre 2 sera principalement consacré à la construction de l’assemblage 
moléculaire formant la base de la biopuce proposée. Ensuite, le Chapitre 3 détaillera la 
stratégie de relargage contrôlé par la voie enzymatique alors que le Chapitre 4 présentera la 
désorption des protéines et des cellules vivantes par un faisceau laser couplé au SPR. Nous 
terminerons avec les conclusions et perspectives sur lesquelles la biopuce capable de tri 
cellulaire pourra s’ouvrir, notamment dans le domaine de la recherche immunologique. 
Enfin, le lecteur aura connaissance de procédures expérimentales et des références citées 
dans le travail. Les informations complémentaires aux résultats décrits dans le corps du 
texte seront comprises dans la partie Annexes.  
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Résumé Chapitre 2  
Concept de l’assemblage moléculaire sur biopuce 
Ce chapitre sera consacré au développement de l’assemblage moléculaire sur lequel 
s’appuie la fonctionnalité de la biopuce. Parmi les différentes stratégies de relargage 
contrôlé à multiéchelles proposées dans la littérature, celles qui impliquent l’utilisation de 
molécules d’ADN offrent plusieurs avantages comme : la facilité de fabrication des puces 
à ADN et leur stabilité dans le temps, l’accès à de nombreuses séquences 
d’oligonucléotides et finalement leur susceptibilité à la manipulation chimique, 
enzymatique ou physique. Pour le besoin de cette étude, nous proposerons une approche 
particulière qui permet de transformer une simple matrice d’ADN en une puce à anticorps 
capable de réaliser la capture spécifique de cellules. La microplateforme en question sera 
ainsi basée d’une part sur une surface d’or fonctionnalisée par différentes séquences 
d’oligonucléotides et d’autre part sur la conception d’une molécule hybride composée d’un 
anticorps (IgG) conjugué avec une courte séquence complémentaire d’ADN. Cette 
approche nécessite l’établissement d’un protocole de couplage qui sera ici discuté. En 
utilisant un agent hétéro-bifunctionnel, l’IgG sera covalemment lié à l’ADN puis purifié 
par la chromatographie échangeuse d’anions. Le produit final étant une molécule IgG-
ADN monoconjuguée sera ainsi isolé et par la suite caractérisé par mesure d’absorbance et 
suivi d’un test de révélation en fluorescence.  
Dans la partie finale du présent chapitre,  le lecteur fera connaissance avec le 
principe de détection utilisée et les détails instrumentaux de l’imagerie SPR. Cette 
technique servira alors à confirmer la fonctionnalité de l’assemblage moléculaire sur 
biopuce dont la construction étape par étape sera mise en évidence.  
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Résumé Chapitre 3  
Relargage contrôlé par clivage enzymatique  
Dans ce chapitre nous explorerons la première stratégie de relargage contrôlé basée 
sur le clivage enzymatique réalisé dans le format de biopuce. Cette approche repose sur 
l’utilisation de l’assemblage moléculaire décrit dans le chapitre précédent. En effet, les 
oligonucléotides utilisés pour le montage fonctionnel sur biopuce contiennent des 
séquences qui peuvent être spécifiquement reconnues par les endonucleases (les sites de 
restriction). En utilisant une série de séquences de restriction associées à des enzymes bien 
définies, une libération spécifique de différentes cibles pourra avoir lieu.  
Le concept sera dans un premier temps validé sur des cibles moléculaires 
correspondantes à plusieurs séquences de restriction, chacune conjuguée à un anticorps 
modèle – IgG du lapin. Ainsi, nous nous pencherons sur l’optimisation des conditions 
expérimentales afin d’établir un protocole permettant de réaliser une digestion efficace du 
substrat d’ADN immobilisé sur la surface. La spécificité du clivage enzymatique sera mise 
en évidence par suivi en temps réel permis par la technique SPRi. Par la suite, le système 
de relargage contrôlé sera expérimenté lors de tests sur des cellules vivantes.  
Tout d’abord, nous adresserons les lymphocytes sur la biopuce à l’aide de 
molécules conjuguées composées de l’anticorps spécifique à l’antigène cellulaire bien 
défini couplé à la séquence d’ADN. Des premiers essais de désorption par les enzymes de 
restriction seront menés sur des cellules-modèles issues de lignées cellulaires (les 
hybridomes des cellules du type B et T). A l’occasion de ces tests préliminaires, nous 
discuterons des conditions expérimentales qui sont cruciales pour limiter l’adsorption non-
spécifiques de cellules (traitement de surface, paramètres hydrodynamiques). Un protocole 
optimal sera ainsi développé et par la suite appliqué à des tests avec des cellules primaires 
– les lymphocytes B et T issues de la rate de souris. Cette étude montrera une 
reconnaissance spécifique des lymphocytes sur les plots concernés et leur relargage 
subséquent par clivage enzymatique. La SPRi permettra non seulement de suivre les étapes 
de l’expérimentation à l’échelle des biomolécules mais également de détecter les 
phénomènes cellulaires.   
A la fin de ce chapitre, une étude supplémentaire sera présentée. Elle sera axée sur 
l’application de la méthodologie développée à d’autres échantillons cellulaires. Ainsi, nous 
montrerons une capture spécifique de bactéries et mettrons ensuite en évidence leur 
relargage contrôlé par la voie enzymatique. Cette étude est proposée comme une approche 
originale à l’analyse d’échantillons pour des applications microbiologiques.  
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Résumé Chapitre 4  
Désorption par chauffage localisé 
Le chapitre 4 présentera une approche originale de désorption de biomolécules et 
d’objets biologiques immobilisés sur la surface de la biopuce selon le montage moléculaire 
développé précédemment. Le relargage contrôlé des différentes cibles repose sur la 
dissociation des doubles brins d’ADN générée par un chauffage localisé. Ce phénomène 
résulte de l’effet photothermique induit par un faisceau laser sur la surface du métal (l’or 
en l’occurrence) dans les conditions de SPR. Dans un premier temps, nous expliquerons ce 
phénomène particulier en nous basant sur des exemples tirés de la littérature. L’effet 
photothermique trouve notamment de potentielles applications dans les domaines des 
nanobiotechnologies et la médecine qui seront brièvement décrites pour en apprécier les 
potentialités. Le chauffage localisé assisté par le plasmon de surface peut également être 
très utile dans le champ des biocapteurs. Ainsi, cette approche sera explorée dans le cadre 
du présent projet. 
Tout d’abord, nous détaillerons la configuration instrumentale que ce concept 
nécessite. Par la suite, nous procéderons à l’exploration de l’approche qui repose sur le 
relargage contrôlé des espèces moléculaires et cellulaires préalablement immobilisées sur 
la biopuce. Cette stratégie est basée d’une part sur l’emploi d’un faisceau laser focalisé sur 
la surface d’or dont l’énergie est couplée aux plasmons de surface et d’autre part sur 
l’exploitation du caractère thermolabile du double brin d’ADN. Dans un premier temps, ce 
concept sera utilisé lors de tests à l’échelle moléculaire où l’optimisation des paramètres 
expérimentaux sera discutée. La spécificité de la désorption de différentes protéines sera 
confirmée par l’analyse en aval en spectrométrie de masse des échantillons relargués. Une 
fois la capture et le relargage des biomolécules mis en évidence, les résultats concernant 
des objets de taille micrométrique seront présentés. Nous observerons d’abord les résultats 
d’un test de désorption de microparticules capturées sur la surface de la biopuce et avant de 
discuter des résultats obtenus lors d’une étude similaire avec des cellules vivantes – les 
lymphocytes en l’occurrence. La réversibilité du système basée sur les propriétés 
intrinsèques de l’ADN sera également confirmée. Les cellules (ou les protéines selon le 
cas) pourront en effet être de nouveau immobilisées en des endroits où la matière aura été 
précédemment décrochée par le faisceau laser.  
 20 
 
21 
 
Résumé Chapitre 5 
Conclusions et perspectives 
Suite aux résultats obtenus dans le cadre de la présente thèse, nous présenterons les 
conclusions générales ainsi que les perspectives sur lesquelles ce travail peut finalement 
s’ouvrir. A travers ce projet nous avons développé une biopuce permettant d’effectuer une 
capture spécifique de lymphocytes et leur relargage subséquent suivi en temps réel. Cette 
étude propose ainsi un outil miniaturisé capable de réaliser un tri cellulaire à partir d’un 
mélange hétérogène de cellules. Ici, nous avons mis en évidence une séparation de 
lymphocytes B et T qui ont été spécifiquement répartis sur la surface de la biopuce selon 
un montage moléculaire particulier. En effet, les cellules ont été adressées sur une matrice 
d’ADN via une reconnaissance avec des anticorps spécifiques aux lymphocytes conjugués 
avec les oligonucléotides. Par la suite le relargage des cellules ciblées a été réalisé selon 
deux stratégies indépendantes.   
Premièrement, nous avons démontré que les différentes cibles immobilisées sur la 
surface peuvent être décrochées sélectivement par des enzymes de restriction. La multitude 
de séquences d’oligonucléotides associées à des endonucleases différentes ouvre la 
possibilité d’élargir la désorption sur plusieurs cibles. Néanmoins, l’extension de ce 
système peut engendrer l’augmentation des coûts ainsi qu’entraîner un risque de réactivité 
croisée. Une deuxième méthode pouvant servir à un tri sélectif de cellules a été également 
développée. Elle consiste à une désorption depuis la surface basée sur les propriétés  
thermolabiles du double brin d’ADN. Cette stratégie est donc plus directe et peut 
également être étendue en utilisant des substrats d’ADN avec un équilibre 
thermodynamique différent (e.g. mutations ponctuelles, séquences de différentes 
longueurs). Cette deuxième approche nécessite toutefois l’utilisation d’une configuration 
instrumentale sophistiquée qui comprend l’optique SPRi, une source laser ainsi qu’un 
système de pilotage du faisceau laser. Dans le cadre du futur développement de ce 
dispositif expérimental, le laser travaillant en mode continu pourra être  remplacé par un 
laser pulsé et mis en place de façon à pouvoir réaliser simultanément les étapes du 
décrochage et de la détection.  
Les deux méthodologies proposées par le présent travail offrent plusieurs avantages 
sur le plan de la réalisation d’un tri cellulaire. Elles reposent sur la reconnaissance 
spécifique de cellules qui sont adressées sur la surface grâce à des anticorps pour être 
ensuite libérées de façon contrôlée par clivage enzymatique ou chauffage localisé. Toutes 
les étapes sont réalisées dans le format d’une microplateforme basée sur une matrice 
d’ADN et des molécules conjuguées IgG-ADN. L’assemblage particulier sur puce permet 
la régénération et l’utilisation de la matrice originelle de nouveau. En outre, le système est 
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accompagné par la détection en temps réel et sans marquage. Ceci n’implique pas d’étape 
de prétraitement de l’échantillon contrairement à des méthodes de laboratoire utilisées en 
routine comme par exemple FACS® ou MACS®, et offre ainsi l’opportunité de travailler 
avec des échantillons cellulaires bruts.   
L’étude réalisée dans le cadre de cette thèse nous mène à de potentielles 
applications dans les domaines de la recherche et du diagnostic. En effet,  le système de 
biopuce que nous proposons permet de réaliser un tri des cellules sanguines qui ouvre des 
perspectives d’études plus poussées sur une population des cellules du sang bien définie 
(e.g. lymphocytes d’un phénotype particulier). Ceci consiste ainsi en une brique 
élémentaire de la recherche avancée dans le champ de l’immunologie humaine qui 
permettrait d’avoir un aperçu plus large sur les complexes mécanismes de l’immunité (lors 
d’infection ou de cancer, rejet de greffe ou maladies auto-immunes). Les études 
fonctionnelles des lymphocytes du même type (l’activité sécrétrice) ou les investigations 
sous l’angle protéomique et transcriptomique concernant une famille individuelle de 
lymphocytes pourront ouvrir des nouvelles voies de développement thérapeutique (e.g. 
nouveaux vaccins) et du monitoring médical (e.g. suivi de marqueurs cancéreux, de l’effet 
des drogues).  
Dans ce domaine, une approche permettant d’étudier une cellule individuelle est 
extrêmement intéressante. En perspective, nous présenterons ainsi des études préliminaires 
qui ont déjà permis de capturer des lymphocytes individuels dans un micropore 
fonctionnalisé selon le montage moléculaire développé par ce travail de thèse. Cette 
méthodologie exige néanmoins des étapes d’optimisation qui feront l’objet de travaux 
réalisés dans un proche avenir. 
23 
 
Résumé Chapitre 6 
Partie expérimentale 
Ce chapitre constituera la partie expérimentale du présent travail de thèse. Elle 
détaillera tous les aspects de l’expérimentation qui ont fait l’objet des chapitres précédents. 
Une liste exhaustive des réactifs sera ainsi présentée comprenant les séquences 
d’oligonucléotides, les anticorps et autres protéines, les tampons utilisés ainsi que les 
échantillons cellulaires testés. Par la suite, le lecteur aura connaissance de protocoles 
expérimentaux concernant différentes étapes de l’expérimentation mentionnées dans le 
corps du présent manuscrit : fabrication de puce à ADN, couplage et purification de l’IgG-
oligonucleotide, validation des produits conjugués par test d’immunofluorescence, 
préparation des échantillons (microparticules, lymphocytes, bactéries), capture et relargage 
par clivage enzymatique et par l’effet photothermique, analyse en spectrométrie de masse. 
La description détaillée des procédures expérimentales permettra de mieux comprendre les 
résultats obtenus ainsi que leur éventuelle reproduction dans le futur. 
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At the beginning of the present PhD thesis, the reader will be introduced to the 
general scientific context that lays a motivation for the given work. Firstly, the complexity 
of a biological specimen will be stated by giving the example of blood sample. 
Significance of profound analysis of this particular sample will be stressed in terms of its 
utility not only for clinical diagnostics but also for research purposes. A special attention 
will be focused on studies carried out on complex processes of the immunological response 
that are of a great interest in the field of biological and medical sciences. Natural 
complexity of immune defense mechanisms makes such studies difficult and we therefore 
need novel high-throughput methods guaranteeing a wider insight. Exhaustive 
investigations of immune response phenomena can drive to better understanding of various 
processes that human body is involved in (e.g. infections, cancer) and thus help to improve 
existing methods of treatment and elaborate new medicines or vaccines. An important step 
in acquiring new knowledge on the functionality of different immune cells consists in the 
efficient out-of-sample extraction of lymphocytes implied in the immunological response. 
This approach enables profound investigation at the specific cell population level.  
Several methods of cell sorting from heterogeneous samples have been used for 
many years but they frequently imply considerable sample volumes, preparation steps, 
long-time analysis or non-negligible costs. I will thus make an overview of existing cell 
analysis and sorting methods, giving the purpose to engineer new and efficient devices. In 
this matter, recent achievements in the field of microtechnologies arise as a solution in the 
construction of new tools for cell sorting purposes. Such microfluidic platforms or lab-on-
a-chip systems remain more interesting because of their attractive features represented by 
rapidity, precise control of microenvironment, analysis parallelization, multiplexed 
detection and finally tiny quantity of biological material needed. Therefore, the present 
manuscript will describe the development of such exemplary micro-device capable of 
specific isolation and sorting of B and T lymphocytes. The proposed biochip shall be thus 
explored as a potential tool for advanced research or medical diagnostics. 
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Figure 1.1 Flowchart of the introduction chapter 
1.1 BLOOD SAMPLE DIAGNOSTICS 
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1.1 Blood sample diagnostics 
Common biological samples such as blood or biopsy specimen are extracted from 
living organisms as heterogeneous mixtures composed of various molecular and cellular 
components. Their qualitative and quantitative assessment is of great importance in the 
field of clinical diagnostics and basic biological research. Among many examples of 
biological extracts, human blood represents a specimen of prime interest for medical and 
scientific applications. Indeed, it is an essential source of extremely important information 
concerning the functioning of the whole organism. As we all know, thanks to heart and 
blood vessels this life-sustaining fluid circulates throughout the body in order to deliver 
oxygen and nutritional elements to all cells structuring an organism. Among many 
important functions, blood flow enables also an efficient transport of metabolism 
substances produced by different organs to other tissues where they might be consumed 
(e.g. glucose in brain) or removed from the body (assisted by lungs, kidney or liver).  
Moreover, blood plays an essential role in human immune defense since it provides 
distribution of the immune cells to different anatomical compartments where they might 
produce specific immune responses or provide immuno-surveillance function. That is why, 
a quantitative and qualitative analysis of blood sample is needed to access many elements 
conditioning a patient’s state (pathological or not). Monitoring of blood component 
concentration (cells, molecular entities) gives us the essential data concerning numerous 
diseases and is of great importance for both medical and research purposes.  
 
 
Figure 1.2 Main functions of blood in a human organism 
 
The numerous functions of blood make this tissue an extremely rich source of 
clinical and scientific information. The blood sample consists of two main fractions: live 
cells and plasma. The latter one is a water-based mixture containing various molecular 
items such as antibodies, hormones or glucose and is considered as the largest 
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representation of the human proteome.1 Furthermore, whole blood volume is almost in a 
half composed of cells predominating in erythrocytes (red blood cells - RBC) 
complemented by reticulocytes (immature RBCs), thrombocytes (platelets) and white 
blood cells (WBCs) of different kind (leukocytes). Classical approach for blood sampling 
relies on assessment of standard diagnostic parameters such as hemoglobin level, leukocyte 
count or biochemical profile (e.g. cholesterol level, hormones). However, currently 
employed techniques of blood sample preparation are usually time- and sample-
consuming, and require laborious preparations. That is why, novel technological solutions 
are being developed in order to provide high-throughput analysis in shorter time (several 
minutes) and starting from barely few microlitres of a sample.  
 
 
Figure 1.3 Composition of cellular fraction in healthy blood. The images adapted from 
www.sciencephoto.com and the table issued from Toner et al. 2 
 
Over the last few years, a considerable progress in the field of blood sampling 
microsystems is made and prone to revolutionize the world of laboratory diagnostics, by 
introducing in the near future “point-of-care” devices (available immediately at the site of 
patient care).2-4 Among many potential candidates for such microsystems, we can point out 
e.g. a microfluidic biochip capable of rapid blood typing,5 a micro-platform providing in 
situ profiling of plasma proteins6, 7 or a lab-on-a-chip system that enables fast and 
simultaneous assessment of the hematocrit (erythrocyte volume fraction) and plasma 
protein profile.8  In terms of blood sample preparation for diagnostics, an interesting study 
by E. Sollier (CEA Grenoble/LETI, France) explores new microfluidic solutions allowing 
efficient isolation of blood plasma from cellular components.9 All these examples represent 
an energetically developing domain that aims to conceive novel blood sampling 
technologies able to rapidly furnish the most important diagnostic parameters. Apart from 
giving a deep insight into physiological or pathological state of the examined patient, these 
data may be helpful to clarify functional aspects of blood (e.g. immunological function) 
and thus are attractive for scientific research as well.  
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1.2 Blood cell samples in the scientific research scope 
Profound analysis of blood sample components is a crucial point not only for 
clinical needs but may also serve to understand different physiological mechanisms, 
especially those involving blood cells. That is why cell-based blood sampling is naturally 
desired for research purposes. Isolation of pure fractions containing well-defined cell 
populations is of particular interest but constitutes a challenging approach if large diversity 
of blood cells and disproportionate cellular content in whole blood are taken into account. 
In fact, a normal blood sample is composed of a predominant fraction represented by 
erythrocytes. Although RBC examination is precious from the biomedical point of view 
(evaluation of the hematocrit, hemoglobin level or blood group typing), the erythrocyte 
physiology is not widely explored in the scientific research. In this matter, more fruitful is 
to assay white blood cells that are responsible for the functionality of the human immune 
defense characterized by a complex nature. 
 
 
 
 
 
Figure 1.4 Exploration of the blood sample for diagnostic purposes (red-framed boxes) and biological 
research (green-framed boxes).  
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Analytic strategies aiming to interrogate white blood cells may appear problematic 
if we consider the fact that leukocytes represent only a small fraction of the total cell 
number in whole blood. Furthermore, an extremely challenging approach is to provide an 
exclusive examination of the lymphocyte fraction (less than 0.1 % of whole blood), 
especially because lymphocytes are themselves divided into several subpopulations. Since 
they play a major role in the adaptive immune response and their participation in 
immunologic defense processes is complex, these studies are of great interest for modern 
immunology and appoint main motivation of the present PhD work. Efficient isolation and 
characterization of lymphocytes of a precise phenotype may open up new horizons for 
more exhaustive studies on immune functionality at the level of well-defined cell 
populations. In the following section, we will therefore discuss the significance of 
profound studies on immune response phenomenon, mainly justified by its complex 
character still not integrally discovered. 
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1.3 Exploration of immune defense phenomena 
The immunologic system is undoubtedly of great importance for a living unit since 
it plays an essential role in protecting host organism from a whole gamut of pathogens 
ranging from viruses and bacteria to infectious fungi and parasites. It is also responsible for 
responding in presence of foreign molecules (e.g. some vaccines), tumor cells or even own 
antigens (autoimmunity disorders). Human defense consists in biochemical or cellular 
mechanisms mediated by early reactions of the innate (natural) immune system or later 
responses generated by the adaptive immune system acquired over time.10 These reactions 
are provided by different molecules (e.g. cytokines, antibodies) and cells of various types 
(leukocytes). The innate immune system provides an early line of defense against microbes 
and is based on recognition of common pathogen features (thanks to receptors encoded in a 
germline). Although these natural mechanisms are executed rapidly, they act in essentially 
the same way and may be evaded by many pathogenic elements. Hence, each human 
organism benefits from the adaptive immunity reactions that provide protection from a 
constant barrage of potentially large variety of pathogens. 
The key elements of adaptive immune system are different populations of B and T 
lymphocytes. These immune cells are able to recognize and distinguish a large spectrum of 
antigens. Such particular ability lays the foundation for two main features of the immune 
response: specificity (high affinity to precise antigen) and memory (rapid response to 
formerly encountered antigen). The functionality of lymphocytes is based on an extensive 
outfit of cell surface receptors (B cell receptors, or BCRs; T cell receptors, or TCRs) 
providing characteristic response to an antigenic determinant. The cellular membranes 
within different lymphocyte populations are decorated with an incredible diversity of 
receptors. Unlike other leukocytes, B and T lymphocytes bear distinct cell receptors which 
result from somatic recombination of receptor gene segments.11 The adaptive immunity 
reactions are thus enabled by a large total repertoire of receptors that can virtually 
recognize any antigen. Complex nature of the immunological system is thus exemplified 
by wide molecular diversity of antibodies and T-cell receptors which reflect a multitude of 
mutual dependences and interconnections (e.g. signaling by cytokine network, cf. Fig.1.5). 
Furthermore, circulating lymphocytes may be divided into several subclasses characterized 
by a specific set of cell surface molecules identified as cluster of differentiation (CD). 
Presence of this distinct surface marker depends on the function of a single lymphocyte 
(e.g. cytotoxic CD8+, helper CD4+), its differentiation state (e.g. naïve, memory) and even 
housing tissue (e.g. spleen, blood, thymus). Hence, such large diversity helps to imagine 
how multifaceted immune response process may be and evokes an unquestionable need for 
deep understanding of immunity mechanisms.   
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The recent years have brought many important advances in the field of immunology 
and point out the usefulness of research in this area in spite of funding challenges in 
different countries.12-14 For 2011, the National Institutes of Health (NIH) provided almost 
$13 billion of financial support for research related to immunology which is more than for 
the general clinical research ($11 billion).15 The main research scopes are therefore 
focused on better understanding of such processes like infections (including emerging 
infectious diseases e.g. pandemic influenza virus H1N1), autoimmunity or transplant 
rejection phenomena16 as well as on development of new therapeutic vaccines (AIDS, 
cancer)17 and discovery of new immunological biomarkers.18 Different immunity 
phenomena can be studied by classical techniques or advanced high-throughput 
technologies recently reported. 
 
 
 
 
Figure 1.5 Complexity of the immune response process on the example of cytokine network. Different 
immune cells mutually communicate by secreted cytokines (e.g. interleukins ILs or interferons IFNs) acting 
in networks or cascades. Image adapted from QIAGEN GmbH (www.qiagen.com).  
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As conventional methods used for assessment of immune response, two approaches 
of different level of study can be generally discerned: molecular and cellular (cf. Table 
1.1). The first of the mentioned strategies makes use of standard biochemical techniques of 
immunoassaying based on antibody titration to an antigen of interest. Classical ELISA 
(Enzyme-Linked Immunosorbent Assay), Electro-ChemiLuminescence (ECL) 
immunoassay19 or recently developed immuno-PCR (Imperacer®)20 can be here 
enumerated as exemplary methods. By dint of these methodologies, antibody-antigen 
recognition events can be detected, given by colorimetric read-out (ELISA), electric 
energy transfer (ECL) or, as the most efficient, exponential amplification of DNA in 
immuno-PCR approach.21 The second family of currently employed immuno-methods is 
directly founded upon lymphocyte assays and aims the detection of cell specific secretions 
(antibodies or cytokines) that are generated during immune or inflammatory responses. 
ELISPOT is a flagship technique developed by C. Czerkinsky and inspired from ELISA 
test that enables indeed to measure single cytokine or antibody produced by T or B cells, 
respectively.22, 23 In order to assess multiple cytokines expressed by T lymphocytes, an 
intracellular staining approach (ICS) can be put into action. This method exploits flow 
cytometry technique to detect intracytoplasmatic cytokines produced in permeabilized 
cells.24, 25 Even if such approach provides multiple detection of immunologically involved 
molecules, it is however harmful for physiological integrity of cells that are eventually 
submitted to death. As an alternative, whole living lymphocytes of a particular 
functionality may be characterized by means of fluorescence- or magnetic-activated flow 
cytometry (FACS or MACS) according to secreted cytokine or expressed antibody.26, 27  
The spectrum of the above specified methods for immunological investigation is 
based on end-point analyses which give only punctual data related to secretory activity of 
assayed lymphocytes. Indeed, conventional immunoassays such as ELISPOT or ICS are 
able to interrogate only a subset of lymphocytes thus providing only partial immunological 
information. Immunity mechanisms involve though many different molecules and/or cells 
and therefore need thorough characterization at a larger scale. Taking into account the 
heterogeneity of lymphocyte populations and the possible interdependence of their 
functional properties, new high-performance immunoassays providing a wide insight into 
human immunity aspects need to be established. This goal might be achieved by the 
development of miniaturized devices that emerge as versatile tools to conduct fast and 
multiplexed studies on different lymphocyte populations.  
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Technique Performance Features 
molecular level (antibody-antigen titration) 
ELISA colorimetric read-out of 
immunorecognition 
- end-point analysis 
- punctual data, limited 
immuno-information  
ECL19 
electro-chemiluminescence 
signal upon antigen-antibody 
interaction 
Immuno-PCR20 DNA amplification 
lymphocyte level (secretory activity) 
ELISPOT22, 23 detection of single antibody  (B cell) or cytokine (T cell) 
- qualitative information 
(number of secreting cells) 
- single cytokine/antibody 
assayed within one assay 
ICS24, 25 detection of intracytoplasmatic 
cytokines 
- cell permeabilization 
- loss of cell integrity 
FACS®26 
fluorescence or magnetic 
detection of secreted cytokine 
or expressed antibody 
- need for pre-labeling of a 
cellular sample  
- limited amount of 
fluorescence or magnetic 
tags 
MACS®27 
immunoassays at a micro-scale 
microarray 
immunofluorescence read-out 
of T-cell secretory activity28, 29 - high-throughput assay 
- multiparametric detection 
of several antibodies or 
secreted cytokines 
- real-time detection (SPR) 
- possibility of single-cell 
assaying 
biochip combined with SPR real-time detection of 
cytokines30, 31 
microfluidic platform 
simultaneous detection of 
several secretory products32 
single-cell immunoassay 
B-cell immunoassay33, 34 
T-cell immunoassay35, 36 
 
Table 1.1 Tools for immunological examination used in biological and clinical research 
 
 
Recent review by Reddy and Georgiou reports on up-to-date advances in the field 
of high-throughput technologies amenable to studying adaptive immunity processes.37 
Microscale platforms are stated as an attractive opportunity to realize detailed and 
quantitative characterization of lymphocyte functional properties (e.g. secretory activity), 
up to acquisition of deep information at proteomic (e.g. serological profiling) or genomic 
(e.g. sequencing of immune repertoires) level. For example, with help of antibodies 
specific to lymphocyte membrane markers or to immune secreted proteins, the secretory 
activity of a well-specified subset of lymphocytes can be detected.28, 29 Knowing that 
lymphocyte functional activity may be altered in relation to changing cell environment, a 
1.3 EXPLORATION OF IMMUNE DEFENSE PHENOMENA 
37 
 
more attractive strategy is to follow kinetics of cytokine or antibody production by immune 
cells. Such solution offers rich and time-resolved information concerning immune response 
and generated in presence of a mitogenic agent or defined pathogen. A potentially useful 
tool capable of monitoring molecular38, 39 or cellular40 interactions in real time is 
represented by techniques based on optical phenomenon of surface plasmon resonance 
(SPR). Indeed, some groups report that label-free SPR-based analysis may be applied to 
explore immune responses in a continuous way, e.g. by monitoring lymphocyte secretions: 
B lymphocytes antibodies30 and cytokines (e.g. interferon) produced by T-type 
lymphocytes.31 In this matter, further step is to provide similar studies at single cell level 
which may open up to novel opportunities for detailed characterization of immune cell 
effector function.33-36 
In conclusion, the understanding of immunological phenomena at a greater 
resolution is extremely attractive not only for research purposes but also from a biomedical 
point of view. Among various applications, detailed and quantitative immunologic 
monitoring leads to reliable assessment of humoral and cell-mediated immunity and is a 
crucial element of efficient immunotherapy.16, 17, 41 High-throughput microscale platforms 
are considered as versatile tools for clinical assays. Microdevice approach enables high-
informative evaluation of immune response provided by all individual subsets of 
lymphocytes. Furthermore, recent findings evidence that T lymphocytes result in 
production of heterogeneous response in terms of secreted cytokines, even if they represent 
similar T cell phenotype.32 It proves therefore how intricate immune cell responses are and 
gives motivation for exhaustive investigations of well-defined lymphocyte populations. 
Taking into account complexity of blood sample as well as phenotypical and functional 
diversity of lymphocytes, we thus need efficient techniques to extract an exclusive 
lymphocyte family in order to realize downstream analyses. The approach of that kind will 
certainly lead to a more comprehensive insight into fundamental aspects of the human 
immunology.  
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1.4 Cell sorting methods 
Taking into consideration the aforementioned statement, one may realize that 
development of reliable cell sorting methods is of great demand when willing to extract 
individual cellular subsets from a heterogeneous biological sample. Such approach needs 
to rise to a few important challenges such as extreme diversity of blood cells (even 
lymphocytes themselves) and their responsive character to the surrounding environment. 
Cell sorting should fulfill the requirement of precise control of a cell microenvironment 
and finally result in recovery of a cell sample of high purity. Even if these conditions seem 
to be demanding, this particular need for conception of reliable cell sorting methodology 
becomes a leading objective of the present PhD work where alternative strategies to 
various existing methods are proposed. That is why this section makes an overview of cell 
sorting approaches currently being developed as well as those widely employed for 
scientific or clinical purposes.  
The cell sorting procedure is frequently an integral element of basic biological 
research, advanced biotechnology and biomedical applications. As a cell sorting technique, 
it may be considered a procedure that allows the obtention of defined cell subpopulations 
from a heterogeneous sample and according to cell physicochemical, morphological or 
physiological properties.42 This analytical strategy results in separation, isolation or 
enrichment of a specific cell type and meets the requirements of several essential 
applications such as screening at genetic or proteomic level as well as further investigation 
on a purified cell sample (e.g. immunoassays). In general, cell sorting methods rely on the 
individual characteristics of cells founded on parameters of mechanical nature (e.g. 
density, size), reaction to the external environment (electrical, magnetic or optical 
stimulus) and more specifically on adhesion aptitude specific to each cell type (e.g. 
immunoaffinity). Conventional filtration or centrifugation methods, based on cell size or 
density are frequently used in standard research or biomedical protocols. They require 
however large scale sampling and are therefore inappropriate for small volume samples 
and with a narrow distribution of cell size. Other commonly employed methods rely on 
flow cytometry approach combined with fluorescence (FACS) or magnetic (MACS) 
activation of a cellular sample.27 These analytical strategies often need laborious pre-
processing of specimens and the analysis itself is costly and time-consuming. Hence, 
recent progress in the development of miniaturized systems could bring new technological 
solutions to efficient separation of cellular samples. 
Cell-based system miniaturization has recently emerged as an energetically 
evolving concept of efficient bioanalytic tools that may be widely applied for modern cell 
biology goals.43 Miniaturized platforms offer numerous possibilities of multifunctional 
analysis of cellular sample such as cultivation in controlled conditions, monitoring of 
metabolism and secretory activity up to cell counting and separation to defined subsets. In 
the last years several reviews appeared and revealed multifaceted usefulness of 
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microdevices in the field of cellomics – high-throughput studies of cells.43-45 “Lab-on-a-
chip” (LOC) systems have several advantages which are also attractive in the development 
of micro-technologies for cell sorting. Apart from reducing cost and time input, other 
benefits can be listed such as precisely controlled microenvironment, gentle handling of 
cellular samples and multiparametric sampling which provides analysis of complex 
biological specimens. Taking into account recent expansion of studies on novel micro-
scale cell sorting technologies, I herein propose a short overview of available 
methodologies, accompanied by adequate literature references where detailed information 
can be found. 
The first family of microdevices capable of cell sorting is founded on physical 
separation events as an analogy to classical filtration, sedimentation and centrifugation 
methods. Functionality of such systems is mainly related to size and density that 
differentiate targeted cells from the others. Microtools of this type are exemplified by 
microfabricated filters capable of mechanical cell trapping46 or microstructured fluidic 
channels where selective sorting results from hydrodynamic flow conditions.47 Kim et al. 
give a wide insight into microfluidic devices of various geometries resulting in a set of 
different mechanical constrains exercised on cells and potentially deployed in the 
separation approach.48 Physical-based cell sorting methodologies are however limited to 
morphological discrimination and are not suitable to precisely separate cells of similar 
physical parameters (e.g. B lymphocytes versus T lymphocytes).  
In order to increase the level of precision in the separation of well-defined cell 
subsets, we may benefit from inherent reactivity of living cells to external manipulation of 
physical or chemical nature. One possible solution is to impose an electric stimulus being 
relatively easy to produce in micro-scale devices within microfabricated electrodes. The 
difference of the electric potential applied between two electrodes may create localized and 
switchable traps for cell sorting purposes. It can be realized by an electro-osmotic flow of 
charged cellular entities within a microchannel49, 50 or dynamic dielectrophoresis (DEP) 
when application of an external electric field results in generation of polarized particles.51 
The electro-osmosis approach has however limited use in separation of several cells 
because most of them have similar electrophoretic mobility. DEP appears as a more 
practical solution since it allows the separation of different biological cells in microfluidic 
or microchip devices. This method is reported as a cell friendly separation technique and 
can be potentially employed for effective enrichment of rare cells.52 
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Figure 1.6 Development of microdevices devoted to cell sorting purposes.  
A) Multitarget microMACS system. Magnetically tagged cells are sorted from a continuous flow by applying 
magnetic fields at the level of microfabricated magnetic strips (MFS);53 B) Ephesia system developed by 
Saliba et al. Cells of interest are sorted from the microfluidic flow onto magnetic microbead columns covered 
by a specific antibody;54 C) Microarray composed of individual dielectrophoretic (DEP)  traps devoted to cell 
sorting and imaging;51 D) Micro-scale optical tweezers. Cells are optically trapped from a microfluidic 
channel on a set of microlenses;55 E) MicroFACS platform capable of separation at single cell level. 
Fluorescent cells are excited by a laser light guided through a microfluidic channel and manipulated at the 
sorting junction by a piezoelectric actuator (PZT);56 F) Lymphocyte capture into individual microwells 
coated with poly-L-lysine (PLL);57 G) Capture and release of cardiac fibroblasts on peptide-modified alginate 
gel in a microfluidic channel;58 H) Spatial separation of lymphocytes onto an antibody microarray – within 
DNA-directed immobilization (DDI);59 I) Isolation of circulating tumor cells (CTC) on antibody-covered 
microposts coupled to a microfluidic device.60 
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Another group of stimuli-based cell sorting methods consists in the manipulation of 
cell microenvironment by an external magnetic field. This strategy can be readily 
employed in microsystems since it does not require high power input and ensures 
biocompatibility with living cells.61 As an example, the cell sorting task may be 
accomplished in a rapid and label-free manner by using ferrofluids being colloidal 
suspensions of ferrite nanoparticles. Application of a magnetic gradient within the 
microchannel enables therefore efficient separation of different cells driven by differences 
in their velocity.62 A more frequent approach takes advantage of magnetic-activated cell 
sorting (MACS) realized in miniaturized format. MicroMACS strategy involves 
preliminary conjugation of cells with magnetic tags which are subsequently introduced to 
microfluidic chip where separated upon magnetic field gradient.53, 63, 64 Target cells are 
tagged by magnetic particles (having different magnetic properties for multiple target 
sorting) coated with a cell-specific antibody. The use of non-modified cellular targets is 
however more attractive since it allows sampling of crude biological extract. Accordingly, 
Saliba et al. propose a particular cell sorting method called Ephesia which provides the 
separation of a desired cell type directly on microarray by the means of magnetically 
induced anchors (micro-bead columns) covered by cell-specific antibodies.54  
Apart from application of electric or magnetic field, some other physical stimuli 
may be deployed to perform cell sorting in biological samples. An intriguing solution is 
represented by acoustic stimulation capable of cell trapping and transporting throughout 
microfluidic channel submitted to ultrasound fields.65, 66 Other more practical possibilities 
of cell micro-manipulation are ascribed to optical forces.67 Sorting tasks may be thus 
accomplished for example by using microscale optical tweezers – focused laser beam 
providing attractive or repulsive forces. This strategy can be illustrated by a sophisticated 
optical microsystem relying on set of silica microlenses arranged on a chip.55 Application 
of a laser focused by each microlens generates multiple optical tweezers creating a 
steerable optical trap capable of cell capture from microfluidic channel. Analogically to 
large-scale cell sorting tool based on classical flow cytometry assisted by fluorescence 
read-out (FACS), microfabrication also opens an opportunity to realize similar protocols in 
devices of miniaturized format. Indeed, microfluidic geometry may provide a robust 
strategy based on optically mediated sorting on microchannel junctions.68, 69 An example of 
highly developed Lab-on-a-chip FACS system is given by Cho et al.56 They report on an 
integrated microfluidic device capable of single cell level separation provided by a 
piezoelectric actuator installed at the sorting junction. High-speed response generated by 
the piezoelectric module as well as an excitation light guided along microfluidic channel 
makes this microFACS system a versatile tool for high-throughput cell sorting, particularly 
interesting for rare cell enrichment.  
Although the aforementioned methods offer large spectrum of potential 
applications for cell sorting purposes, microdevices of this type require the integration of 
microstructured chip or channels with external manipulation or detection modules made of 
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optical, electronic or magnetic elements. They are also less flexible regarding to 
multiplexed sampling and in some cases need preliminary preparation of cellular sample 
involving photo- or magneto-sensitive labels (µFACS and µMACS).  That is why a 
definitely more attractive strategy is to conceive microsystems based on adhesive surfaces 
modified with ligands specific to each cell type.70  
Hence, sorting of living cells of an exclusive type from a complex sample may be 
achieved in a label-free manner based on proper biomolecular interactions. This strategy is 
achieved by immobilization of specific ligands on localized surfaces. A flagship model of 
cell-ligand interaction is represented by recognition of cell surface biomarker by a 
molecule of specific antibody. When separating biological cells, we can thus benefit from a 
great diversity of the cell membrane decoration proper to each cellular type. One of the 
first examples of cell separation founded on binding to antibody was proposed by Wysocki 
et al. as an efficient procedure to isolate B lymphocytes from a heterogeneous mixture.71 
However since miniaturization has entered the field of analytics, development of 
immunorecognition-based systems for separation and enrichment of cellular samples has 
gained impetus. Antibody micro-patterns are explored as effective cytometry platforms 
capable of selective cell sorting to predetermined chip localizations.59, 72 They have been 
reported to efficiently trap rare cells from complex medium as it was demonstrated on 
example of circulating tumor cells (CTC) in whole blood.60 Selective cell isolation on well-
defined regions of a microfluidic channel surface may be also achieved with other adhesive 
molecules. Indeed, different cells are reported to express a certain level of affinity with 
such substrates like peptides73 or even DNA-aptamers74 which can be successfully 
employed to isolate biological cells from microfluidic flow.  
As we can see, the miniaturization of cell-based bioanalytic systems creates a wide 
field for development of efficient and poorly invasive procedures for cell sorting purposes. 
The example of high-throughput devices might be particularly assigned to strategies of 
specific cell adsorption realized in a micro-array format. By dint of parallelized proper 
interactions with cells, these systems provide spatial organization of a few cellular targets 
on high-density arrays. Furthermore, once the cell micropatterning has been accomplished, 
target cells may be subsequently released from the surface by using selective 
biocompatible methods.57, 75, 76 Such approach permits to obtain fractions of individual cell 
subsets from a heterogeneous biological sample. The isolated well-defined populations of 
immune cells may be potentially submitted to downstream analysis in order to provide 
better understanding of complex immunologic processes. This particular concept of 
specific on chip cell sorting and subsequent release makes object of the present PhD 
project. 
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1.5 Presentation of the PhD project 
This work is motivated by the fact that the immune response is an extremely 
complex biological process and isolation of specified population of lymphocytes remains a 
challenging step of sample exploration. That is why, the present PhD thesis is devoted to 
the development of an alternative methodology providing an efficient sampling of 
lymphocyte mixture in a biochip format. The main goal is to enable SPECIFIC 
CAPTURE of phenotypically different immune cells and their SUBSEQUENT 
RELEASE under spatio-temporal control. This approach aims to perform the cell 
sorting task at a microscale and thus generate isolated fractions of individual subsets 
of lymphocytes prone to become an object of further analyses. Similar studies could 
offer a priceless insight into various immunological mechanisms at molecular or cellular 
level and are of great interest for clinical and research purposes. 
More precisely, we herein explore two different strategies leading to cell-specific 
separation of B and T primary lymphocytes. A cell-based miniaturized tool is developed to 
ensure addressing of defined B and T lymphocytes onto a DNA microarray. By means of 
hybrid molecules composed of short DNA oligomers combined with lymphocyte-specific 
antibodies, cells are sorted into spatially resolved locations of the functional matrix. In a 
further step, we realize orthogonal release of thus captured cells which sequential 
desorption potentially leads to obtain isolated fractions of B and T cell populations. To 
achieve this final goal, two independent strategies are put forward and based on a proper 
molecular assembly built on the biochip surface. Both of the developed approaches take 
advantage of intrinsic properties of the DNA substrate underlaying lymphocytes 
immobilized by dint of specified antibodies. The first of proposed strategies makes use of 
restriction enzymes capable of highly effective recognition of an exclusive nucleic acid 
sequences and subsequent cleavage to separate fragments.  The latter concept of controlled 
release is driven by straightforward melting of the double stranded DNA generated by 
locally confined heating and produced by an external laser source. Both of the explored 
methodologies benefit from label-free detection provided by Surface Plasmon Resonance 
Imaging (SPRi). The technique here employed enables therefore a real-time monitoring of 
molecular and cell-involving phenomena that take place in the vicinity of the biochip 
surface.  
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Figure 1.7 Schematic representation of the two strategies developed by the present PhD thesis. Lymphocytes 
are immobilized on a DNA biochip via specific antibody combined with a DNA complementary strand. Cell 
sorting task is accomplished either through local heating induced by a laser beam (on the left) or enzymatic 
digestion (on the right).  
 
 
 
 
The reported study requires evaluation of different elements that are explicitly 
introduced within the body of the present manuscript.  It thus comprises: adaptation of 
chemistry for biochip functionalization, elaboration and optimization of both proposed 
release strategies, accommodation of experimental conditions to work with living cells and 
finally configuration of necessary instrumental set-up. The reader may easily remark that 
this work is focused on different aspects corresponding to various domains of competences 
ranging from biomolecular engineering, cell sample handling up to optical physics. In 
order to provide high level of presentation clarity, I decided to introduce all necessary 
information accompanied by adequate bibliographic references along with discussed 
results and throughout the given manuscript. I hope this composition will clearly guide the 
reader to comprehensive understanding of the reported work. 
 45 
 
 
 
 
Chapter 2 Conception of the 
biochip molecular assembly 
Conception of the biochip 
molecular assembly 
 
 46 
 
2.1 INTRODUCTION 
47 
 
2.1 Introduction 
2.1.1 Specific capture and controlled release methodology in a micro-scale 
This chapter is essentially devoted to explore the molecular aspects of the biochip 
system construction which constitutes a basic issue of the biosensor functionality exploited 
in the present work. The objective is to propose a biosensing surface capable of selective 
immobilization of cells and their sequential release. Such achievement would fulfill the 
need of novel methodologies ensuring controlled cell capture and desorption steps in one 
single micro-scale device. Though, an important issue related to this development is to 
provide optimal operating conditions deprived of extensive physical or chemical 
perturbations that may possibly influence the live cell viability. The target cell 
immobilization in a microarray or microfluidic format can be achieved by cell-adhesive 
surfaces of several types frequently reported in the scientific literature. Ones can be 
therefore directed by the cell-specific biomolecules like for instance proteins of 
extracellular matrix (e.g. fibronectin),77, 78 specific antibodies,29, 79 peptides,73, 80 aptamers74, 
81
 or even DNA if using cells tagged with complementary strand.82, 83 Consequently, live 
cells trapped on a solid substrate may be released from their microenvironment and thus 
achieve the final goal of such biosystem ranging from fundamental research to advanced 
diagnostic applications. Straightforward methods of cell detachment may be exemplified 
by enzymatic digestion of binding protein (e.g. by using trypsin treatment),76 direct cell 
removal by optical forces,84 micromanipulation,85 microfluidic shear forces,86, 87 or even in 
situ cell lysis if further determination of genomic/proteomic characteristics is needed.60 
Nevertheless, when developing new cell sorting strategies, the key point is to realize 
spatio-temporal control of capture/release steps under physiological conditions. It is 
particularly advisable to ensure the cell integrity before running downstream analyses. To 
attain these goals, multiple strategies are proposed in the literature and their short overview 
is hereafter presented. These methodologies may find an application in micro-scale tunable 
devices providing an efficient capture of living cells and their subsequent recovery with 
possibly minimal perturbation for cell viability and functionality.  
When engineering remotely tunable biomaterials, a great challenge is to ensure 
precise control of adhesive properties between the developed substrate and a cellular 
sample. In order to allow controlled attachment and detachment of naturally adhesive or 
non-adhesive cells, leading development is focused on the design of specific molecular 
motifs incorporated in the biosensing solid support.88, 89 Different chemistries are therefore 
worked out to generate stimuli-responsive surfaces that are or may be subsequently 
deployed for cell release. One of the solution found in the scientific literature is to perform 
spatially controlled cell desorption from antibody-modified self assembled monolayers 
(SAMs) generated on gold microelectrode surfaces.90 Applying reductive potential 
difference of -1.2 to -0.9 V results in electrochemical desorption of cells captured by the 
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underlying antibody layer that can be easily regenerated with high level of 
reproducibility.91 Some other groups propose to introduce an electro-sensitive modification 
to SAMs forming the adhering surface. Electrochemical oxidation/reduction is enabled by 
incorporation of such redox-active functions like for example hydro(quinone)92-94 or 
ferrocene.95 Therefore, the applied electrical potential fires gentle release of a live cell 
previously trapped by the modified monolayer into the bulk medium. According to this 
strategy, Mrksich’s group reports on an orthogonal release of two cellular samples 
captured on a single micro-device, depending on the electrical stimulus (positive or 
negative potential).96 This approach is however limited to only two target species since 
their release is enabled by either oxidation or reduction process. Alternatively to electrical 
stimulation, remotely triggered release may be achieved over other physical stimuli such as 
electromagnetic field (e.g. release from modified magnetic particles embedded in 
hydrogel),97 temperature variation (by using designed thermoresponsive surfaces)98-100 or 
UV illumination.101 In each case, efficient cell detachment is observed upon external 
stimulation, although potential stress generation (e.g. thermal or UV) may influence further 
biomolecular investigations carried out on a cellular sample.  
Some other strategies that might be potentially explored for controlled cell 
desorption are based on chemically or biochemically switchable substrates. Indeed, 
capability of a bioadhesive surface to smartly release living cells for biosensing 
applications is obtainable by an impulse of chemical or biochemical nature. An example of 
such approach, however not explored so far on a planar surface, exemplifies the release of 
physicochemically bound target upon rising of the pH value that switches off the 
electrostatic interactions with structured substrate.102 Another interesting strategy may 
provide cell detachment by addition of chelating or metal binding agent (e.g. EDTA, 
imidazole) to a substrate based on Ni2+ ion complexed in nitrilotriacetic acid (NTA) and 
polyhistidine tag assembly.103, 104 Employment of strong chelator is reported as an example 
of highly biocompatible strategy deployed to release fibroblasts from peptide-
functionalized hydrogels formed with Ca2+ ions.58 However, these methodologies may be 
hardly applied to design of remotely controlled systems where high throughput 
performance is desired.  
Advanced approaches to tunable bio-adhesive surfaces are focused on a conception 
of more developed chemistries that enable cell specific addressing and controlled spatio-
temporal release of several cellular targets bound on a biochip. In this scope, a great 
interest may be assigned to DNA-based substrates. Indeed, a multiple choice of DNA 
sequences, their automated synthesis and robust attachment on solid surface make them 
ideal tool for multiplexed analysis. Moreover, microdevices based on DNA matrix may be 
exploited to realize selective and programmable release of bound analyte – cellular target 
in particular – by the means of enzymatic cleavage75, 105, 106 or thermal desorption.99 We 
therefore benefit from the intrinsic properties of double stranded DNA that is susceptible to 
be precisely cut by restriction enzymes or to dissociate if adequate temperature is reached. 
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As we will see in the subsequent chapters, these two approaches are explored within the 
scope of the present work as potential strategies for cell sorting purposes. 
 
2.1.2 DNA-driven cell capture  
In the recent years, cell-based microsystems aroused tremendous interest in the 
field of modern biotechnologies aiming both research and biomedical application.43, 107 A 
decade ago, the very fist example of cell biochip was published, demonstrating that solid 
support can be turned into a versatile miniaturized platform capable of highly parallelized 
investigations at cellular level.108 Among efficient strategies to address biological cells of 
multiple type on well-defined locations of a microarray surface, many efforts have been 
deployed for the fabrication of protein biochips.109 The cell-specific immobilization is 
mainly achieved within immunorecognition process by dint of accessible repertoires of 
antibodies produced for cell immunophenotyping.110-112 However, some recent works show 
that DNA-based architectures may become a versatile way to achieve robust, fast and 
reliable cell-based microarray fabrication.59, 75, 80, 82, 83, 113, 114 In order to ensure specific cell 
capture on a biochip provided by DNA hybridization step, we may generally proceed 
according to two strategies. The first approach involves a preliminary synthetic 
modification of the cell membrane by DNA motifs introduced under surface 
bioengineering protocol found in the literature82, 83, 113 or proposed by a commercially 
available methodology (e.g. KODETM technology).115 Once the cell decoration with 
oligonucleotides is achieved, their subsequent hybridization on a DNA-biochip may be 
realized. The second approach relies on conception of a protein-DNA conjugate (in a 
covalent or non-covalent coupling) and its immobilization on the microarray, followed by 
incubation and specific capture of cells.80, 114 By comparing these two strategies, the latter 
one appears more straightforward since crude cellular sample might be directly loaded on a 
biosensing surface built out of properly organized and functional cell-specific 
architectures. 
The strategy based on protein conjugation to DNA may be successfully used to 
specifically address several cellular targets on a DNA microarray. The on-chip capture of 
living cells according to so-called “DNA Directed Immobilization” (DDI)114, 116 is 
therefore achieved and assisted by regular hybridizations between complementary strands. 
Such approach is more suitable for biochip design because it avoids direct grafting of 
structurally fragile proteins (often antibodies) on a surface. The main advantage of DDI 
method is the much higher stability of DNA microarrays, by comparison to protein 
microarrays, and the infinite number of oligonucleotide sequences potentially deployed to 
fabricate dense microarrays. Niemeyer, who pioneered in this method,117 reports that 
DNA-directed protein microarrays characterize spot homogeneity as well as intra- and 
inter-experimental reproducibility in comparison to responses issued from direct grafting 
of proteins on a microarray.116  
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Figure 2.1 Schematic representation of living cell immobilization on DNA-based biochip. The specific 
capture is achieved by three-level molecular architecture: 1) oligonucleotide probe immobilized on the gold 
surface, 2) intermediate DNA strand, 3) hybrid IgG–DNA molecule bridging the target cell through a cell-
specific antibody.  
 
Therefore, the protein-DNA conjugate approach (or more precisely antibody-DNA 
conjugate) is explored in the present study, in order to develop biochip system suitable for 
primary cell sorting. Briefly, we create a DNA matrix by deposition of an oligonucleotide-
modified conducting film of polypyrrole on a gold surface. (cf. Fig.2.1) Subsequently, the 
biochip molecular edifice is elevated with an intermediate DNA strand and finally 
completed by an antibody-DNA conjugate. Since the antibody molecule (IgG) is directed 
to a precise marker situated on a particular cell membrane, such biochip construction 
provides specific immobilization of well-defined cell types. In the final step, captured cells 
are remotely released from the platform according to one of two programmable strategies 
based on the properties of double stranded DNA. In the former one (cf. Chapter 3), cellular 
target release is fired by dint of enzymatic cleavage provided by DNA restriction site 
which is precisely recognized by specific endonucleases (restriction enzymes). The latter 
desorption approach is directly realized within dsDNA dissociation induced by local 
heating and based on a photothermal phenomenon described in Chapter 4. Moreover, both 
strategies guarantee reproducibility of the capture/release process thanks to DNA-based 
construction that may be eventually regenerated and the original DNA matrix retrieved for 
further use. In this chapter, the reader will thus become acquainted with the designed 
biomolecular on-chip assembly involving construction of the hybrid antibody-DNA 
molecule addressed onto DNA-functionalized biochip according to complementarity rules. 
Overall construction is monitored in a real-time and a label-free manner by using Surface 
Plasmon Resonance (SPR) imaging.  
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2.2 Fabrication of the DNA biochip 
Nucleic acids as well as other biomolecules may be addressed onto the surface 
within many available functionalization  methods ranging from one-step deposition by 
contact to more developed lithographic techniques.118 In the scientific literature, we may 
find many examples of solid substrates deployed in biosensor applications like for example 
glass, silicon, indium tin oxide (ITO), gold or even crystalline carbon (e.g. diamond). The 
immobilization of a probe matrix may be achieved within covalent linking (e.g. EDC-
mediated attachment) or physicochemical interaction (SAMs,119 STV-biotin bridge). 
Deposition of probe-modified conducting polymers is an example of stable and robust 
biochip fabrication method.120, 121 Therefore, for the need of the present study, pyrrole-
modified DNA probes are specifically addressed to gold surface in form of polypyrrole 
films generated with help of an electrochemical impulse. 
 
 
Figure 2.2 Fabrication of a DNA biochip by the electrospotting process.  
a) electropolymerization reaction: pyrrole-modified DNA probe is copolymerized with pyrrole moieties 
upon an electric pulse and deposited on the gold surface in form of a polypyrrole film (~ 5 nm in thickness). 
b) electrochemical microcell: 2 V potential difference is applied between the gold surface (WE - working 
electrode) and platinum wire (CE - counter electrode) immerged in the spotting solution (DNA-Py + Py 
monomer). Spot size is determined by the plastic tip opening (400-1200 µm in diameter) and spot position 
is controlled by external motors.   
 
 In order to immobilize the molecules of interest over a metallic layer, a home-
made instrumental set-up is employed122, 123 which enables multiple deposition (spotting) 
of several probes by dint of motile electrochemical cell (cf. Fig. 2.2) The DNA biochip 
matrix is fabricated on a solid material based on a glass prism or slide covered by thin gold 
layer (~50 nm). In fact, gold is a support substrate of choice for the biochip design because 
of its interesting properties - the metal is poorly oxidable, chemically stable in the presence 
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of biologic samples and easily undergoes functionalization by organic molecules (e.g. 
thiol-based probes). Moreover, it can be readily used as a working electrode (WE) which 
constitutes an integral part of the electrodeposition system here exploited.  
The biochip surface is microarrayed with a few DNA probes by using the microcell 
composed of a micropipette tip equipped with a thin platinum filament (counter electrode 
or CE). The electrodes are connected to the external potentiostat which generates a 2-V 
potential diffference during the deposition step. Electrochemically driven synthesis of the 
polypyrrole (Ppy) film lays a foundation for the fabrication of DNA spots.121 Namely, 
pyrrole (Py) molecules and 5’ pyrrole-modified oligonucleotides are copolymerized upon 
the electrical stimulation. The electro-oxidization of Py monomers is very fast and results 
in a metal-adherent polymer film of nanometric thickness, deposited on the surface of 
working electrode (gold).123 Such strategy ensures efficient linkage of DNA probes with 
the biochip surface provided by high stability of the Ppy film and its resistance to 
experimental conditions. Since the polymer growth is spatially defined by the 
electrochemical cell size (400-1200 µm in diameter), successive polymerizations of several 
oligonucleotide probes enable to obtain a functional matrix of DNA spots. 
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2.3 Chemistry of antibody-DNA conjugate 
 
2.3.1 Overview of protein-to-DNA conjugation methods 
From the introduction to this chapter, we have learnt that protein-DNA conjugates, 
thanks to their combined properties, may become versatile molecular tools of great interest 
for immunoassay and biosensing applications. Synthetic oligonucleotides have been 
modified for years to bridge their intrinsic properties to those borne by partner 
molecules.124-126 Therefore, we may discern many examples of an efficient conjugation of 
semisynthetic DNA oligomers with polypeptides and proteins of different sort (including 
enzymes,127-130 antibodies131, 132 and other functional proteins).117, 133-135 This 
bioengineering approach finds an application in such developments like new biological 
fluorophores for optical detection in nanobiotechnology,134, 136 cell-based microarrays59, 114 
or multiplexed immunoassays (e.g. immuno-PCR).20, 137 Thus, I would like to outline the 
most pertinent strategies of protein-DNA conjugation which have been recently deployed 
for biosensing needs and both for diagnostic and research purposes.  
In general, we distinct two independent approaches where protein-DNA conjugates 
are generated according to either covalent coupling chemistry or non-covalent molecular 
assembly. Aiming DNA-protein conjugation procedure, several methods, which are not 
based on direct chemical bonding, are proposed. As example, we can benefit from metal-
complexing properties of the nitrilotriacetic acid (NTA) and subsequent metal ion (e.g. 
Ni2+) interaction with polyhistidine (e.g. His6) molecular tail. Therefore NTA-modified 
DNA oligomers possibly complex nickel(II) ion and consequently interact with His6-
tagged protein in order to eventually form a stable DNA-protein architecture.103 Another, 
more prevalent non-covalent strategy is established upon remarkably strong interaction 
between biotin molecule and homotetrameric proteins: avidin and streptavidin. Gentle 
procedures of biotinylation and therefore the availability of biomolecule-biotin derivates 
(e.g. DNA, antibody) make molecular assemblies based on STV-biotin couple useful for 
the on-chip functional construction.20, 114, 138 An exemplary protocol introduces a 
streptavidin molecule covalently bridged to a short oligonucleotide as a first step of the 
molecular assembly117 that constitutes a versatile platform for further conjugation to 
biotinylated molecules139 such as IgG in living cell microarrays.114 However, the 
construction of such molecular assembly requires stoichiometric control of DNA-protein 
conjugation and the tetrameric structure of streptavidin may thus become a barrier because 
it provides multiple potential interactions with biotin-modified species.  
Alternative solutions are brought by using covalent coupling between well-defined 
functional groups pending on the biomolecules of interest. If precise reaction conditions 
are applied, an efficient linkage may be generated involving such moieties like primary 
amines or thiols naturally occurring (e.g. lysine or cysteine as protein building blocks) or 
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synthetically introduced to biomolecules (e.g. commercially available oligonucleotides 
modified by –NH2 or –SH). One of imaginable strategies may imply activation of 
carboxylic function (e.g. by EDC) to enable its reaction with primary amine, thus forming 
a stable amide bond.140 The example of such straightforward conjugation is however 
hardly found in the literature. It is because nearly all proteins contain both –NH2 as well as 
–COOH functions and coupling strategy incurs a risk of protein auto-aggregation 
generating significant purification difficulties. Therefore, common routes for covalent 
coupling of oligonucleotide and proteins mainly rely on protocol composed of two 
separated steps and frequently involving bi-functional cross-linking agent. The cross-linker 
is introduced in the first step and bears either homo-127, 132 or hetero-functionalities.128, 134, 
135, 141
 
In the goal of DNA and protein (antibody in particular) coupling, commonly 
applied cross-linking agents are composed of two functional groups providing efficient 
amine-to-sulfhydryl conjugation such as amine-reactive ester (N-hydroxysuccinimide 
ester) and maleimide group (prone to react with thiols). On the one hand, formation of 
stable amide linkage is therefore enabled owing to nucleophilic character of the amino-
groups that remain reactive towards high electrophilic carbon of NHS ester group 
(provided that well-defined pH conditions are respected). On the other hand, thioether 
bond is generated according to nucleophilic addition of thiol to an electron deficient α-
carbon of the maleimide group. Many examples of DNA-protein conjugation published so 
far report on efficient reaction between a thiol-modified short oligonucleotide and a protein 
necessarily equipped with amino groups by the means of lysine residues.117, 128, 130, 131, 138, 
142, 143
 Some other groups describe a reverse synthesis based on the NHS-maleimide cross-
linker which alternatively involves an amino-modified DNA and a bioengineered protein 
tagged by cysteine residues, exposing –SH functions for coupling.133, 134, 136 However, this 
approach can not be directly applied to conjugation of native antibody molecules where 
sulfhydryl groups are tethered in disulfide bonds. Following a reduction step, only 
fragments of immunoglobulin undergo the effective coupling.144, 145 Another alternative 
strategy may benefit from the primary amine group pending on antibody which is 
chemically modified to either latent sulfhydryl group and conjugated to a DNA-NH2106 or 
disulfide bond eventually exchanged to another disulfide involving DNA-SH molecule.135 
Thioether bond is however more frequently deployed because of its higher stability over 
disulfides. All these strategies consist of two conjugation steps - the former one providing 
protein activation for coupling and the latter one affecting a modified oligonucleotide. In 
the present study we firstly attempt to use a homobifunctional linker but such approach 
does not result in satisfactory coupling, as it is discussed below. Therefore the final 
strategy providing conjugation of an antibody with short DNA oligomer is realized by 
using cross-linking agent of NHS-maleimide type.  
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2.3.2 Conjugation by using homobifunctional cross-linker 
As a first approach to synthesize the hybrid molecule composed of an antibody 
linked with DNA strands, we opted to use a homobifunctional conjugation agent - 
disuccinimidyl suberate (DSS). This chemical linker is reported as a useful molecular tool 
in protein bioconjugation procedures since it contains NHS esters that, in defined pH 
conditions, are highly reactive to primary amines.127, 132  
 
Figure 2.3 Antibody and DNA coupling reaction via DSS. At first, an oligonucleotide is coupled to the 
cross-linking agent which enables conjugation to an IgG molecule in the latter reaction step.  
 
In the first step of the developed protocol, DSS molecule is coupled to an 
oligonucleotide strand modified by an alkylamine at 3’ end (excess of the cross-linker is 
required to avoid DNA inter-linkage).146 Reaction occurs rapidly (over barely few minutes) 
and after DSS excess removal, NHS-activated DNA undergoes subsequent coupling with 
an immunoglobulin G bearing primary amine functions throughout lysine moieties. 
(Fig.2.3) Purification of the final protein-DNA product is provided by size exclusion132 or 
anion exchange chromatography.127, 130 In the present study, the second purification 
method is chosen to separate the unreacted substrates (IgG and oligonucleotide) from the 
desired conjugation product (IgG–oligonucleotide). However, tests of coupling realized 
between IgG from rabbit serum (rab-IgG) and different amine-modified oligonucleotides 
(EcoRI*, NcoI* and PvuII*) show that DSS-based strategy does not give acceptable 
results. It turns out that independently from the purification conditions and IgG/DNA 
coupling ratio, the conjugated product is hardly discerned by chromatographic purification 
(cf. Fig.2.4). It means that either DSS-driven conjugation does not take place or the 
coupling yield is very low. We speculate that the most probable reason explaining the 
observed conjugation failure is that the intermediate NHS-oligonucleotide degrades before 
being coupled to protein molecule. This conclusion is confirmed by mass spectrometry 
analysis kindly realized by C. Saint-Pierre from Nucleic Acid Lesions laboratory (LAN, 
CEA Grenoble). Namely, the MS results obtained for the intermediate EcoRI-NHS 
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evidence complete hydrolysis of the introduced succinimidyl ester (Appendix A). The 
efficient conjugation is neither revealed by modifying the intermediate step conditions 
(acid medium and low temperature) that are supposed to reduce further NH2 reactivity and 
degradation of NHS.147 Taking into account these findings, the coupling strategy based on 
DSS cross-linker is not longer retained in the present study. An alternative solution is 
proposed which as we will see hereafter, results in definitely higher coupling efficiency 
and this one is ultimately employed. 
 
 
Figure 2.4 Chromatographic purification of products issued from the conjugation of rab-IgG and PvuII*-NH2 
by using DSS coupling agent. HPLC profile evidences two main peaks corresponding to non-coupled 
substrates: rab-IgG (tR = 1.038 min) and PvuII* (tR = 16.692 min) confirmed by independent purifications of 
native IgG and DNA sample (upper images). Elution conditions: 1 ml/min flow rate, NaCl gradient 137 mM 
– 1000 mM (pH 8.0). HPLC column: HiTrapTM Q FF (GE Healthcare) 1 mL, 45-165 µm of bead size (6% 
highly cross-linked agarose modified by -N+(CH3)3). 
 
2.3.3 Efficient coupling by using a cross-linker of NHS-maleimide type 
As a consequence of the above presented results, antibody-DNA coupling strategy 
is finally switched to another conjugation chemistry based on indirect amine linkage with 
thiol groups. As explained in the introduction to this section, cross-linkers of NHS-
maleimide type are widely used in bioconjugation procedures since they enable proper 
coupling between primary amines (with help of  N-succinimidyl-activated ester) and thiol 
functions (by maleimide group). Considering IgG and oligonucleotide chemical 
interconnection, two possible synthesis paths are conceivable: amine-modified DNA 
coupling to IgG molecule or DNA-thiol conjugation to native IgG (Fig.2.5). The first 
alternative is however less suitable since IgG thiol functions required for coupling are 
mainly incorporated in disulfide bonds. Their chemical reduction, even upon mild 
conditions,144, 145 risks to destroy the functional structure of an IgG which is crucial for 
immunoassays and cell-based microarrays. Thus the second strategy is more rational since 
nearly all IgGs bear several NH2 functionalities and thiol-modified oligonucleotides are 
commercially available.  
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Figure 2.5 Strategies of IgG and DNA coupling by using a heterobifunctional cross-linker composed of 
maleimide group (prone to react with thiols) and N-hydroxysuccinimide ester (sensitive to nucleophilic 
substitution by primary amines).  
 
According to the aforementioned statement, we decide to proceed in a two-step 
protocol, firstly involving antibody activation by means of the N-succinimidyl ester and 
subsequent coupling to 3’ thiol-modified oligonucleotide through the maleimide-induced 
nucleophilic addition. [cf. Fig.2.6 a)]. To do so, a heterobifunctional cross-linker based on 
polyethylene glycol (PEG) structure is used (SM(PEG)12 - succinimidyl-[(N-
maleimidopropionamido)-dodecaethyleneglycol). Compared to other reagents containing 
purely hydrocarbon spacer arms,128, 136, 143 linking reagents equipped with PEG chain are 
rather more convenient alternative.140 The PEG presence improves water solubility and 
limits the risk of bioconjugate aggregation. It offers an increased flexibility of the 
bioconjugation reaction, resulting in reduced immunogenic response potentially provoked 
by the spacer itself. A hydrophilic character of the main structural chain ensures efficient 
water solvatation of the reagent and final conjugate molecule as well. Unlike PEG-based 
reagents, cross-linkers built out of hydrophobic spacer arm require application of organic 
solvents (e.g. DMSO) which may affect biomolecule stability and render purification step 
difficult. By using SM(PEG)12, an efficient purification and conjugation steps are 
performed in aqueous solutions.  
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Figure 2.6 Conjugation of IgG and thiol-modified DNA by using SM(PEG)12.  
a) cross-linking reaction scheme; b) flowchart of the synthesis and purification protocol. 
 
In the present work, several cell-directed antibody molecules are coupled to 3’-thiol 
modified oligonucleotides containing restriction sites (EcoRI*-SH, NcoI*-SH and PvuII*-
SH). However, an optimization step of the cross-linking reaction is performed by using a 
representative IgG antibody issued from rabbit serum (rab-IgG). Conjugation protocol and 
purification procedure are therefore adapted, and inspired from previously reported studies 
as well as from SM(PEG)12 supplier recommendations.148 The overall procedure of here 
developed IgG-to-DNA covalent linkage is schematically illustrated on Figure 2.6 b). Our 
goal is to obtain a conjugation product corresponding to one IgG molecule of interest 
synthetically bound to one oligonucleotide strand (monoconjugated hybrid molecule). For 
this purpose, the antibody loading with DNA is assessed by UV absorbance measurement 
executed on conjugation product fractions issued from final purification step.117 The 
desired product is drawn apart by dint of anion exchange chromatography which enables a 
charge-depending separation of species. Therefore, polyanionic oligonucleotide fragments 
can be easily isolated from protein molecules provided that chromatographic purification 
conditions are closely related to IgG isoelectric point (pI) where its overall molecular 
charge is nearly zero. In the case of a human IgG, these conditions are estimated between 
6.4 and 9.0 pH value and neighbor pH of neutral environment.149  Accordingly, the 
protocol of chromatographic purification here applied puts in practice elution in a buffer of 
pH 8.0.  
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Figure 2.7 Purification of the IgG–DNA conjugation products by anion-exchange chromatography. 
Chromatographic profile evidences the following product fractions: F0 (native IgG), F1 (antibody modified 
by the cross-linking agent), F2 (the desired one-to-one conjugated molecule), F3 (multiconjugated product 
and/or free DNA oligomer). Elution conditions: 1 ml/min flow rate, NaCl gradient 137 mM – 784 mM (pH 
8.0). HPLC column: HiTrapTM Q FF (GE Healthcare) 1 mL, 45-165 µm of bead size (6% highly cross-linked 
agarose modified by -N+(CH3)3). 
 
2.3.4 Optimization of the IgG–DNA coupling reaction 
In order to establish an efficient antibody-DNA coupling methodology several 
parameters have to be considered. A major issue of the reaction scheme is the 
stoichiometric control of the amount of DNA strands covalently linked to each protein 
molecule. Willing to obtain desired one-to-one bioconjugate, different substrate ratios are 
tested and antibody loading with DNA evaluated. The number of oligonucleotide 
fragments grafted on IgG molecules is assigned by chromatographic separation followed 
by absorbance measurements of the discriminated fractions. 
The first step of the coupling procedure relies on IgG activation by SM(PEG)12. In 
order to provide high reactivity of primary amines towards NHS ester, this stage has to be 
realized in delimited pH conditions – from 7.0 to 9.0 (PBS buffer of pH 7.4 in our case). 
Large excess of the cross-linking reagent is required to ensure proper conjugation of the N-
succinimidyl-activated esters to primary amine functionalities pending on IgG molecules. 
Three values of the SM(PEG)12 stoichiometric excess are tested (10, 50 and 100) and 
resulting chromatographic profiles investigated (Fig.2.8). Following the HPLC purification 
step, we discern three major product fractions: F1 corresponding to NHS-activated 
antibody, F2 which is the one-to-one conjugation product and finally F3 ascribed to free 
oligonucleotides and/or multiple-conjugated molecules (cf. Fig.2.7). Fraction assessment 
results from the absorbance measurements as well as immunofluorescence assay discussed 
in farther part of the present chapter.  
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From the registered HPLC profiles, we can conclude on the coupling efficiency 
obtained for the three tested SM(PEG)12 ratios. As observed, F1 fraction is slightly shifted 
to higher retention times (tR) if more of the cross-linker is employed. Knowing that the 
elution of native IgG (F0) occurs in the first minute after the injection to column (proving 
neutral net charge), we deduce that F1 corresponds to the maleimide-bearing antibody, 
interpreted as IgG molecules with modified net charge. Moreover, the maleimide groups 
are randomly introduced on the antibody molecule and higher cross-linker content results 
in a larger relevant peak.  
Concerning the remaining part of the observed chromatographic profiles, one may 
notice that the F2- and F3- corresponding peaks are not perfectly resolved. These results 
demonstrate that the more of SM(PEG)12 is employed for coupling, the more F2 and F3 
peaks overlap. This can signify that an increased ratio of the linking reagent generates 
considerable level of derivative compounds built out of IgG linked to an undetermined 
number of DNA strands. Unfortunately, multiple coupling of DNA oligomers to single IgG 
molecule can not be completely circumvented. The F2 fraction can be however attributed 
to the desired monoconjugated product. It is because this fraction is characterized by an 
absorbance ratio (A260/A280) of around 1.0 which is consistent with previously reported 
findings.117 The three given experiments are performed for the same molar quantity of 
protein and therefore the F2 peak magnitude may be approximated to coupling yield. 
Taking into account this fact, we consider 100 equivalent excess of SM(PEG)12 cross-
linker as suitable for efficient DNA and IgG conjugation. Higher excess is not attempted 
because an extensive charging of the IgG molecule is not desired regarding to the antibody 
functionality.  
 
Figure 2.8 IgG–DNA coupling performed in different IgG : cross-linker ratios. Stoichiometric excess of 
SM(PEG)12 is evaluated (10, 50 and 100) for the conjugation of rab-IgG and NcoI*-SH.  
 
Once an IgG molecule is combined to the cross-linking agent and unreacted 
residues of SM(PEG)12 removed by size exclusion chromatography, the maleimide-bearing 
antibody undergoes coupling to a thiol-modified oligonucleotide. As it makes up the latter 
step of the coupling strategy, such reaction involving maleimide functionality is more 
convenient compared to final linkage through N-hydroxysuccimide ester (e.g. DSS 
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strategy). It is because maleimide group is more stable in aqueous solution in contrast to 
NHS ester that rapidly sustains hydrolytic degradation. Maleimide stability and reactivity 
to sulfhydryls is however pH dependent as the group slowly hydrolyses at pH values 
greater than 7.5. Therefore the optimal conditions for the second stage of coupling reaction 
are placed between pH 6.5 and 7.5. In order to produce an efficient linkage by formation of 
thioether bond, the use of maleimide demands free sulfhydryl groups as binding partner. 
That is why thiol-modified oligonucleotides are submitted to chemical reduction prior to 
their conjugation to the activated IgG molecules. 
In the fields of biochemistry and molecular biology, the most commonly used 
reduction agents are dithiothreitol (DTT) and 2-aminoethanthiol. Apart from their capacity 
to efficiently reduce disulfide bonds, as thiol-based compounds themselves, they may 
interfere in SH-involving reactions if they are not completely discarded. Thus, the protocol 
evaluated here relies on an alternative reducing conditions based on TCEP (tris(2-
carboxyethyl)phosphine). This reagent is an advisable solution not only because of it 
physicochemical properties (odorless, non-volatile and resistant to oxidation in air) but 
mainly because of its capacity to selectively and completely reduce even the most stable 
water-soluble alkyl disulfides over a wide pH range. By using TCEP, the reduction side-
product is a phosphine oxide which is non-reactive compound to other functional groups. 
After an oligonucleotide-SH is treated with TCEP, reduced sample is desalted on a size 
exclusion column (NAPTM 5) and subsequently recovered in EDTA-containing buffer. 
Presence of the chelating agent aims to hinder metal ions to induce disulfide bond 
regeneration before the DNA strand is coupled to antibody. The acidic-basic conditions 
(pH 6.8) ensure high reactivity of the maleimide functionalities pending on the IgG 
molecule towards thiol-modified oligonucleotides.  
A key point of the cross-linking strategy here developed, is to provide appropriate 
stoichiometric conditions in order to obtain monoconjugated IgG–DNA product with 
considerable final yield. An important element is therefore to establish optimal coupling 
ratio between substrates involved in the ultimate step, i.e. maleimide-activated antibody 
and reduced DNA-thiol. Literature references frequently report on equimolar quantity of 
both biomolecular substrates which has been intuitively applied to the tests described 
above.138, 143 (Fig. 2.8) However, IgG and DNA are biomolecules of distinct nature and 
contrasting structure mainly because of their size, charge distribution and accessibility of 
potentially reactive groups. IgG–maleimide molecules and DNA-thiol strands jointly 
suspended in solution may engender covalent linkage in a statistically random manner. 
Consequently, it is worth to optimize IgG/DNA ratio and evaluate the yield of desired 
conjugation.  
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Figure 2.9 IgG/DNA conjugation by SM(PEG)12 with different stoichiometric ratios of the substrates. Excess 
of the IgG (rab-IgG) and oligonucleotide (PvuII*) is hereby evaluated.  
 
Accordingly, the coupling reaction is performed by providing a greater molar 
content of the oligonucleotide-SH (1 and 10) or the activated IgG (2, 5 and 10) in order to 
examine the aforementioned concern. Following the incubation, reactive solutions are 
submitted to purification by anion exchange chromatography - the relevant chromatograms 
are represented on Figure 2.9. From the obtained results, we may clearly conclude that 
increased stoichiometric content of oligonucleotide used in the reaction does not generate 
higher rate of desirable IgG–DNA combined product, a priori represented by F2. 
Proportionally to the applied oligonucleotide excess, one may notice a magnification of F3 
peak which retention time corresponds to the free DNA molecule. As to extension of the 
antibody molar contribution in the coupling reaction, proportional amplification of 
concerned peaks (F1 and F2) is similarly perceived. The mentioned peaks are not only 
higher but also less resolved on chromatographic profile if an important excess of the 
protein is used in the reaction. Considerable augmentation of the IgG/DNA ratio is able to 
produce an extension of derivative products and is therefore baseless. In such case, the 
registered absorbance signal reveals an elevated degree of non-coupled antibody as well 
(F1).  
As observed on the obtained chromatographic profiles, IgG/DNA ratio equal to 2:1 
yields a good resolution of F2 peak corresponding to monoconjugated product of our 
interest. This stoichiometric proportion is consequently proposed for the final coupling 
protocol which is applied to conceive the programmed antibody-oligonucleotide 
conjugates (Table 2.1). Although a considerable fraction of the antibody is still not coupled 
(~18% of starting IgG amount in recovered F2 fraction), the chosen protocol results in 
good yield of the monoconjugated IgG–DNA (14% – 29%). Further, confirmation of the 
efficient coupling is brought by absorbance measurements referred to theoretical values 
and described hereinafter. A proof for suitable antibody functionality is finally assessed by 
immunofluorescence assay and SPR imaging.  
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antibody IgG–DNA 
conjugate application 
coupling 
yield 
IgG from rabbit serum 
rab-IgG–EcoRI* 
conjugation reaction optimization, 
tests of biochip molecular 
assembly and enzymatic release 
20% 
rab-IgG–PvuII* 22% 
rab-IgG–NcoI* 16% 
rab-IgG–Zip2* fraction assessment in immunofluorescence assay 19% 
rat IgG 
anti-mouse CD19 CD19–EcoRI* 
specific capture of B lymphocytes 
(CD19 membrane marker) 23% 
rat IgG 
anti-mouse CD90 CD90–PvuII* 
specific capture of T lymphocytes 
(CD90 membrane marker) 29% 
mouse IgG 
anti-HcB domain HcB–NcoI* 
negative control  
(non-relevant antibody) 14% 
 
Table 2.1 Antibody-oligonucleotide conjugates synthesized within the framework of the present project. The 
coupling yield is expressed as ratio of the IgG amount in fraction corresponding to the monoconjugated 
product (F2) and starting quantity of the antibody employed in the reaction.  
 
2.3.5 UV absorbance measurements 
Consequently to the IgG and oligonucleotide coupling reaction, followed by 
purification on an anion-exchange chromatographic column, four main product fractions 
are discerned (F0, F1, F2 and F3). The relevant retention times observed on 
chromatograms give significant premises on the type of the obtained conjugation products 
(compared to tR registered for native IgG or free DNA strand). The isolated fractions are 
however concentrated and their absorbance determined at 260 and 280 nm light 
wavelength. The measured absorbance ratios (A260/A280) are straightforwardly applied to 
evaluate the average number of DNA strands loaded on each antibody molecule (Appendix 
B).117, 131 This is because the experimental values may be compared to the theoretical ones 
issued from Lambert-Beer absorbance law, knowing that absorbance maximum is placed at 
260 nm for DNA and 280 nm for proteins. 
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Figure 2.10 Estimation of the IgG loading by DNA molecules based on 260nm and 280nm absorbance 
measurements. Three fractions obtained from the conjugation reaction are considered (F1, F2 and F3). The 
experimental A260/A280 values (in blue) are compared with the theoretical ones (in red) assigned to the 
monoconjugated IgG–DNA.   
 
Figure 2.10 represents average absorbance ratios registered for fractions F1, F2 and 
F3 issued from conjugation of an IgG-type antibody with the relevant oligonucleotides. 
These empiric values are assembled with those observed for native IgG and DNA as well. 
A260/A280 ratio is obtained from independent absorbance measurements and standard 
deviation is given. The experimental data are finally compared to the values theoretically 
assigned to the monoconjugated IgG–DNA. Determination of the theoretical value of 
absorbance ratio is based on Lambert-Beer formula taking into account the additivity of the 
absorbance law and assuming that the conjugation does not influence the extinction 
coefficients of DNA and protein. Comparison of 260nm/280nm absorbance ratios 
determined experimentally with their theoretical equivalents enables estimation of 
antibody loading level with DNA. Therefore, we affirm the presence of desired 
monoconjugated product in the fraction F2 which approximates the calculated value at 
most. Fraction F1 is thus identified as non-conjugated IgG, unlike the fraction F3 
composed of multiconjugation products that can not be avoided (free oligonucleotide 
might be present as well). These conclusions are reflected by an additional examination 
realized on each of the recovered conjugation fractions and based on a fluorescence signal 
read-out.  
IgG–DNA 
conjugate 
experimental A260/A280 calculated A260/A280 
F1 F2 F3 IgG DNA IgG–DNA 
IgG–EcoRI* 
0.64 
(0.06) 
0.98 
(0.09) 
1.50 
(0.09) 
0.56 
(0.03) 
1.75 
(0.02) 1.10 
IgG–PvuII* 0.64 (0.03) 
0.94 
(0.08) 
1.37 
(0.05) 
1.51 
(0.05) 1.00 
IgG–NcoI* 0.65 (0.02) 
0.98 
(0.03) 
1.36 
(0.04) 
1.71 
(0.03) 1.09 
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2.3.6 Fraction assessment by immunofluorescence assay 
Fluorescence microscopy is a robust detection technique deployed to identify DNA 
entities on microarrays due to its high sensitivity and multiplexing capabilities.150 
Therefore, an easy method for reliable assessment of the fractions collected from 
chromatographic separation of the bioconjugation products is to realize an on-chip 
immunoassay based on the fluorescence read-out. Such immunofluorescence test 
conducted on a DNA microarray enables validation of hybridizing capability of IgG–DNA 
conjugates and their coupling efficiency. Accordingly, this control is led on an 
oligonucleotide microarray functionalized with three probe sequences. (Fig.2.11.). In such 
configuration, Zip1 constitutes a positive control signal, Zip2 is devoted to fraction assay 
and Zip3 serves as a negative control. After incubation of each fraction issued from the 
rabbit-IgG conjugation to DNA (complementary Zip2*), a secondary immunorecognition 
antibody is introduced onto the biochip. The secondary anti-rabbit IgG conjugated with 
biotin enables interaction with streptavidin-R-phycoerythrin protein (STV-PE) based on 
high affinity of STV to biotin molecule (dissociation constant is around 10-15 M).151 R-
phycoerythrin is a versatile fluorescence label with strong light absorption (about 550 nm) 
and emission peak in green-yellowish light area (575 nm). Upon STV-PE binding, 
fluorescence signal may be directly observed. 
 
 
Figure 2.11 Immunofluorescence assay for assessment of the IgG–DNA conjugation products.   
a) schematic representation of the experimental protocol: i - hybridization of the assayed fraction (rab-IgG–
Zip2*) and positive control sequence (Zip1*-biotin), ii - incubation with biotinylated secondary antibody 
(anti-rab-IgG), iii - incubation with streptavidin-R-phycoerythrin (STV-PE) and fluorescence signal read-out; 
b) revelation of the fluorescence signal in three independent tests of the fractions (F1, F2 and F3) issued from 
rab-IgG coupling to Zip2* oligomer.  
 
i ii iii 
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In consequence of the test here described, fraction F1 does not show any 
fluorescence compared to Zip1 positive control. It confirms that the conjugation product is 
not involved in this fraction which may be attributed to the linker-activated IgG as it was 
proposed before. Regarding to F2 and F3 fractions, both hybridize properly on the given 
DNA-biochip resulting in strong signal from the Zip2 probe. We notice that Zip2 spots 
reveal enhanced fluorescence by comparison to the control complementary strand injected 
along each fraction (Zip1*-biotin). Unlike one biotin moiety on the control Zip1* 
sequence, numerous biotins pending on the secondary antibody (anti-rabbit IgG) are 
capable of multiple interactions with STV-PE, resulting in strong Zip2 fluorescence. 
Although fraction F2 appears as a single well resolved peak on the chromatogram, the F3 
fraction is actually composed of multiple conjugation products (or free oligonucleotide), 
obviously due to possible covalent grafting of several oligonucleotides on the same IgG 
molecule. These findings are consistent with the aforementioned considerations based on 
the absorbance measurements at different wavelengths. Hence, it confirms the presence of 
the desired IgG/DNA monoconjugate in the fraction F2 that will be preferentially used in 
further experimentation to build the designed biochip assembly. 
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2.4 Real-time monitoring of the biochip molecular assembly 
Molecular design of the biochip system here proposed, requires a versatile tool to 
follow construction of the assembly involving hybridization of short oligonucleotides and 
antibody-DNA conjugates as well as further detection of cellular targets in ensuing 
experimentation. To do so, the present work takes advantage from an optical method based 
on surface plasmon resonance (SPR) phenomenon. This analytical technique is widely 
used in the field of biosensors and deployed for various biological and chemical sensing 
applications.39, 152 Small sample volume, real-time monitoring and possibility of 
parallelized detection makes SPR-based method a useful tool to investigate biomolecular 
interactions of different nature.38, 153-155 More recently, it has been shown that particular 
technique of SPR imaging (SPRi) is also convenient for the label-free monitoring of living 
cells immobilized on a solid support.40, 79 For these reasons, the SPR imaging has been 
chosen to track the biochip molecular build-up as well as cell capture/release events 
discussed in farther part of the manuscript. To understand the detection phenomenon, a 
general insight to SPR features is hereafter proposed and followed by description of the 
employed instrumental set-up.  
 
 
Figure 2.12 Surface plasmon resonance in Kretschmann’s configuration. The gold layer SPs are excited by 
an incident light beam in total internal reflection conditions (TIR). The incoming photons are coupled to the 
free electron oscillations on the metal/dielectric interface, provided that the corresponding electric field 
components are parallel (kxphoton = kxSP) which is proper to TM-polarization. The evanescent wave of surface 
plasmon penetrates into local medium at around 100 nm depth. The lateral resolution of the electric field 
decay is ~7 µm.  
 
2.4.1 Surface plasmon resonance phenomenon  
Surface plasmon resonance is an optical phenomenon that lays the foundation of 
particular biosensing systems.156 SPR-based methods permit to follow variations of the 
refractive index in the neighborhood of a dielectric/metal interface and thus enable to 
observe specific biomolecular interactions. This feature is a result of the energy coupling 
that occurs between incoming photons (incident light) and free electron oscillations of the 
metal surface (surface plasmons - SP). The surface plasmon waves are produced upon 
CHAPTER 2 CONCEPTION OF THE BIOCHIP MOLECULAR ASSEMBLY 
68 
 
excitation by light wave and propagate along the interface (cf. Fig.2.12). Several conditions 
are required to obtain an efficient photon coupling to the electrons.  
The developed biochip system based on the SPR detection employs a gold-coated 
glass prism (60° angle) according to configuration proposed by Kretschmann.157 In such 
geometry, an incident beam of light strikes a thin gold layer (here ~50 nm) deposed on the 
prism in the conditions of total internal reflection (TIR). Willing to excite surface electron 
waves, the incoming light must be polarized in a transverse magnetic (TM) mode. This 
polarization ensures that the electric component of electromagnetic wave is normal to the 
interface and consequently parallel to the electric field vector of metal SPs.158 Under a 
specific angle of incidence (cf. Fig.2.13), the incoming photons undergo a resonant 
coupling to the gold surface electron oscillations, which results in decrease of the reflected 
light intensity (resonance angle θR). Hence, the generated evanescent wave of surface 
plasmon remains sensitive to any refractive index changes induced in the neighborhood of 
the biochip surface. When working in fixed angular conditions (SPR imaging), the optical 
index changes produced by molecular adsorption phenomena are detected as a variation of 
the reflectivity depending on the occurring interaction. The SPRi instrumental set-up 
provides a real-time monitoring of a large biochip area (about one square centimeter) and 
allows simultaneous tracking of various biomolecular interactions specific to several 
immobilized probes.123  
 
 
 
 
 
 
Figure 2.13 Plasmon curves on polypyrrole-based DNA spots and bare gold surface. 
 a) intensity of the reflected light (%) in function of the incident angle observed for grafted probes (Zip1, 
Zip2 and Zip3), control oligonucleotide (NC) and bare gold (Au); b) principle of the SPR imaging 
measurement upon complementary DNA hybridization. SPRi monitoring is performed at a fixed angle of 
incidence (working angle), biomolecular interactions are detected as the reflectivity shift. The reflectivity 
minimum is registered by CCD camera at θR corresponding to the angle of resonance. 
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2.4.2 SPR imaging instrumental set-up   
The experiments demonstrated in the present work are based on SPR imaging set-
up provided by Horiba Scientific-GenOptics (unless specified) and based on the 
Kretschmann’s configuration (Fig.2.14) A DNA-functionalized biochip is placed in the 
optical detection system together with a flow cell (described in farther parts) and supplied 
with a running buffer by dint of proper microfluidics (syringe pump and injection valve). 
The experimental buffer is transported through a degassing system and delivered to the 
reaction chamber at a controlled flow rate. Samples are introduced in the liquid flow by 
using a 6-channel injection valve ensuring negligible dead volume. Biochip and flow cell 
set-up is housed in an incubator set at 37°C within a whole experiment. 
 
 
Figure 2.14 Surface Plasmon Resonance Imaging set-up. Samples are manually injected by a 6-channel 
injection valve and driven to the reaction chamber (flow cell) through a proper microfluidic system. The 
running buffer is delivered by remotely controlled syringe pump. The SPRi system (Horiba Scientific-
GenOptics) is equipped with a LED (λ = 660 nm) and the reflectivity is registered by CCD camera connected 
to a computer and data acquisition is controlled by proper software. The optical system is incubated at 37°C 
within the experiment.  
 
A heart of the SPRi detection system is composed of several elements of the optical 
nature. The incident light wave (660 nm) is generated by a light-emitting diode (LED) and 
collimated by a biconvex lens. Farther optical pathway is equipped with a rotating 
polarizer providing TM (SPR detection) or TE (total reflection used as reference) 
polarization mode. The incident light is reflected on the biochip surface and resulting light 
received by CCD camera (16-bit). An appropriate software provided by Horiba Scientific-
GenOptics is used to monitor reflectivity variations observed at well-defined zones 
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corresponding to several assayed probes. Images are registered by the camera and 
processed data are represented on kinetics curves (% of reflectivity plotted in time). 
 
2.4.3 SPRi monitoring of the DNA-based molecular assembly 
As we have learnt, the SPR-based detection techniques offer great possibility to 
investigate large variety of biomolecular interactions. This is motivated by at least two 
major characteristics: label-free detection of any biomolecular target penetrating in the 
vicinity of a metal/dielectric interface (~100 nm) and real-time monitoring of target–probe 
interactions. Such approach gives the access to kinetic parameters, which usually can not 
be retrieved by conventional end-point analysis methods.159 SPR imaging is hereby 
employed to assess functional assembly of the designed biochip, relying on IgG–DNA 
conjugate hybridization which enables consequent transformation of DNA microarray to 
an antibody pattern. Therefore three series of DNA features are arrayed on the gold 
surface according to the aforementioned electrospotting technique. Each probe is 
composed of a poly-T spacer arm on 5’-end followed by 24 base-long hybridizing 
sequence (cf. Table 6.1). The relevant probe sequences are of the same length and of 
similar thermodynamic properties. Besides, different base sequences disable cross-
hybridization and enable probe-specific immobilization of designed targets. DNA-based 
addressing of antibodies is hereby demonstrated as preliminary step that evaluates the 
biochip functionality for further applications.    
The set of immobilized oligonucleotides serves as a matrix to realize corresponding 
three-component molecular architectures which step-by-step erection is followed by SPRi 
(Fig.2.15). Each of the three grafted Zip probes is firstly hybridized with longer 
intermediate strand containing complementary Zip sequence on 3’-end and a restriction 
site on the 5’-end. Consequently, the relevant antibody-DNA conjugates are introduced on 
the biochip and immobilized according to the complementarity rules. Hence, the hybrid 
protein-DNA molecules composed of the restriction site-containing sequences combined 
with IgG are subsequently added to complete the molecular edifice. The specificity of 
successive hybridizations is confirmed by SPR imaging that generates proper reflectivity 
shifts consistent with the injections of each molecular building block. For the clarity of 
signal read-out, the background reflectivity of a control non-relevant probe (the NC probe) 
is subtracted from each SPR curve traced upon time (Appendix E).  
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Figure 2.15 The biochip molecular assembly monitored by SPR imaging. In the first step, the 
complementary intermediate strands are introduced over the Zip sequence matrix (Zip1*-EcoRI, Zip2*-PvuII 
and Zip3*-NcoI). 5µM and 10µM stand for the Zip concentration in the electrospotting solution. The 
molecular edifices are completed by successive hybridizations of the conjugation products composed of a 
rabbit IgG combined with the corresponding DNA oligomer (IgG–EcoRI*, IgG–PvuII* and IgG–NcoI*). The 
experiment is incubated at 37°C and driven in the following running buffer: PBS, MgCl2 10mM, pH 7.4.  
 
As we may interestingly observe, the addition of hybrid antibody-DNA conjugates 
triggers much higher reflectivity shifts compared to those registered for the underlying 
intermediate strands. This may be explained by the fact that reflectivity variation results 
from local modification of the refractive index, highly depending on the quantity of the 
adsorbed material. Therefore, the observed signal difference may be attributed to 
molecular weight of the immobilized species which is about 150 kDa for IgG molecules 
and only 15 kDa for the intermediate DNA strands. Since SPRi signal is proportional to the 
mass of captured molecules,160 we opine that only one IgG–DNA conjugate is immobilized 
per each three to five complementary DNA strands. Target anchoring to all the available 
sites is hardly achieved probably due to steric hindrance effect related to the antibody 
molecule size. Nevertheless, the obtained results demonstrate that designed molecular 
assembly may be successfully build-up and followed under construction by SPRi detection 
technique. Moreover, thanks to the three component molecular architecture strategy, the 
DNA-microarray can be easily regenerated and original matrix eventually retrieved.122 
The recycled microarray can be thus used for several successive experiments without any 
significant signal loss provided that suitable storage conditions are respected (data not 
shown). 
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2.5 Conclusions: transformation of DNA biochip to functional 
antibody microarray 
When designing biosensing surfaces, a key element is to enable efficient and 
specific binding of desired targets on a modified solid support. The findings described by 
the present chapter reported on the DNA-based microarray that can be easily turned into 
the antibody biochip. This feature is ensured by a molecular tool composed of an IgG 
molecule combined with an oligonucleotide strand. Accordingly, the antibody-DNA 
conjugation reaction was hereby proposed. The obtained product was consistent with the 
monoconjugation scheme (one-to-one hybrid molecule) which found confirmation in UV 
absorbance measurements. Furthermore, an independent immunofluorescence assay 
demonstrated the functionality of the IgG combined to short DNA and evidenced that the 
designed coupling protocol is not immunogenic. Additionally to this end-point analysis, 
the molecular assembly involving the antibody-oligonucleotide conjugate (fraction F2) was 
subsequently validated in real-time detection approach by using Surface Plasmon 
Resonance imaging.  
In the developed chemical approach, DNA moieties are arbitrarily coupled to the 
IgG, owing to statistic distribution of many amine groups on an antibody molecule. This 
kind of molecular engineering does not certainly provide a non-modified antigen 
recognition site (Fab region). Unlike a biochip assembly ensuring antibody orientation (by 
using immunoglobulin-binding proteins expressed in bacteria and exhibiting specific 
interaction with Fc portion of an antibody molecule),161-163 the synthetic IgG–DNA 
conjugate offers a random orientation of the IgG paratope to a desired target. Nevertheless, 
the DNA-Directed Immobilization remains a versatile strategy in construction of 
biosensing platforms capable of efficient addressing of different targets ranging from 
proteins138 to whole living cells.114 The designed molecular assembly is hereby applied to 
specifically immobilize several cell types which will be explored in the following chapters. 
Controlled release of the bound cells from the DNA-based biochip will be subsequently 
attempted, taking advantage from the presence of the restriction sites or thermosensible 
character of the DNA duplex. The feasibility of both cell sorting strategies will be 
demonstrated by using a label-free technique of SPR imaging. SPRi is therefore shown to 
follow in real time the biomolecular phenomena and the capture/release steps at cellular 
level as well.  
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3.1 Introduction 
 
DNA molecule exemplifies a type of biopolymer that can be easily manipulated in 
a desirable manner in standard molecular biology protocols as well as for biosensing 
purposes. In the preceding chapter, we reported on design of the particular molecular 
assembly based on the oligonucleotide microarray that can be turned into an antibody 
pattern. We hereby exploit this molecular construction for further applications that aim to 
provide a versatile strategy of programmable release. We benefit from the intrinsic 
properties of the double stranded DNA and its susceptibility to enzymatic manipulation, in 
this particular case relying on digestion of oligonucleotide sequences.  
 
 
 
 
The enzymatic cleavage of a nucleic acid substrate is reported as a specific and 
controllable reaction, thus desirable in development of new platforms for various 
biosensing goals.164, 165 A particular example of biosensor concept is to realize selective 
and enzymatically driven removal of an analyte immobilized on a solid support.105 An 
approach of this kind shall provide mere cleavage of DNA substrate106, 166 or, more 
interestingly, trigger localized release of more sophisticated objects such as 
nanoparticles167, 168 or living cells75, 81 as well. Because cells are highly fragile and 
sensitive to any variation in their environment (salt concentration, pH, temperature, etc.), 
we propose a mild enzymatic cleavage process as a strategy for tunable cell sorting 
purposes. We make therefore use of restriction endonucleases capable of site-specific DNA 
digestion, ensuring fast reaction times and easy parallelization of target releasing events. 
The enzymatically driven desorption of cells from the microarray is enabled by 
Figure 3.1 Schematic representation of cell release strategy driven by restriction endonucleases. EcoRI 
enzyme specifically recognizes Zip1-based construction (Zip1 + Zip1*-EcoRI + IgG–EcoRI*) and PvuII 
cleaves Zip2-based assembly (Zip2 + Zip2*-PvuII + IgG–PvuII*). B- and T-type cells are captured by 
proper antibodies (anti-CD19 IgG and anti-CD90 IgG respectively).  
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conjugation of cell-specific immunoglobulin G (IgG) to short oligonucleotides containing 
restriction sites. (Fig. 3.1) After full molecular build-up, the DNA-based sensor is indeed 
shown to efficiently capture living cells, whose orthogonal release is subsequently fired 
directly from the biochip.  
When conducting the enzymatic digestion step, an advisable detection strategy is to 
enable real-time monitoring of enzymatic reaction exercised on DNA in order to get an 
insight into process kinetics. In situ assessment of cleavage phenomena may be for 
example performed by continuous measurement of fluorescence intensity169 or an 
electrochemical signal.170 In the present study, where target biomaterial is released from 
proper molecular architecture previously built on the microarray, we make use of label-free 
detection method based on surface plasmon resonance phenomenon as described in the 
previous chapter.  
 
 
Figure 3.2 Enzymatic cleavage of double stranded DNA at well-defined restriction sites EcoRI and PvuII. 
Upon enzymatic digestion, the relevant sequence is cut into two separate fragments characterized by sticky or 
blunt ends. Three-dimensional structures of endonucleases are represented according to Protein Data Bank 
(EcoRI is reported under PDB ID: 2OXV and PvuII as 3KSK).172  
 
Restriction enzymes employed for the need of the current work (EcoRI and PvuII) 
are small homodimer proteins (MW ~70 kDa) capable of recognition and cleavage of short 
(4 – 8 bp) palindromic DNA sequences.171 They are characterized by a high specificity to 
recognize well-defined restriction sites. To provide an enzymatic cleavage event, at first 
endonuclease molecule randomly binds to encountered dsDNA and is linearly diffused 
along the nucleic acid molecule. It is an efficient biochemical machinery that eventually 
locates its target sequence and produces hydrolysis of two opposite DNA backbones. Thus, 
enzymatic cleavage generates two separate DNA fragments (3’-hydroxyl and 5’-phosphate 
ends) equipped with so-called sticky (EcoRI) or blunt ends (PvuII). (Fig. 3.2)  Within this 
simplified mechanism concerning DNA substrate immobilized on a gold surface, we tend 
to realize target-specific release from biochip. Our attention is not in reality focused on 
exploring the enzymatic reaction kinetics but mainly on the final effect of precisely 
programmable desorption strategy which is hereafter discussed. 
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3.2 Enzymatic cleavage of microarrayed DNA strands 
 
3.2.1 Optimization of the enzymatic digestion in biochip format 
Restriction enzymes are proteins of fragile nature demanding proper handling and 
storage. In order to achieve the optimal digestion of nucleic acids, several key factors, such 
as buffer content, temperature, reaction time, solution volume and finally amount of 
enzyme, have to be considered and adapted in function of proper application. In standard 
enzymatic digestion protocols, the activity of restriction enzymes is executed on DNA 
material suspended in aqueous solution. However some groups report on the use of 
different proteins with hydrolase activity in the format of a microdevice where targeted 
molecules are immobilized on a solid support.173, 174 The work here presented, benefits 
from oligonucleotides containing various restriction sites which are arrayed on a biochip 
surface and employed as molecular tools fin controlled capture and release purposes. 
Feasibility of the designed strategy needs therefore a detailed insight into several 
experimental conditions of the microsystem here developed. 
Previously realized studies have shown that temperature is a crucial parameter to 
ensure high efficiency of enzyme-catalyzed cleavage driven in a biochip format.146 The 
highest enzymatic activity was registered at 37°C maintained during whole digestion 
reaction time. Indeed, this is the optimal temperature recommended by the enzyme supplier 
for the given endonucleases. Here employed SPRi instrumental set-up is housed in an 
incubator that enables remote temperature control. Apart from the optical equipment, the 
main part of microfluidics system is therefore placed in the incubator set at 37°C within all 
experimentation steps. These conditions exactly correspond to further objectives, since 
they are compatible with cellular sample that will be loaded into the system in order to 
achieve the final goals. Even if the injection valve is installed externally to main 
experiment ambience, microfluidics system is based on small diameter tubing (ID of ~250 
µm) and the incoming liquid phase is thus sufficiently conditioned at the right temperature 
prior to get in contact with the biosensing surface. Indeed, upon biochip positioning and a 
few minutes incubation, SPRi signal remains stable within hours (providing that any 
external perturbation comes about) at constant flow rate (up to 100µL/min). Another issue 
is however related to the material structuring the microfluidic system that has to be 
compatible with all injected biomaterials including enzyme molecules and living cells as 
well.  
Proteins are generally very sensitive to their surrounding environment and readily 
sustain irreversible denaturation when getting into contact with solutions or surfaces that 
are not entirely biocompatible. Such contact might be risky for their functional structure 
and generate perturbation or complete depletion of biological task of an antibody or 
enzyme for instance. The biochip system here developed, requires therefore to use such 
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material for construction of injection and microfluidics equipment that is harmonious to 
protein samples. In very preliminary studies, we remarked denaturation effect upon 
enzyme injection into flow cell made of polytetrafluoroethylene (PTFE). The effect was 
observable as macroscopic white flocs of denatured protein on the surface of biochip 
removed from SPRi. PTFE commonly known as Teflon® is a highly hydrophobic material 
based on fluorocarbonic solid structure. Proteins neighboring a material of such properties 
incur risk of their structure and functionality alteration. That is why teflon-based modules 
and tubing should be avoided in enzyme bioassays. Henceforward, the present study 
benefits from microfluidics entirely built by using other polymer - polyether ether ketone 
(PEEK) which is reported as a biocompatible material employed in various biomolecular 
analysis methods (e.g. bioanalytical HPLC column)175 and for medical applications as 
well.176 
Apart from the aforementioned considerations of microfluidic material, such 
experimental parameters like pH or ionic strength have to be pointed out as important 
factors in enzymatic digestion strategies.169 Willing to realize a successful cleavage in 
biochip format, the working conditions need to be adapted to ensure optimal activity of the 
restriction enzyme. Here, the composition of employed buffer is one of the essential issues 
related to functionality of an enzyme. According to the supplier (New England Biolabs), 
optimal conditions for commonly used endonucleases are brought by buffers characterized 
by pH ranging from 7.0 to 7.9 and salt molarity between 60 and 150 mM (e.g. sodium 
chloride, potassium acetate, Tris-HCl). A crucial component of enzyme-destined buffers is 
magnesium chloride.169 Mg2+ ions are essential co-factor of the endonuclease reactivity and 
use of other metal ions is not suitable. The former study reports on the use of an enzymatic 
reaction buffer whose composition merely corresponds to one commercially available.146 
When several experimental steps are concerned, the success of SPRi-based assays relies on 
design of a well adapted running buffer applied in the course of a whole experiment. The 
project here reported, needs application of such reaction environment that is adapted not 
only to enzymatic cleavage but also ensures optimal DNA hybridization and 
biocompatibility with cellular sample. Within this study, any extended optimization of the 
enzymatic reaction buffer is however not attempted and proposed conditions might not be 
ideal for both of herein assayed enzymes (PvuII, EcoRI). We consider that providing 
physiologically adequate environment is an essential concern of great importance in here 
developed microsystem finally applied to cell analysis. In this scope, the designed running 
buffer is based on PBS – a well known saline solution employed in biological research 
because of its isotonic to living cells character. The buffer is however supplemented with 
MgCl2 (10 mM) which, as we will see, triggers specific DNA hybridization signals and 
yields a satisfactory restriction enzyme activity as well.  
When considering enzymatic reaction of any kind, an important issue is to assign 
the amount of enzyme needed to catalyze the conversion of concrete quantity of DNA in 
optimal conditions. In the field of biochemistry, a functional parameter used to express the 
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enzymatic activity is number of enzyme units (U). In the particular case of a restriction 
enzyme, one unit is determined as the amount of the enzyme required to digest 1 µg of λ 
bacteriophage DNA in one hour, in total reaction volume of 50 µl and at 37°C. Therefore, 
protocols established to digest other DNA substrates need to be adjusted by taking into 
account the amount of target substrate and number of enzyme-specific sites.177 
Accordingly, minimal number of units that should be provided, in relation to quantity of 
oligonucleotide material immobilized on gold surface (estimated to 2 pmoles), is 
approximated to barely few units. (Appendix D) The previously reported work states that 
250 U of the restriction enzyme is the optimal value to achieve fair cleavage in a biochip 
format.146 However, those results concern digestion of microarrayed DNA realized in static 
bulk solution merely placed on the biochip surface. SPRi optical technique combined with 
proper microfluidics system provides proper dynamic flow conditions. This is 
characterized by different mass transfer phenomena compared to static experiments based 
on end-point analysis (e.g. fluorescence read-out) where enzyme is generally incubated 
within 1-2 hours.75 Therefore, the kinetics of enzymatic reaction observed in both cases is 
different and can not be directly referred.  
The flow cell used in SPRi experiments is of small volume (~15 µL) and a sample 
introduced to bulk solution sustains particular mass transfer conditions strongly depending 
on the running buffer flow rate. A crucial element of digestion driven by restriction 
endonucleases is their binding to DNA polymer and linear diffusion along it, until target 
restriction DNA sequence is reached. Such mechanism implies spontaneous enzyme 
association with substrate, followed by DNA molecule scanning and enzyme dissociation 
which frequency depends on the applied flow parameters. In fact, when imposing low flow 
rate, we increase the probability of enzyme interaction with several dsDNA, as opposed to 
a higher flow rate that generates faster protein washing away from the biosensing surface. 
Indeed, when loading the enzyme sample (even up to 200 U) at a flow rate applied during 
injections of the molecular specimens (20 µL/min), SPRi signal remains unchanged after 
the enzymatic solution is washed off the reactor. This means that the protein molecules can 
not efficiently act on DNA strands and thus the enzymatic digestion does not take place. 
Satisfactory result may be registered not until running flow is decreased enough, allowing 
enzyme molecules to sufficiently interact with the immobilized substrate.  Cleavage 
efficiency is therefore conditioned by dynamic flow parameters and also, as we will see 
below, by the amount of enzyme entities introduced into the bulk solution.  
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Figure 3.3 Enzymatic reaction efficiency in the biochip format. a) enzymatic cleavage yield (Y) observed for 
different enzyme content (EcoRI in red, PvuII in blue); b) estimation of cleavage efficiency as ratio of SPRi 
signal triggered by enzyme  loading (∆RE) to reflectivity shift upon IgG–DNA hybridization (∆RIgG). Enzyme 
injections are performed at 7 µL/min flow rate. 
 
To execute enzymatically driven release of molecular targets, we inject EcoRI or 
PvuII sample at decelerated flow of 7-10 µL/min, thus providing 20-30 min of reaction 
time. Figure 3.3 demonstrates a comparative study of the enzymatic cleavage efficiency 
depending on a number of the enzymatic units loaded to the biochip system. These data 
evidence cleavage yields corresponding to different amount of the injected restriction 
enzyme ranging from 10 to 200 U. The yields are represented as percentage of the relative 
reflectivity signal lost upon enzymatic digestion in comparison to the reflectivity shift 
previously triggered by the relevant IgG–DNA hybridization. As we may note, cleavage 
efficiency increases with number of enzymatic units used in the experiment and the highest 
yield is observed at 200 U (up to even 93%). This value is significantly higher compared to 
one suggested by theoretical calculations which mention only few enzyme units required to 
digest the given amount of DNA substrate. It is probably because the designed biochip 
molecular assembly relies on antibody addressing to DNA substrate (via IgG–DNA 
conjugate) which may induce certain level of steric hindrance and possibly reduce the 
probability of enzyme interaction with the target oligonucleotide strand. Even if cleavage 
is not complete, we consider the yield of 80-85 % as a satisfactory result and consequently 
opt to apply the evaluated enzyme content in digestion sample (200 U). Taking into 
account further application of the developed system, such solution additionally seems 
correct, since DNA/antibody surface-density will not be the only parameter regarding to 
enzyme accessibility to the substrate. Indeed, incubation of cellular targets may 
additionally reduce direct access to underlying restriction sites because of the cell size and 
probable physicochemical interactions with the enzyme. Need for high enzymatic content 
may be furthermore explained by the fact that conditions of the designed experiment are 
not exactly corresponding to enzyme supplier recommendations in terms of reaction time 
(20 min instead of 1 h), bulk solution volume (barely few microlitres, hydrodynamic flow) 
and optimal buffer composition (PBS + MgCl2).  
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3.2.2 Real time monitoring of enzymatically driven release 
The aforementioned considerations are taken into account in order to realize 
successful cleavage of different target DNA strands immobilized on gold surface by 
polypyrrole chemistry. As we learnt before, SPR imaging technique is a versatile tool to 
observe in real time the construction of probe-specific assembly on the biochip. It allows 
us not only to follow step-by-step generation of molecular architectures but also their 
programmable degradation produced over enzymatic digestions. Molecular target release 
may be straightforwardly registered by relevant reflectivity signal decreases and cleavage 
efficiency therefore properly assigned. In the case of the present study, three particular 
molecular assemblies are built in order to achieve enzyme specific release of two antibody-
DNA targets in two separate steps. Consequently, this experimentation scheme will be 
extended to programmable desorption of cellular samples captured on appropriate biochip 
molecular build-up.  
Analogously to the previously reported on-chip assembly, we herein make use of 
DNA-biochip arrayed with four oligonucleotide probes devoid of cross-hybridization 
possibility: Zip1, Zip2 and Zip3 as well as a non-relevant negative control probe (NC). 
Experiment is entirely carried out at 37°C and in PBS (pH 7.4) supplemented with 10 mM 
of MgCl2. The running buffer is delivered at 20 µL/min flow rate during molecular 
assembly construction and 7-10 µL/min when restriction enzyme is injected. Prior to target 
injections, biochip is incubated with PBS solution of 1 % BSA within 15 min, formerly 
reported in enzyme-based assays realized in a DNA biochip format.122 It seems to be a 
good blocking solution regarding to restriction enzymes used in the present study if we 
take into account the values of their isoelectric points (pI). This parameter may be easily 
found with help of an online calculation tool178 based on primary structure of desired 
enzyme or protein that can be, as to it, retrieved from Protein Data Bank website.172 Thus, 
EcoRI enzyme results in pI ~ 6.2 and PvuII one is approximated to ~ 6.5. It means that in 
the condition of running buffer pH, injected enzyme molecules are characterized by 
negative total charge similarly to the adsorbed on gold BSA (pI=4.7) and we may expect 
their repulsion from surface.  
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As previously described, the first step of the three-component molecular assembly 
is given by hybridization of an intermediate strand complementary to Zip sequences and 
the final one by injection of an IgG–oligonucleotide conjugate. (Fig 3.4) The independent 
molecular assemblies are equipped with three different restriction sites corresponding to 
different enzymes EcoRI, PvuII and NcoI, where the last one is actually not used in the 
enzymatic release strategy and serves as control. Subsequently to successive hybridizations 
and complete molecular build-up, the enzymatic cleavage is fired by consecutive injections 
of two endonucleases (EcoRI and PvuII enzymes,  200 U each). Incubation with EcoRI 
enzyme results in reflectivity signal drop observed for Zip1 probe which correctly 
corresponds to EcoRI restriction sequence. SPRi responses simultaneously confirm the 
integrity of Zip2 and Zip3 molecular assemblies based on PvuII and NcoI sequences, 
respectively. The latter step of the enzymatically driven release is performed by injection 
of the second restriction enzyme PvuII in analogous experimental conditions. Once again, 
control NcoI-containing hybrid architecture remains intact (Zip3) whereas PvuII-based 
signal probe (Zip2) exhibits similar negative SPR response as Zip1 probe formerly 
concerned by cleavage. We may thus state that the developed biochip conditions provide 
target-specific enzymatic cleavage amenable to being applied in tunable strategies.  
Figure 3.4 Enzymatic cleavage of the biochip molecular assembly monitored by SPRi. (t0) Zip1, Zip2 and 
Zip3 probes grafted on the gold surface; (t1) intermediate strand hybridizations (Zip1*–EcoRI, Zip2*–
PvuII, Zip*3–NcoI); (t2) immobilization of IgG–DNA conjugates (rab-IgG–EcoRI*, rab-IgG–PvuII*, rab-
IgG–NcoI*); (t3) EcoRI enzymatic cleavage; (t4) PvuII enzymatic cleavage. All SPRi signals are rectified 
by a subtraction of NC signal (negative control probe). 
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Kinetics of enzymatic reaction is a parameter that, in the case of here proposed 
biochip system, can not be properly studied. This is because injection of enzyme solution 
generates global refractive index change observed by SPR imaging as an abrupt reflectivity 
rise. (Appendix E) Such effect results from abundant composition of the enzymatic sample 
(protein, up to 5% of glycerol) which strongly affects optical properties of the reaction 
medium neighboring the biomolecular features immobilized on the surface. Consequently, 
subtraction of the negative control (NC signal) results in over-correction of the SPRi signal 
mainly due to the lack of its linearity in the conditions of considerable refractive index 
change (SPRi signal saturation). Thus, a straightforward interpretation is disabled during 
the enzymatic incubations and enzyme functionality can not be assigned as long as it is not 
washed off the reactor. Nevertheless, the cleavage specificity is unanimously proven by 
differential images issued from SPRi monitoring. (Fig. 3.5) Together with ∆R signals, they 
confirm high level of enzymatically driven release that is estimated to about 85 %. These 
findings are conclusive when considering programmable target release which will be 
consequently explored in living cell assays. 
 
 
 
 
 
 
 
 
 
Figure 3.5 Differential SPR images registered upon molecular assembly and enzymatic release steps.  
(t1) hybridization of intermediate strands on Zip1, Zip2 and Zip3 probes; (t2) complete molecular build-up 
involving IgG-DNA conjugates (rab-IgG–EcoRI*, rab-IgG–PvuII*, rab-IgG–NcoI); (t3) EcoRI enzymatic 
digestion directed to Zip1 substrate; (t4) PvuII enzymatic cleavage executed on Zip2 molecular assembly. 
The observed spots are of 800 µm in diameter.  
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3.3 Specific capture and controlled release of living cells followed by 
SPR imaging 
 
3.3.1 Cellular samples 
The designed biochip capture–release strategy is finally applied to live cells – 
lymphocytes essentially, involved in immune response phenomena. Such approach 
provides an important development in the matter of novel research tools employed in the 
field of immunology and hereby fulfill the objectives brought by the present PhD thesis. At 
first, we conduct a proof-of-concept study with well-defined cells issued from established 
cell lines. Consequently, we make use of the enzymatically driven release strategy to 
primary cells directly issued from a living organism. 
The initial study is realized with B- and T-type lymphocytes originating from 
regular cell lines: 3A9 and LS-102.9, kindly provided by P. Marche from Institut Albert 
Bonniot (IAB) in La Tronche (France). The first cellular type corresponds to T cell 
hybridomas whereas the latter one is represented by B lymphocyte hybridomas. Hybrid 
cell lines, so-called hybridomas, are bioengineered cells produced by fusion of a specific 
cell of interest (e.g. antibody-producing B lymphocyte or activated T cell) with parent 
tumor cells (e.g. myeloma or thymoma cells). This technology was originally developed to 
produce high amount of monoclonal antibodies from stable and rapidly dividing cell lines. 
Indeed, hybridomas have the capacity to grow spontaneously in standard culture conditions 
devoid of stimulating components and are therefore interesting tool for biological research. 
Hybrid cells are featured by their intrinsic properties established from the original cell and 
may, for instance, secrete a specific antibody or cytokine. Here employed 3A9 and LS-
102.9 cell lines are characterized in terms of membranar marker expression and 
demonstrate high-level expression of CD19 marker on LS-102.9 (CD19+ CD90-) and 
CD90 by 3A9 (CD90+ CD19-). These phenotypes enable to realize controlled addressing 
of living cells on microarray by using cell-specific antibodies.79 
Excepting lymphocytes issued from cell lines, we subsequently assay the developed 
biochip system on primary cells retrieved from mouse spleen. In a living organism, this 
organ plays an important role in active immune responses. Apart from red blood cells, 
spleen is built out of lymphoid tissue aggregates, composed of a large variety of B and T 
lymphocytes and other accessory cells (monocytes, dendritic cells). Here used splenocytes 
are a mixture of B and T lymphocytes (with large majority of B type cells) that is collected 
from C57Bl/6 adult mice and directly provided from IAB. Manipulation of primary cells 
issued from a living organism is more demanding compared to well-established cell lines 
because of their fragility and culture requirements. Indeed, splenocytes freshly isolated 
from mouse spleen need to be cultured in enriched culture medium in order to stimulate 
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specific marker expression and ensure efficient cell proliferation. Therefore, prior to use in 
the biochip assay, the mixture of primary B and T lymphocytes is incubated for 24 – 48 
hours in complete culture medium at 37°C (cf. section 6.2.7). The incubation solution is 
supplemented with antibiotics and concanavalin A – a mitogenic agent particularly 
increasing T cell division.179 Even if working with cell lines seems to be a more practical 
solution, studies on primary cells constitute an important advance. In this case, cells 
originate from a physiologically independent organism and are not obtained from 
biotechnological manipulation. Such approach gives therefore the opportunity to precise 
determination of immunological response in relation to a specific biological subject (e.g. 
patient).   
 
3.3.2 Adaptation of the experimental conditions to living cells 
When working with living cells, an important concern is to ensure that the 
experimental conditions are compatible with the biological sample. The parameters 
formerly optimized for enzymatic digestion purpose fit fairly well with the prerequisites of 
a biochip system where cell injection and incubation are performed. Namely, microfluidic 
set-up is built by using biocompatible PEEK material, highly adapted to cell-based 
microsystems. Besides, experimental protocol enabling efficient enzymatic release from 
the biochip surface is designed to maintain bulk solution temperature at 37°C and 
anticipates use of PBS-based running buffer – conditions closely related to physiological 
environment. Biocompatibility of PBS buffer supplemented with 10 mM of MgCl2 is 
assessed empirically. Indeed, primary lymphocytes, a priori more susceptible to 
unfavorable environmental conditions in comparison to stable cell lines, demonstrate high 
level of viability when incubated in the proposed running buffer within a few hours. (Fig 
3.6) Noteworthy is the fact that commercially available buffers optimized for enzymatic 
reaction are hardly adapted to cell-based assays. Some of commercial buffers might 
contain a particular supplementation providing enzyme stability and activity. Such 
formulation which may also influence cellular physiology and reduce viability of cells (e.g. 
surfactant Triton X-100 added to EcoRI buffer). Application of PBS buffer supplemented 
with magnesium ions providing efficient enzymatic digestion is therefore a well-grounded 
solution.  Therefore, PBS + 10 mM MgCl2 formulation is implemented as a running buffer 
all along the experiment, i.e. molecular assembly construction, lymphocyte capture and 
incubation, and finally enzymatic cleavage step.  
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a) Surface blocking optimization 
Introduction of a cell suspension on the biosensing surface implies an important 
optimization step aiming to establish an adequate state of surfaces of contact. Alike the 
aforementioned enzymes, there exists an important need to provide proper treatment of the 
biochip surface in order to reduce non-specific adsorption of cells which may occur 
independently from the hydrodynamic conditions. Namely, living cells are decorated by a 
large variety of biomolecules (lipids, proteins and sugars) and can thus interact with their 
surrounding environment (e.g. biochip surface) by the means of physicochemical 
interactions of different nature: electrostatic, hydrophobic, dispersion (e.g. Van der Waals 
interaction), by hydrogen bonds, etc. From the cell micropattern point of view, surface 
modification is therefore a key requisite in order to ensure proper cell immobilization 
assisted by the absence of any non-specific interactions.  
In this matter, many approaches are based on poly(ethylene glycol) self-assembled 
monolayers (PEG-SAM) that are stable in time and shown to efficiently inhibit protein 
adsorption.180, 181 Chemically modified PEGs are characterized by more hydrophilic 
properties and thus increased cell-repellent ability.182, 183 Good results are observed as well 
with PEG chains covalently linked to surface in the form of microgels capped with an 
adequate protein. Therefore, PEG-microgels capped by BSA exhibit an efficient resistance 
to cell adhesion in contrast to bovine fibrinogen-capped coatings.184  
Apart from PEG chemistry, high-molecular-mass organosilane compounds 
equipped with perfluoroalkyl groups are proposed as an alternative solution for protein- 
and cell-repellent surface modifications.185, 186 However, these are examples that mainly 
require precise surface engineering provided by microfabrication methods in combination 
with molecular assembly techniques. It makes object of an extensive review by D. 
Figure 3.6 Monitoring of splenocyte viability in different incubation media. Cells are incubated within 3 
hours at 37°C in the conditions of 95% humidity and 5% CO2. The assayed buffers are: RPMI culture 
medium (supplemented with 10% FBS, 50 U/mL penicillin and 50 µg/mL streptomycin), PBS (pH 7.4), 
PBS + MgCl2 (10 mM), EcoRI commercial buffer (50 mM NaCl, 100 mM Tris-HCl, 10 mM MgCl2, 
0.025 % Triton X-100, pH 7.5). Considerable loss of viability is observed in the EcoRI buffer unlike the 
other solutions. The increase of viability in time results from eradication of dead cells.  
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Falconnet et al.187 In our approach we do not benefit from such advanced techniques to 
elaborate biosensing surface which is based on polypyrrole chemistry. That is why for the 
need of our study, we will use a simple alkane-thiol blocking (1-dodecanethiol) combined 
with protein backfilling. Application of this protocol, as we will see, results in a 
satisfactory effect. 
The present work relies on biochip fabrication that is founded upon electrochemical 
deposition of probes over hydrophobic gold surface generated by former incubation with 1-
dodecanethiol solution. In order to produce a cell-repulsing layer, common strategies 
involve surface backfilling with proteins. For cell-based assays, one of the solutions is to 
realize surface passivation by using running buffer (or even culture medium) supplemented 
with fetal bovine serum (FBS). FBS is prenatally collected from calf and contains a large 
variety of proteins (mainly BSA). It is frequently used as component of the culture medium 
employed for in vitro cell cultures. In a protocol proposed by S. Milgram (CREAB), 
blocking solution consists of RPMI medium supplemented with 10 % of FBS and is 
applied prior to introduction of cell samples on the microarray surface.30  
Preliminary tests realized within the framework of the present study show that the 
protocol cited above may not be suitable. Namely, upon incubation with 10 % FBS in PBS, 
considerable decrease of hybridization signals is observed. We speculate that this may be 
due to phenomenon of surface over-loading or even degradation of DNA probes. However, 
this can not be certainly concluded because FBS-based solution was attempted point-wise 
and no regular studies confirm the unfavorable conditions. Consequently, we decide to 
switch to blocking solutions based on bovine serum albumin previously employed in the 
enzymatic cleavage experiments. 
Several tests with BSA-containing solutions realized under microscopic 
observations evidence that a longer incubation (45 – 60 min) with blocking buffer exhibits 
lack of the non-specific cell adsorption (images non-available). Optimal effect is observed 
with PBS-based solution containing 10 µM of BSA and supplemented with cytochrome c 
at 5 µM of final concentration. In practice, these two proteins have different 
physicochemical properties. Namely, BSA is a 69.3 kDa commonly used protein with an 
isoelectric point of 4.7 whereas cytochrome c is a smaller protein (12.4 kDa) with more 
basic isoelectric point of about 10. It means that in the conditions of the running buffer pH 
(7.4), the two proteins demonstrate divergent values of net molecular charge: BSA is 
negatively and cytochrome c positively charged. Regarding to these characteristics, we 
may consider that these two components differently interact with biosensor surface and 
thus provide higher backfilling of out-of-spot surface. That is why, the BSA/cytochrome c 
blocking solution will be preferentially used in the cell-based assays.  
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b) Microfluidic parameters in regard to cellular sample injection 
The complexity of cellular samples leads us to consider not only physicochemical 
concerns as buffer content or blocking strategy. Lymphocytes introduced into the biochip 
system are of microscopic size (~ 10 µm in diameter) and therefore submitted to 
mechanical constraints when channeled through the microsystem. Owing to their 
volumetric properties, cell diffusion in a microfluidic system is particularly conditioned by 
mass transfer parameters such as the running buffer viscosity, microfluidic tube cross-
section, flow rate and presence of counter ions. Adapted microfluidic system should be 
based on tubes of sufficient internal diameter in order to reduce risk of shear forces 
possibly exercised on the injected cells. For the sake of the present study, the cell-destined 
tubing is characterized by ID of about 760 µm unlike 250 µm ID of microfluidic tubes 
providing molecular sample flow through (building blocks of the biochip molecular 
assembly and restriction enzymes). To do so, the system is additionally equipped with a 
switchable 200 µL secondary loop devoted to injections of lymphocyte samples. Cell 
injection loop is installed directly over the flow cell (so incubated at 37°C during whole 
experiment) and separated from bulk solution by a small dead volume (less than 10 µL). 
(Fig 3.7) Injected cells promptly arrive over functionalized surface and are not retained in 
tubing for a long time (sample loop is loaded just before the injection to reactor). Such 
approach enables moreover to physically isolate two steps of the experiment: specific cell 
immobilization and enzymatically driven cell release from the surface. 
 
 
Apart from the employed microtubing, flow cell is other essential element of fluidic 
system set-up. Design of a flow cell module (i.e. volume, shape) imposes proper 
hydrodynamic constrains that are responsible for mass transfer in the liquid environment 
directly surrounding the biosensing surface. Reaction chamber construction conditions the 
diffusion profile of ions and small molecules, and particularly influences bigger entities 
like biomolecules and living cells. We observe that lymphocytes introduced to bulk 
solution exhibit different behaviors depending on flow module dimensions conditioning 
Figure 3.7 Microfluidic set-up with two separate injection valves. Secondary injection loop is engaged in 
the flow exclusively during cellular sample injections.  
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bioreactor volume and cell distance from specifically functionalized interface. Use of deep 
reaction chamber (600 – 1000 µm in depth) requires employment of low flow rates (10 
µL/min) in order to ensure sufficient sedimentation of cell entities in the neighborhood of 
specific antibodies situated over DNA biochip matrix. However, such approach hardly 
enables to control specific addressing of cells on surface and mainly incites their non-
specific adsorption registered by SPRi (Fig. 3.8). That is why, a suitable solution is to 
implement reaction chamber module of smaller volume that allows driving cells closer to 
their recognition site and makes cell capture from dynamic flow easier.  
 
 
 
 
In the present experimentation, two PEEK-made flow cells are employed ensuring 
reaction chamber of an approximate volume of 15 µL and 100 µm in depth. (cf. Fig. 3.9 
and Appendix F) In these conditions, we opine to have laminar flow with a cone-shaped 
streamline by taking into account aqueous character of the running buffer, the small cross-
section and relatively low flow rate. This feature may be indicated by non-specific 
adsorption of injected cells depending on flow conditions. Indeed, at certain value of flow 
rate, hybridomas have tendency to non-specifically adsorb in lateral zones of the flow cell 
whereas central biochip reveals specific on-spot immobilization of the introduced cells. 
From this example, we see that velocity of running buffer stream is a crucial element and 
has to be individually adapted to each injected cell type. 
 
 
 
 
 
Figure 3.8 Non-specific adsorption of lymphocyte hybridomas in non-adequate flow conditions. Applied 
flow rate is too slow (10 µL/min) and flow cell too deep (here 600 µm) which correspond to a very weak 
linear velocity (0.03 mm/s at the central cross-section). Cells are mainly adsorbed near the inlet of the 
reactor. Observed halo effect results from insufficient adjustment of micro-pipette tip to the gold surface 
during electrospotting process (proper spot diameter is 400 µm).  
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Generally, optimal flow rate needs to be sufficiently high to minimize non-specific 
adsorption of cells on surface and low enough to ensure cell interactions with specifically 
binding antibodies. In practice, during injections of the cellular samples a compromised 
flow rate is applied in order to generate a volumetric mass transport adequate to injected 
cell sample. We remark higher values for hybridoma samples (50 – 100 µL/min) than for 
primary cells (20 – 60 µL/min), which may be explained by different levels of surface-
marker expression determining the probability of lymphocyte capture. An average linear 
flow rate observed at central cross-section of the 100 µm deep bioreactor is estimated to 
1.25 mm/s for hybridomas and 0.67 mm/s for primary lymphocytes. Alternative solution to 
aforementioned type of flow cell may be exemplified by serpentine-type PEEK module 
where injected samples are directly flown over functionalized spots.(Fig. 3.10) In the case 
of hybridoma injection, such system exhibits specific capture of lymphocytes devoid of 
side-adsorption at low running buffer flow rate (down to 10 µL/min which corresponds to 
0.83 mm/s  of flow velocity). 
 
 
 
Figure 3.9 Schematic design of the PEEK-made flow cells applied in the study.  
a) hexagon-shaped flow cell used for the experiments with hybridomas; b) oval flow cell employed in 
assays with hybridomas and primary cells; c) central cross-section of the reaction chamber lumen. In order 
to enable efficient immobilization of lymphocytes, flow cells work at linear flow rates of 0.33-1.67 mm/s 
(observed at the central cross-section), depending on the injected cell type.  
  
Figure 3.10 Serpentine-type flow cell potentially used in the cell capture experiment. 
 a) Photograph of PEEK module with serpentine shape flow (upper caption details the dimensions of the 
flow channel lumen); b) SPR differential image upon injection of T lymphocyte hybridomas (3A9) at 10 
µL/min; cell are specifically immobilised on Zip2 spots (on red) without significant side-adsorption. 
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3.3.3 Specific immobilization of murine cell lines and their subsequent 
enzymatic desorption 
The study here described is carried out with B- and T-type hybridomas (murine cell 
lines) that are specifically addressed to biochip surface by dint of specific antibodies (IgG 
anti-CD19 and IgG anti-CD90). Once 3A9 and LS-102.9 lymphocytes are captured, we 
proceed to their sequential release through an enzymatic digestion protocol. The test 
realized on cells issued from well-established cell lines is interpreted as a proof-of-concept 
approach that defines necessary experimental step before the biochip strategy is finally 
applied to primary lymphocytes. For this purpose, a DNA-microarray with 
electrochemically generated Zip spots is placed in SPRi configuration and turned into cell 
capturing antibody microarray in the course of the experiment. Accordingly, following 
antibodies are introduced onto the biochip: anti-CD19 IgG covalently coupled to EcoRI* 
sequence and having great immunoaffinity to B cell (LS-102.9)188 as well as anti-CD90 
IgG combined with PvuII* oligomer which corresponds to T-cell (3A9) recognition (cf. 
Fig.3.1).189 On-spot cell immobilization phenomena are registered by proper reflectivity 
shifts observed on Zip1 and Zip2 signals which correspond to specific capture of B and T 
lymphocytes respectively. (Fig 3.11)  It is demonstrated that the injected cells are not 
recognized by non-relevant antibody tethered on control Zip3 spots. Furthermore, we can 
notice that SPRi signals triggered upon the injections of lymphocytes hardly attain a 
plateau. We suppose that this may be the effect of cell on-spot flattening, generated by 
membranar marker recruitment near the site of their specific recognition. Condensation of 
the plasma membrane at the site of lymphocyte activation190 is driven by the intrinsic 
dynamics of the bilipidic layer which enables diffusion and organization of 
transmembranar domains.191 
  
 
 
 
Figure 3.11 SPRi monitoring of specific immobilization of B and T hybridomas.  
a) SPR signals observed upon injections of T cell hybridomas 3A9 (red arrows) and B cell hybridomas 
LS-102.9 (blue arrows); b) differential images registered after each cell capture step (800 µm of spot 
diameter). T lymphocytes are captured on Zip2 probe and B cells on Zip1 probe thanks to specific 
molecular assembly (anti-CD90 IgG and anti-CD19 IgG respectively), whereas no cell is observed on 
control Zip3 probe.  
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As a consequence of stepwise injections of cellular samples, we however observe 
slight decreases of SPRi signals that are not concerned by factual cell incubation. 
Declining reflectivity results from subtraction of the negative control probe signal (NC) 
which is probably more affected by refractive index variations of the background solution. 
We speculate that hybridoma samples may contain residues of culture medium that are 
susceptible to interact with spots equipped with bare DNA strands. Nevertheless, B and T 
lymphocytes are correctly trapped on corresponding spots which is confirmed on 
differential images obtained from the SPR imaging apparatus. Apart from accurate 
construction of the biomolecular assembly, we may thus clearly identify zones of specific 
lymphocyte recognition. Observations of differential images evidence efficient addressing 
of hybridoma cells on appropriate molecular architectures which furthermore confirm the 
high expression of membrane markers: CD19 on LS-102.9 and CD90 on 3A9.  
Interestingly, specific capture of B- and T-type lymphocytes takes place even at 
very low density of grafted DNA probe and consequently immobilized antibody. High 
level of immunorecognition is proven by many cell attachment events observed on spots 
grafted with barely 0.2 µM solution of oligonucleotide or even registered on characteristic 
“comet tail” resulting from inappropriate rinsing step (realized directly after the 
electrospotting process). (Fig. 3.12) It is noteworthy to point out that immobilization of 
living cells on a microarray, in reality depends on density of antibodies grafted throughout 
DNA matrix. In the present study, DNA matrix obtained with low spotting concentration 
(oligonucleotide probe at 0.2 – 1 µM) results in satisfactory capture of hybridoma. As we 
will see later on, grafting density needs to be increased in case of primary cells that express 
less cell-specific markers in comparison to well established hybridoma.  
 
 
 
In order to complete biochip system performance, once lymphocytes are 
specifically trapped on the microarray, subsequent enzymatic digestions are fired and 
followed in real time by SPRi. Restriction endonucleases are introduced into reactor in 
separate steps by using the primary injection valve and not the one accessorily installed 
and devoted to cellular samples. (Fig. 3.7) Therefore, properly loaded enzyme arrives to 
Zip3 
(rab-IgG) 
Zip1 
(anti-CD19) 
Zip2 
(anti-CD90) 
Figure 3.12 Immobilisation of B and T lymphocyte hybridomas on spots exhibiting “comet tail”. Comet 
effect is evidenced by SPRi and caused by inappropriate rinsing step following the electrospotting process. 
Interestingly, cells are captured on comet tail as well, which may prove high expression level of specific 
membrane markers. Spots have a 400 µm diameter.    
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the reaction chamber in about 1 min and flow rate is then decreased to the desired value of 
7-10 µL/min. Such proceeding provides sufficient incubation time to ensure efficient 
biomaterial release. Even if during this time SPRi signal can not be directly interpreted, 
once enzyme is washed off from the bulk solution, desorption events are evidenced (Fig. 
3.13) 
 
 
Indeed, EcoRI-specific signal drop is observed on Zip1 and followed by a negative 
reflectivity variation registered on Zip2 upon PvuII enzyme injection. Responses induced 
by enzymatic cleavage steps are however not precisely consistent with those triggered 
upon cell capture. We may thus think that cell release is not complete or even that the 
released lymphocytes are non-specifically retained near biochip surface in the conditions 
of decreased flow. Confirmation of specific cell release is however brought by analysis of 
SPR differential images registered after the enzymatic cleavage steps. Indeed, we can 
clearly remark localized desorption of biological objects as soon as the accelerated flow 
washes out the enzymatic sample. Differential images prove individual lymphocyte 
detachment events that are referred to microscopic cell-prints, observed after the relevant 
digestion steps. B-type hybridomas are shown to be desorbed in EcoRI step as opposed to 
T-type hybridoma release by PvuII driven digestion. The obtained results meet the 
requirements of proof-of-concept approach and consequently allow us to execute this 
programmable release strategy on more fragile cell samples, such as splenocytes. 
Figure 3.13 Real-time monitoring of subsequent release of B and T lymphocyte hybridomas specifically 
immobilized on the antibody-DNA matrix. 0–60 min: hybridization of IgG-DNA conjugates (anti-CD19–
EcoRI*, anti-CD90–PvuII*, rab-IgG–NcoI*); 60min: injection of 3A9 hybridomas; 75min: injection of 
LS-102.9 hybridomas; 120–150min: digestion by EcoRI enzyme; 190–215min: digestion by PvuII 
enzyme. Differential image captions represent Zip1 and Zip2 spot (800µm of diameter) before and after 
the enzymatic cleavage steps by EcoRI and PvuII, respectively. All SPRi signals are rectified by 
subtraction of NC signal (negative control probe). 
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3.3.4 Capture/release strategy employed to primary cell assay 
Application of the designed capture–release biochip system to primary cells is a 
challenging approach. Cells used in the present study are retrieved from the spleen of a 
wild-type mouse (C57Bl/6) and defined as a mixture of various B- and T- type 
lymphocytes in different ratio. In contrast to well established cell lines, splenocytes are less 
regular regarding to expression of the specific marker and more troublesome in culture 
because they do not divide spontaneously unless stimulation protocol is applied. Non-
stimulated primary cells are small and, as experience shows, hardly observable when 
introduced to SPRi-based biochip. We speculate that freshly isolated from spleen cells are 
resting lymphocytes characterized by low level of cellular metabolism. Possible features of 
such state are reduced cytoplasmatic volume as well as low exposition of membrane 
domains which disable efficient on-chip capture and SPRi detection. In order to disrupt this 
kind of “stand-by” physiology, the splenocytes must be activated prior to injection. This is 
realized by incubation in complete culture medium supplemented with concanavalin A 
(ConA). ConA is a growth factor particularly inducing proliferation of T lymphocytes179 
which fraction is minor in the assayed cellular sample. Cells are incubated in controlled 
atmosphere (37°C, 95% humidity, 5% CO2) for 24 - 48 h and their accurate stimulation 
assigned by classical microscopy observations – activated lymphocytes appear bigger and 
form aggregates. Prior to injection into biochip system, cultured splenocytes are recovered 
in the cell-compatible running buffer (PBS + 10 mM MgCl2). 
Analogously to the study realized on hybridoma cells, step-by-step process of the 
multi-spot building-up as well as cell capture events are monitored in real time by using 
SPR imaging. (Fig. 3.14) The ability of designed microarray to specifically immobilize 
primary cells is therefore investigated. To do so, we execute DNA-directed immobilization 
of antibodies specific towards membranar markers expressed by different immune cell 
populations: anti-CD19 IgG targeting immune B lymphocytes and anti-CD90 IgG directed 
to T lymphocytes. Three-component architectures are built, containing anti-CD19 or anti-
CD90 on Zip1 and Zip2 probe, respectively. Alike to previous tests, Zip3 probe is 
deployed as a negative control to both enzymatic cleavage (NcoI restriction site) and 
immobilization of living cells. In the present study, Zip3 probe is indirectly assembled with 
IgG–NcoI* conjugate obtained for a non-relevant monoclonal antibody. Namely, anti-HcB 
mouse IgG, kindly provided by L. Bellanger from CEA/IBEB (Marcoule, France), is 
directed to a non-relevant HcB domain. The use of the non-specific monoclonal antibody 
instead of a classical polyclonal IgG is required to avoid improper cell binding.  In fact, a 
polyclonal IgG (e.g. isolated from rabbit serum) is not advisable because of its unknown 
affinity to cells originated from a wild-type organism.   
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Consequently to correct molecular on-chip erection, splenocytes are introduced 
onto the microarray. In this case B and T cells are jointly injected and signal generated by 
lymphocyte immobilization may be solely differentiated from Zip3 negative control. The 
stepwise loading of the cellular sample surprisingly results in only slight increase of 
reflectivity signal which contrasts to signals observed for B- and T-type hybridoma. We 
attempt however to explain this finding by the fact that splenocytes expose probably fewer 
specific markers compared to the cell lines. The observed SPRi signal is weak since a 
small amount of primary cells is captured but also because only minor fraction of cellular 
volume penetrates within the detection layer (resulting from 100 nm evanescent wave). 
Nevertheless, specific on-biochip capture of the injected lymphocytes is confirmed by SPR 
images and microscopic observations realized in an independent assay. Analogously to 
previously reported detection of hybridoma, primary lymphocytes are clearly visualized as 
discrete objects confined to anti-CD19 and anti-CD90 spots. (Fig. 3.15)  
Figure 3.14 B and T lymphocyte capture and sequential release by enzymatic cleavage  
a) SPRi monitoring curves: Step 1 - intermediate DNA strand hybridization (Zip1*–EcoRI, Zip2*–PvuII, 
Zip*3–NcoI); Step 2 - IgG–DNA conjugate immobilization (anti-CD19–EcoRI*, anti-CD90–PvuII*, anti-
HcB–NcoI*); Step 3 - injections of splenocytes (containing both B and T lymphocytes); Step 4 - 
lymphocyte T specific release within PvuII enzymatic cleavage; Step 5 - lymphocyte B specific release 
within EcoRI enzymatic cleavage. All SPRi signals are rectified by subtraction of NC signal (negative 
control probe). b) microscope images (×4) of the captured cells. c) SPRi differential images registered at 
the end of step 3 to 5 (reference images are taken at the beginning of each step in order to highlight the 
capture/cleavage specificity).  
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Specifically immobilized B and T lymphocytes are eventually submitted to 
orthogonal release from the biochip surface, performed by incubations with PvuII and 
EcoRI endonucleases. Similarly to former findings, reflectivity variations confirm fast and 
specific cleavage precisely restrained to spots equipped with the relevant restriction sites. 
Once again, important drops of reflectivity are registered on the Zip1 and Zip2 signals, and 
specificity of the enzymatic digestion is proven by the integrity of non-concerned Zip3 
control signal. Even if the reflectivity variations are mainly related to loss of molecular 
assembly, withdrawal of the individual cells from the microarray is clearly monitored by 
zooming in on the individual spot features (Fig. 3.15). We may thus identify well resolved 
cellular entities and validate their prompt detachment (over barely few minutes) in the 
enzymatically driven release step. This experiment shows that specific capture of primary 
cells can be followed by their programmable orthogonal release in the format of the 
proposed biochip system.  
 
 
 
3.3.5 Cell recovery upon the enzymatic release steps 
An important feature of cell sorting system is not only to provide programmable 
selective fractionation of cell populations but also efficient recovery of the discriminated 
fractions. The biochip here designed biochip relies on DNA-directed immobilization of 
cells on the microarray, thus providing their sorting into distinct spatial locations and 
guided by cognate antibody-oligonucleotide assembly. It is therefore an example of 
versatile platform for multiplexed sorting purposes.59 Successive enzymatic cleavage steps 
enable the controlled release of proper cell populations from well-defined biochip locations 
with the help of restriction endonucleases highly specific to the corresponding DNA 
sequences. Recovery of lymphocyte fractions desorbed in step-by-step process of the 
enzymatic digestion is subsequently attempted.  
Efficient collection of individual cellular fractions forming a part of more complex 
biological sample (e.g. blood) offers a priceless possibility for downstream analysis of 
specifically recovered cell types. Moreover, demonstration of functionality and viability of 
sequentially released cells is of great importance in the development of cell sorting 
strategies. That is why the released lymphocytes are collected in fractions desorbed in two 
separated enzymatic digestion steps. Accordingly, cells are retrieved directly from the 
Figure 3.15 Magnified views of a single Zip1 spot during EcoRI enzyme incubation. Image sequence 
shows spot evolution in time (0s image is the reference). Release of the individual cells is evidenced by 
dark imprints on the differential images. The star–like shape of the individual cells observed on SPR 
images is due to optical aberrations of the experimental set–up (see Appendix G). Image treatment is 
performed in ImageJ (Wayne Rasband, National Institutes of Health, USA). 
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outlet of microfluidics and in total volume of about 300 µL. Taking into account fair 
content of B and T lymphocytes in the released sample, it is extremely difficult to detect 
the eluted cells in such important sample volume. Indeed, visualizations of concentrated 
fractions reveal poor quantity of the recovered cells (only four cells were identified within 
three independent trials, cf. Fig. 3.16 b). This remains an important issue for downstream 
characterization.  
 
 
 
 
In regard to encountered difficulties to perform an easy detection of cellular entities 
issued from designed cell sorting experiment, further work should be carried out in this 
matter. As imaginable solution to increase the probability of cell disclosing in desorbed 
sample, we may imagine to extend the range of specific cell micropatterning or adapt 
microfluidics system to generate small sample volumes.192 An example of integrated set-up 
could enable on-line identification of released biological cells directly in the flow by 
guiding the sample through a narrow channel where the read-out of cell-specific signal can 
be done (e.g. by optical or electrical means193).  
Putting aside so sophisticated developments, we may nevertheless summarize that 
the overall findings reported in the present section give sufficient premises to suppose 
viability of lymphocytes introduced in the developed biochip configuration. Namely, we 
state the biocompatibility of running buffer and show that hydrodynamic flow conditions 
are harmonious with cellular sample which can be observed after being flown throughout 
microfluidics set-up (Fig. 3.16 a). Living cells specifically captured on biochip are 
additionally detected as discrete objects on SPR images and their morphological integrity 
may be furthermore confirmed by observations under classical microscopy. Moreover, 
lymphocytes trapped by interaction with specific antibody and incubated within several 
hours on a microarray surface demonstrate proper functionality registered for example as 
high level of secretion activity.29, 30 Here developed biochip strategy of “cell catch and 
release” may be hence considered as a promising approach for cell sorting purposes 
realized on complex biological samples.  
Figure 3.16 Lymphocytes observed over microscope. a) Surplus of injected to biochip splenocytes 
observed in sample retrieved from the outlet of microfluidics during injection; b) individual cell detected 
in a sample recovered upon enzymatic cleavage.  
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3.4 Application of the controlled capture-release strategy to bacterial 
sample analysis 
 
3.4.1 Biosensors devoted to microbiological assay 
Previous sections have shown that sequential enzymatic cleavage of DNA 
substrates immobilized on solid support may be turned to programmable procedure 
providing selective release of several cell populations captured on a DNA microarray. In 
the scope of applying such strategy to analyze various cellular samples, we evaluate the 
designed biochip system on cells other than lymphocytes and potentially devoted to other 
research areas. 
Development of micro-systems capable of multiparametric, rapid and precise 
analysis of bacterial samples is of great interest for both health and food safety issues. 
Standard protocols employed nowadays in this field are mainly laborious and require long 
preparations. That is why micro- and nanotechnologies emerge as desirable solution for 
novel research and diagnostic tools.194 Apart from many studies reporting on eukaryotic 
cells assayed in micro-devices (neurons, tumor cells, blood cells etc.), bacteria may be also 
introduced to similar systems of miniaturized format thus providing parallelized and high-
throughput screening of the sample of interest. One of the rapidly growing trends in the 
field of microarray technology is focused on development of microbial whole-cell arrays 
where bioengineered bacteria are patterned on a solid support and exploited as functional 
biosensing layers.195-197 Usefulness of similar systems is oriented to biotechnological 
applications (e.g. gene expression analysis) or to environmental specimen characterization 
(e.g. contamination monitoring or toxicity testing). On the other hand, microarray 
technologies are explored as sensitive platforms to realize fast and quantitative detection of 
bacterial strains, mainly for food safety purposes. DNA- or antibody-based biochips are 
employed to identify characteristic bacterial pathogens198-200 or accurately detect bacteria 
of a specified type.201, 202 Among others, SPR is reported as a label-free method for real-
time and qualitative assaying of bacterial sample.203 In the present work we combine SPR-
based technique and IgG–DNA conjugate chemistry to provide efficient detection and 
release of bacterial cells of interest. This approach is therefore an example of biosensing 
system potentially devoted to analyze samples of microbiological nature.   
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3.4.2 Bacteria capture and desorption from DNA-based biochip 
 In the present assay of cell capture and release, we use the bacterial strain 
Streptococcus pneumoniae (R6) provided thanks to collaboration with T. Vernet from the 
Institut de Biologie Structurale (IBS) in Grenoble (France). This bacterium is reported to 
be an important source of invasive infections in human and responsible for several diseases 
such as pneumonia or meningitis.204 Choline-binding protein E (CbpE) is one of the 
proteins from the Cbp family exposed on S.pneumoniae surface. CbpE is shown to be a 
virulence factor playing a major role in host/pathogen interactions.205, 206 This bacterium 
may be therefore recognized and trapped on a biosensing surface with the help of a CbpE-
specific antibody. In the present experimentation, we use the anti-CbpE immunoglobulin 
obtained at the IBS, kindly purified and characterized by S. Bouguelia (CREAB). We 
realize efficient addressing of bacterial cells on a DNA microarray by the means of IgG–
oligonucleotide driven assembly.  On-chip capture of the injected cells and their 
subsequent desorption from surface by enzymatic digestion are followed by using real-time 
SPRi technique. (Fig. 3.17)  
 
 147 min 169 min 221 min 227 min 249 min 
an
ti-
Cb
pE
 
 
(Z
ip
1) 
  
 
  
ra
b-
Ig
G
 
(Z
ip
2) 
 
 
 
 
 
 
 
Figure 3.17 SPR monitoring of S.pneumoniae capture and subsequent release. Step 1: intermediate DNA 
strand hybridization (Zip1*–EcoRI, Zip2*–PvuII); Step 2: IgG–DNA conjugate immobilization (anti-
CbpE IgG–EcoRI*, rab-IgG–PvuII*); Step 3: injections of bacteria suspended in PBS; Step 4: enzymatic 
release of S.pneumoniae by EcoRI cleavage; A repeated injection of bacterial sample (250 min) confirm 
that anti-CbpE IgG is efficiently removed. Eventually, the DNA biochip is regenerated by NaOH washing 
(260 min). All SPRi signals are rectified by subtraction of NC signal (negative control probe). 
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The provided antibody (IgG anti-CpbE) is covalently conjugated to EcoRI* 
oligonucleotide sequence according to synthetic approach described in the Chapter 2. The 
obtained product assigned to monoconjugated IgG–DNA is employed to realize proper 
molecular assembly capable of S.pneumoniae capture on biochip. Prior to use, DNA 
functionalized gold surface (Zip1, Zip2 and Zip3) is saturated with PBS solution of 10 µM 
BSA/5 µM cyt c. The whole experiment is driven in PBS buffer (pH 7.4) and incubated at 
37°C. Stepwise on-chip construction is monitored by SPRi and evidences correct signals 
triggered by molecular build-up steps. Following specific immobilization of anti-CbpE–
EcoRI* conjugate, bacterial sample (109 cells per mL) is consequently loaded in the 
bioreactor by using the secondary injection valve (200 µL). Two successive incubations of 
appreciatively 20 min result in positive variation of reflectivity observed for Zip1 probe 
which is ascribed to S.pneumoniae-responding antibody. Bacteria can not be however 
discerned as discrete objects on concerned spots visualized by SPRi, as it was the case of 
lymphocytes, because single bacterium size (~1 µm) is smaller than the optical system 
resolution. Nevertheless, specific capture events are confirmed by comparison of Zip1 
signal to control Zip2 probe equipped with non-relevant IgG and characterized by 
insignificant reflectivity shift (interpreted as global change of background solution 
refractive index). Phenomenon of proper on-chip capture of S.pneumoniae bacteria is 
additionally confirmed by microscopic observations realized in an independent test (cf. 
Fig. 3.18). 
 
 
 
Once bacteria are immobilized on the biosensor surface, the desorption step is 
realized by injection of EcoRI enzyme specifically directed against DNA substrate 
underlying S.pneumoniae cells. As expected, it results in specific decrease of Zip1 
reflectivity signal confirmed by images issued from SPRi. After enzymatic digestion step, 
sample is recovered at final point of microfluidics and evidences considerable number of 
isolated micrometric objects that may be ascribed to the released bacteria (microscopic 
images not available). Apart from that, accurate biomaterial desorption from proper 
biochip locations may be additionally confirmed by a repeated injection of bacteria, 
realized by the end of the described experiment. Lack of specific interaction represented by 
absence of SPR signal related to this injection proves that antibody layer and consequently 
Figure 3.18 Specific capture of S.pneumoniae bacteria on Zip1 probe 
(anti-CbpE IgG) visualised under microscope.  
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bacteria have been efficiently removed. These findings illustrate once again a proof-of-
concept study, showing that the developed strategy of programmable biochip system may 
be successfully applied to bacterial specimens. In the future, such approach may enable 
multiplexed sample analysis from the angle of its microbiological content, leading to 
identification of characteristic bacterial strain present in sample of various provenances.  
 
3.5 Conclusions and perspectives 
 
The findings presented in this chapter illustrate the example of programmable 
strategy that may be potentially employed to characterization of cellular samples. This 
approach relies on highly biocompatible processes of controlled release from the biochip 
generated with help of specific endonucleases. Surface functionalization and proper 
molecular assembly are the key elements of the methodology here proposed. As 
demonstrated, DNA-based biochips can be easily turned into cell capturing microarrays by 
the means of cell-specific antibody combined with short oligonucleotide sequence. The 
biosensing interface is in consequence able to specifically address living cells of different 
types to well-defined locations on the microarray. Using SPRi label-free detection 
technique, we provide the opportunity to assay native cells originating from a crude 
biological sample. Since no cell labeling is required, such biochip system is therefore a 
promising tool to realize universal characterization of cells issued from complex mixtures. 
Therefore, the designed methodology can find an application to sort different type of cells 
(e.g. lymphocytes and bacteria) providing that accurate immunorecognition is ensured.  
As we have evidenced, once living cells are specifically captured on the microarray, 
they can be subsequently released by site-specific enzymatic digestion. The approach of 
enzymatic cleavage has been herein explored in the microdevice format, giving concluding 
results at molecular and eventually cellular level. The designed biochip system based on 
DNA matrix may be furthermore upscaled and accommodate many different 
oligonucleotide sequences bearing various restriction sites. We could therefore benefit 
from a large repertoire of corresponding restriction endonucleases that are commercially 
available and easily handled in microarray applications. Such approach would extend the 
range of possible cellular targets that can be addressed on surface and specifically released 
by successive enzymatic digestions. The suggested possibility of multiplexed analysis 
could consequently drive to realization of cell sorting task on complex biological samples.  
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4.1 Introduction 
 
4.1.1 The photothermal phenomenon and its applications 
 
This study explores an original approach to achieve the controlled release of 
molecular and biological targets previously fixed on a biochip surface. The developed 
strategy is based on the physical desorption by local heating generated with the use of laser 
beam. Before we examine this particular approach more closely, let us learn more about 
the photothermal effect which lays a foundation for the here proposed methodology. By the 
present introduction, we will thus get familiar with this phenomenon from the angle of its 
multiple interesting applications in modern biotechnologies.  
 
 
Figure 4.1 Schematic representation of laser-induced photothermal effect assisted by gold surface plasmons 
(in Kretschmann configuration).207 The energy of incoming photons is absorbed by surface electron 
oscillations and converted into heat which is dissipated to local medium. Local confinement of thermal 
energy generation is due to the laser beam focalization. 
 
In scientific literature, one finds various examples of similar processes that are 
jointly associated with the photothermal phenomenon.99, 208-210 Generally, the term 
photothermal effect is applied to particular events when an electromagnetic wave induces 
photoexcitation of a material thus generating thermal energy, i.e. heat. In the specific case 
of a metal surface exposed to a laser beam placed under a certain angular incidence, the 
heating phenomenon can be enhanced owing to the presence of surface plasmons. Heat 
generation arises from the energy transfer between the incident light photons and the 
electron oscillations occurring on gold or other noble metal surfaces. This happens only in 
the conditions of surface plasmon resonance when the electric field vector of the incident 
light wave is parallel to the vector of surface plasmons generated on a metal surface.158 
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Hence, a major fraction of the enhanced surface plasmon energy is converted into heat by 
the means of a non-radiative relaxation to a neighboring medium (Fig. 4.1).211-213  
The laser-induced thermal effect assisted by surface plasmon resonance has been 
considered in detail by X. Xiao et al.214 Authors report on a phenomenon of temperature 
increase in the bulk medium in regard to possible error for SPR measurements assisted by 
a laser. Indeed, considerable elevation of temperature is evidenced when metal surface is 
exposed to laser illumination within a certain time (provided that surface plasmon 
resonance conditions are established).215, 216 This effect is therefore interpreted as 
conversion of the energy from the surface excited state to heat and a subsequent dissipation 
of the following to the surrounding medium. The level of thermal energy dissipation at the 
metal-solution interface depends on a few factors such as hydrodynamic parameters (e.g. 
solution flow rate), compactness of the adsorbed layer or power of the laser beam. 
Noteworthy is to underline the fact that in the case of plane surfaces, temperature increase 
occurs in a very small area where the laser beam is momentarily focused. Beyond 
significant influence on SPR measurements, thus generated thermal effect may in some 
cases become useful and intentionally produced. Indeed, it turns out that the surface 
plasmon-assisted photothermal effect can find some very interesting applications which 
have been particularly explored in the field of nanobiotechnology and nanomedicine. That 
is why I decided to make a short overview of the various potential applications of this 
particular phenomenon, in order to underline its pertinence in development of modern 
technologies. 
The photothermal effect has been widely studied in the case of optically excited 
gold nanoparticles (NPs) due to their great interest for modern biotechnology and 
therapeutics. Richardson and Govorov stated that the heating efficiency is particularly 
strong under surface plasmon resonance conditions and described it in the study of metal 
nanoheaters capable of ice melting217 and water local heating.216 The ability of 
nanoparticles to produce laser-induced local temperature increase has paved the way to 
their multiple potential applications, such as drug delivery,218-220 gene regulation,209 
reaction catalysis,215, 221 microfluidics,222 material processing223 or even non-invasive 
cancer therapy224 and biological imaging.225 Since the photothermal effect is assisted by 
the surface plasmons, design of nanoparticles may offer selection of surface plasmon 
conditions (e.g. laser wavelength). It thus give an opportunity for facile tunability of such 
system in function of the NP composition, size and geometry.226 Therefore, modified 
nanoparticles may be applied to remote release of molecules208, 227 and development of 
such tools is extremely attractive for therapeutic purposes. The introduction of similar 
system in vivo may avoid a radical temperature rise since the heating is confined to few 
nanometer distance, thus keeping neighboring biomolecules or tissue intact.  
A recent review of S.E. Lee and L.P. Lee focuses on the photothermal effect 
generated on DNA functionalized nanoparticles that can be exploited for gene regulation 
purposes.209 The authors mention two different manners for laser-induced genetic material 
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release: photothermal dehybridization by using continuous–wave illumination and 
photothermal melting realized with a pulsed illumination source. In the second case, DNA 
modified nanocarriers undergo melting into spheres resulting in complete destabilization of 
DNA-gold binding and efficient liberation of DNA material (ssDNA or plasmid). Unlike to 
this process that remains definitive, the other approach is reversible since the released 
DNA may re-hybridize out of the laser beam, once the thermodynamic equilibrium has 
been reached again. Reismann et al. demonstrate similar concept of the remote release by 
giving the example of gold nanoparticle disassembly/reassembly system.226 Therefore, this 
study proves the intactness of DNA structural integrity. Functionality of a DNA material 
released from nanorods by the laser irradiation is also evidenced by Yamada et al.228 They 
report on DNA material released by laser induced photothermal effect, further amplified by 
PCR and finally analyzed on gel electrophoresis where none of structural damages are 
evidenced.  
As we can see, the photothermal effect induced on NP surface plasmons is a useful 
phenomenon that has been broadly explored so far and opens up to a multitude of potential 
applications (e.g. cancer treatment). That it why, the laser-induced thermal effect assisted 
by surface plasmons has been particularly well described in the last decade by widespread 
studies of nanoparticles. In this introduction, a particular focus was ascribed to application 
of this interesting phenomenon to remote DNA release which high attractiveness is brought 
by its local character and reversibility of such process. Hence, controlled DNA release 
induced by the local heating constitutes a base of the strategy making object of the present 
chapter.  
 
4.1.2 DNA-driven release from gold surface  
 
In order to develop an alternative strategy of target release from a chemically 
modified biochip surface, we propose a controlled liberation generated by means of 
thermal stimuli brought by a localized laser illumination. As we have learnt above, the 
laser-induced photothermal effect is particularly observable when it is assisted by 
excitation of metal surface plasmons. Thus, here developed methodology takes advantage 
from surface plasmons possibly occurring on the gold surface and originally exploited in 
our configuration for the real-time detection of biomolecular interactions (SPRi). The use 
of thermal energy in terms of controlled release requires conception of a thermo-sensitive 
molecular construction ensuring specific immobilization of several targets of different 
nature (from proteins to whole living cells and bacteria).   
The previous chapters have evidenced that a DNA biochip can be readily 
transformed into a functional antibody micropattern by using the antibody-DNA conjugate 
chemistry. Therefore, such molecular assembly enables several biological targets to be 
captured on individual features by the means of highly specific recognition. In this study of 
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novel approach to capture/release biochip system, we use the analogous biomolecular 
construction erected on the gold-coated prism. Concerning target release step, it takes 
advantage from the physicochemical properties of short oligonucleotide sequences 
immobilized on the biochip surface. Thermodynamic stability of DNA duplexes assembled 
in such biochip format has been widely explored in a previous work carried out in CREAB 
laboratory by J.B. Fiche and J.Fuchs.122, 229 By using the SPRi methodology, it was 
demonstrated that stability of DNA duplex immobilized on the biochip surface depends on 
the environment salinity, presence of denaturing agents and finally temperature. Therefore, 
in our concept of selective and controlled release provided by local heating, we benefit 
from the intrinsic properties of double stranded DNA and its natural behavior regarding to 
temperature increase induced in the neighborhood of the nucleic acid substrate.  
 
 
 
A phenomenon of DNA duplex dissociation may occur if sufficiently high 
temperature is attained (above DNA melting temperature)230 without even minor damages 
of DNA primary structure228 (providing that the temperature rise does not exceed 100°C). 
Thermal energy delivered to DNA duplex breaks up hydrogen bonds between nucleic acid 
strands which are in consequence released one from each other. The susceptibility of the 
double strand to dissociate upon a heat stimulus is expressed by melting temperature (Tm) 
and strongly depends on the nucleic acid primary sequence (G-C base-pairing is generally 
stronger than A-T couple). In thermodynamics, melting point is interpreted as situation 
when statistically half of available DNA remains as double-helical strand while the rest is 
dissociated to a random coil state.231 The inherent thermo-sensitive nature of dsDNA is 
therefore employed in the biochip strategy here proposed.  
Release of biological object of interest immobilized on the biochip relies on a 
separation of the complementary strands by mere temperature increase. Clue point of the 
presented strategy is that thermal events are produced in a locally confined way. In the 
Figure 4.2 Schematic representation of target release strategy based on a local heating by the 
photothermal effect. a) probe oligonucleotide grafted on the gold surface; b) intermediate DNA strand; c) 
protein-DNA conjugate (antibody-DNA in particular); d) molecular or cellular target immobilized through 
specific interactions.  
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introduction to this chapter we have learnt that the energy of photons delivered by a laser 
beam is absorbed by electron oscillations of the gold surface and subsequently transformed 
into heat. In the case of nanoparticles, the local character of the energy conversion is 
related to their nanometric size. As to planar gold surface, the laser beam is focalized on 
the gold layer and thus generation of thermal energy dissipating into surrounding medium 
takes place in an extremely localized way. It provides a temporal and spatial control of 
immobilized target release based on DNA double strand dissociation. Moreover, the DNA 
chemistry enables the reversibility of such process and further target addressing may be 
produced. 
Hence, the present study describes a photothermally driven desorption of various 
target elements ranging from proteins to living cells (cf. Fig.4.2).  Targeted species are 
immobilized on the gold surface according to DNA complementarity rules and via protein-
DNA or - in particular - antibody-DNA conjugates. The photothermal effect is generated 
by an external laser source that requires elaboration of a necessary instrumental set-up. 
Okano’s group also reports on DNA targets efficiently removed from a metal-coated 
surface by thermal denaturation.99 In the cited study, an infrared laser beam irradiates a 
small chip area perpendicularly to its surface and detection of the concerned events is 
enabled by fluorescence microscopy. In contrast to this end-point analysis our approach 
takes advantage of a real-time detection that is realized on a gold-coated prism in the 
configuration of Surface Plasmon Resonance imaging. Indeed, SPRi enables spatial and 
temporal monitoring of specific capture and controlled release steps. The SPRi apparatus is 
furthermore coupled to a laser source in an instrumental assembly revealed in detail by the 
following section.  
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4.2 Instrumental set-up 
 
The instrumental set-up used for the study of laser-driven photothermal desorption 
is based on the previously described SPR configuration proposed by Kretschmann.207 The 
gold-coated prism, functionalized by DNA probes in the electrochemically driven 
deposition, is therefore assembled with a flow cell module ensuring contact with biological 
medium. Surface plasmons are excited by a light beam under well-defined angle of 
incidence and the reflected signal is recovered by camera, thus enabling detection of the 
specific interactions. As we have learnt from the introduction to this chapter, if a light 
bundle of high intensity is delivered in the SPR configuration, locally confined heating 
may occur. Therefore, for the sake of our study the surface plasmon-assisted photothermal 
effect is generated irradiation with a red-light laser. The optical configuration combining 
all mentioned elements has been developed in our laboratory by L.Leroy. Thus, a home-
made system joints the possibility of real-time detection by SPRi, generation of the laser-
induced photothermal effect and visualizations by classical microscopy. This section 
specifies all features of the conceived optical set-up as well as needful microfluidic system. 
The described device is subsequently used to study spatially and temporally controlled 
capture-release steps realized on biomolecules and micro-objects, including living cells.  
 
4.2.1 Microfluidics  
The experiment is driven in a dynamic flow, provided by a syringe pump working 
in 10 to 500 µL/min flow range. An appropriate buffer is delivered by PEEK and 
polyethylene tubes (ID of 760 µm) through a degassing system and injection valve to a 
transparent flow cell. (Fig. 4.3) The flow cell is put together with the gold coated prism 
with help of two vices positioned on the opposite extremities of the prism. These elements 
are accurately assembled in order to avoid any external leaks of liquid. The overall 
assembly is housed on an aluminium support placed between LED and camera, and under 
a microscope objective. The elements of optical nature are detailed in the following 
section. 
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In this work, two types of flow cells are used depending on the experiment 
application. The preliminary studies realized at the molecular level make use of a fluidic 
module fabricated in silicon-based organic polymer PDMS (polydimethylsiloxane) and 
equipped with reaction chamber of 1 mm in depth. (Fig. 4.4) However, tests on capture-
release of micro-objects are realized with another type of the flow module providing a 
smaller reaction chamber volume. As we have seen before, hydrodynamic conditions are 
crucial parameters when considering efficient capture and release of micro-objects, 
including cells. The present study needs therefore to design an experimental reactor of a 
weak volume. By using PDMS flow cell of similarly small depth, we might however 
experience some difficulties. It is because the material elasticity incurs a risk of probe 
matrix damage when assembled together with biochip prism. To overcome this obstacle, 
one solution is proposed to use a thin PDMS film attached to rigid Plexiglass® fragment fit 
out with fluidics inlet and outlet. A flow cell is thus formed by an oval opening carved in 
the PDMS film of 150-200 µm thickness. The flow module of such type remains 
transparent and enables microscopic observations which are essentially used in the 
experiments on biological micro-objects.  
 
syringe pump 
(10 – 500 µL/min) 
 
degassing cell 
injection valve 
biochip 
 flow cell 
waste 
sample loop  
(200 µL) 
Figure 4.3 Microfluidic set-up scheme. The buffer is constantly delivered by a 50mL-syringe pump and 
directed through PEEK or polyethylene tubes to the bioreactor. The flow system is equipped with a 
degassing module and a 6-channel injection valve. 
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4.2.2 Optical configuration 
The assembly of different optical elements is a key part of the instrumentation 
explored in the present study. It consists of a home-made instrumental set-up erected on an 
optical table housed in a dark experimental room. The basic elements are assembled in 
analogous way to the commercial SPRi apparatus (Horiba-Genoptics) used in the previous 
studies. It thus comprises a light emitting diode (λ = 660 nm) equipped with focusing 
lens/polarizer set and a 16-bit CCD camera (Pike F-145B by Allied Vision Technologies 
GmbH), both installed from the opposite sides of the prism [Fig. 4.5 a)]. The LED-
polarizer system is integrated with a goniometer which position is operated by an external 
motor. This precise control enables to set up the light beam at correct angle of incidence 
under which detection of reflectivity variations is optimal (working angle). The reflected 
light is registered by the camera and observed in real time thanks to software interface 
developed in the LabView programming platform.  
inlet 
outlet 
PDMS 
Plexiglass 
a) b) 
PDMS 
Figure 4.4 Flow cells employed in the experiment of photothermally driven desorption.  
a) schematic design of two microfluidic modules: PDMS module with a reaction chamber of 1 mm in 
depth (upper figure); set of Plexiglass and carved PDMS film providing an experimental reactor of 150-
200 µm in depth (bottom image); b) Photograph of the biochip assembled with the flow cell and placed 
into the experimental set-up. 
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Figure 4.5 General scheme of the instrumental set-up used in the experiments of laser-induced desorption.  
a) Surface Plasmon Resonance Imaging mode: real-time monitoring of biochip molecular assembly 
construction and cell capture/release steps b) Lasing mode: photothermal desorption of species induced by a 
laser beam. 
 
 
a) SPR imaging mode 
b) lasing mode 
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Apart from the SPR imaging mode, the here developed instrumental set-up may 
work in parallel in a second mode enabling photothermally driven desorption of the 
material immobilized on the biochip. When required, a red-light laser beam is introduced 
from one side of the prism [Fig. 4.5 b)]. In our studies two laser sources working in 
continuous-wave illumination are used: diode laser of a small intensity (λ = 665 nm) and 
more intense fiber-integrated diode laser (λ = 653 nm). The principle parameters of here 
used lasers are given in Figure 4.6 (more detailed features are included in the Appendix H). 
In order to produce the photothermal effect, a TM polarized laser beam strikes the gold 
surface under conditions of surface plasmon resonance defined by the incidence angle. The 
proper angle is adjusted manually until well-defined black strip is observed on the reflected 
light spot – a phenomenon identified as absorption of laser energy by surface plasmons. 
The starting position of the laser spot is set up with two micrometer screws steering the 
laser support. All the initial settings are done at a weak light intensity. Proper experiment is 
driven at maximally available current and accompanied by remotely directed 
displacements of the laser spot in x/y directions on the microarray surface. Relative 
position of the focalized laser is commanded by external motors (step motor controller by 
Oriel) which provide motions of prism-LED-camera set-up with the reference to location 
of the laser spot. Therefore, laser tracing may be precisely executed on each probe family 
of spots or one spot in particular.  
 
 
 
 
 
 
Figure 4.6 Parameters of the laser sources used in the study. The right image depicts power measurements 
performed on the incoming and reflected light in the conditions with/without surface plasmon resonance. 
Measurement uncertainty is estimated to 5 %.  
Parameter Diode laser 
Fiber-
integrated 
diode laser 
wavelength 665 nm 653 nm 
Pin  73 mW 220 mW 
Pout 25 mW 72 mW 
PSP 15 mW 63 mW 
focalised spot 
diameter 
50 – 150 µm ~ 550 µm 
effective 
surface power a 
~ 1.9 µW/µm2 ~ 0.3 µW/µm2 
a
 effective fraction of laser intensity consumed in coupling to 
surface plasmons (PSP) referred to gold surface unit 
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The instrumental configuration developed for the purpose of the present study is 
additionally enriched by another element of the optical nature. In order to enable direct 
observations of capture-release steps realized with micro-objects (e.g. living cells), a 
microscope objective is placed over the biochip. The optic microscope (Olympus Optical) 
is powered by a halogen lamp and observations are realized in the reflection mode by using 
× 4 and × 10 objectives. Direct visualizations of microscopic object immobilization and 
desorption from the functionalized gold surface are enabled through transparent flow cell 
pressed onto the surface as explained above. Images are acquired by a 8-bit color camera 
(Infinity2-3C by Lumenera) and registered by using a proper software. This element of 
instrumentation is introduced as a complementary tool to enable validation of 
immobilization and desorption events related to micrometric objects that can not be 
integrally registered by SPR imaging.  
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4.3 Use of the photothermal effect for physical desorption at the 
molecular level 
 
In this section, we explore the laser-induced photothermal release of molecular 
targets in the SPR configuration, by using the instrumental set-up previously described. We 
discuss some essential elements of the experimental conditions in order to validate the 
strategy of physical desorption before we move to tests on micro-objects. For this purpose, 
we use the molecular on-chip assembly analogous to one used in the previous studies on 
enzymatically driven release. Such approach provides a certain level of standardization in 
terms of biochip functional assembly. The described herein experiments are carried out in 
the home-made SPR imaging set-up and on a DNA functionalized gold prism. The 
photothermal desorption is executed by a diode-laser of small intensity (Pin = 73 mW). 
Therefore, we show an efficient laser-induced release of several molecular targets, carried 
out under spatial and temporal control. The specificity of here developed desorption 
strategy is confirmed by relevant data issued from SPR imaging and mass spectrometry 
analysis.  Consequently, the present section makes the reader acquainted with all 
indispensable elements that are required to confirm the feasibility of the developed 
methodology. 
 
 
 
 
 
 
Figure 4.7 Schematic representation of laser-induced desorption of various 
protein targets. Several proteins are immobilized on Zip sequence-based 
matrix through corresponding intermediate strands and protein-DNA 
conjugates.   
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4.3.1 Protein release from DNA biochip 
As demonstrated by Okano’s group,  DNA material immobilized on a metal support 
can be subjected to a localized by a laser beam.99 The phenomenon is based on dsDNA 
denaturation which results from the laser-assisted photothermal effect. One of the main 
advantages of such approach is the fact that DNA chemistry enables reversibility of 
dissociation process and once target strand has been released, new hybridization may come 
about according to the complementarity rules. Moreover, DNA sequence recovered from 
photothermal release remains functional and can be thus amplified by PCR method for 
further assays. Therefore, the strategy proposed by Okano et al. has the potential 
application in the field of genomics and can serve as a powerful tool for gene expression 
studies.  
In our approach, we provide an example of study that extends the application of 
photothermally driven desorption beyond the DNA level. Even if the controlled release is 
substantially based upon dissociation of double stranded DNA, an extended molecular 
assembly enables more sophisticated purposes (Fig. 4.7). Typically, the use of protein-
DNA or more particular antibody-DNA conjugates can be thus applied to so-called “ligand 
fishing” from complex mixtures and in more advanced applications to realize cell sorting 
task as well. In development of such elaborated systems based on the photothermal effect, 
an essential prerequisite is to ensure optimal conditions for controlled release by 
preliminary studies at the molecular level.  
The experimentation here discussed makes use of the biochip molecular 
construction based on a DNA matrix consisting of several Zip1, Zip2 and/or Zip3 spots 
obtained according to the electropolymerization protocol. Each probe is subsequently 
assembled with the corresponding intermediate strand and eventually completed by the 
protein-DNA conjugate. Few protein-DNA hybrid molecules have been elaborated 
according to the previously developed conjugation chemistry (cf. section 2.3). Taking into 
account the designed 3-component on-chip construction, conjugation reaction has been 
realized on the same DNA oligomers as previously exploited for enzymatic cleavage 
purpose (EcoRI*, NcoI* and PvuII*). Apart from rab-IgG, the oligonucleotide sequences 
have also been conjugated to an other protein – human creatine kinase (CK). The selection 
of this protein was driven by the possibility of its fairly easy detection by mass 
spectrometry which is the method of choice for the validation of the molecular targets 
released in the photothermal approach. In this scope, the experiments with CK-DNA 
conjugates are hereby demonstrated and exemplify feasibility of the developed strategy. 
Creatine kinase (CK), otherwise known as creatine phosphokinase (CPK) is a 
human enzyme involved in the cellular processes of energy conversion.232 The protein is 
responsible for phosphate group transfer from ATP (adenosine triphosphate) to creatine 
molecule (and reversibly). This enzyme plays a major role in tissues characterized by high 
consumption of energy. In particular, cytoplasmic CK can be found in muscle, heart and 
brain cells. CK is composed of two possible subunits that can be of B type (brain) or M 
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type (muscle). Therefore, three different isoenzymes can be listed: CKBB, CKMM and 
less abundant in the human body CKMB. Each subunit is of about 43 kDa MW and very 
precise mass spectrometry assays attribute 42 970 Da to M fraction and 42 512 Da to B 
fraction of the creatine kinase.233 That is why CKMM-PvuII* and CKBB-EcoRI* 
conjugates have been conceived in order to provide their clear identification by MS 
facility. They are addressed on surface by DNA hybridization and subsequently released 
by the photothermal effect. Separately recovered samples are consequently transferred to 
mass spectrometry analysis which is kindly realized by M. Jaquinod from Proteomic 
Analysis Laboratory EdYP (CEA Grenoble, IRTSV). The ultimate goal of such proceeding 
is to verify the specificity of molecular target controlled release. 
 
4.3.2  “Ligand fishing” approach 
 
As we know, Surface Plasmon Resonance is a powerful technique capable of label-
free monitoring whole range of biomolecular interactions in order to detect DNA, proteins, 
sugars, viruses or even cell. In the case of complex biological samples of unknown content, 
SPR may be combined with other detection instruments to enable more advanced analysis. 
In a particular example, SPR technique is coupled to amass spectrometry device in order to 
perform rapid and versatile sample identification. Such experiment conceptualizes so-
called “ligand fishing” approach which is widely explored in proteomics and mainly by 
using Biacore® SPR systems.  
A number of studies is thus reported to detect small amounts of protein in a 
biological extract or even identify new ligands of unknown affinity to receptors.234-238 In a 
typical ligand fishing experiment, the analyzed sample is loaded onto the recognition 
surface where species are captured and then recovered for further identification. Bound 
elements are eluted in a one-shot operation based on salinity237 or pH238 variation. In SPR-
MS integrated device, the recovered sample is straightforwardly driven through LC column 
if desalting needed. Following ionization step (ESI or MALDI), the sample is analyzed on-
line by mass spectrometer. Several studies report that mass spectrometry may be 
successfully applied to specifically identify interacting proteins down to femtomolar level. 
In the present work, we thus decide to use the MS technique to realize downstream 
detection of proteins released from the surface. Subsequently to laser-induced release, the 
recovered samples are adequately prepared and transferred to mass spectrometer where 
protein profile is investigated. It is not performed in an integrated SPR-MS device as our 
study constitutes a proof-of-concept for photothermally assisted desorption strategy. In 
such approach, MS aims to give us additional information that confirms specificity of the 
developed methodology.  
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a) Experimental protocol 
Some introductory elements concerning this study have already been mentioned in 
the previous sections. Indeed, we have learnt how the photothermal effect may act on 
DNA-based molecular assembly and in which instrumental set-up is explored to attain the 
assumed objectives. Our goal is to demonstrate not only the specific addressing of targets 
on a microarray surface but also their controlled desorption from the solid support and 
further identification. The original experiment reported her, is assisted by combination of 
two detection techniques (Surface Plasmon Resonance and Mass Spectrometry) and may 
be therefore ascribed to a “ligand fishing” strategy. This particular approach is discussed in 
the following lines in the light of the relevant findings. We thus treat of given proteins that 
are specifically recognized by DNA matrix (thanks to protein-DNA conjugates), 
subsequently removed by photothermal desorption and possibly identified in the recovered 
sample by MS analysis (Fig. 4.8). Let us now see if the relevant concept proves correct in 
practice.   
 
Figure 4.8 Run diagram of the proposed “ligand-fishing” approach. Sample is injected to the reactor 
chamber where analytes are specifically immobilized and subsequently desorbed by the local heating. 
Recovered fraction is pre-processed (protein digestion by trypsin, purification by Nano-LC) and analyzed in 
mass spectrometer. Target protein is identified by using proper software and protein library. 
 
According to the previously depicted instrumental approach, the experiment of 
photothermally directed target desorption is driven in the SPRi configuration. A DNA 
functionalized prism is therefore assembled with the PDMS flow cell (1 mm in depth in 
this particular case). The instrumental set-up allows all steps of molecular construction and 
material desorption to be monitored by dint of SPR imaging. Relevant targets are 
sequentially injected to the microfluidic system and flowed over the DNA matrix where 
they are specifically hybridized. Once the on-chip immobilization of protein-
oligonucleotide molecules is accomplished, their photothermal release is achieved by using 
a diode-laser at 665 nm. Because its position can be precisely directed in two axes, laser 
tracing is performed for each spot family in separate steps. In parallel to this, 
corresponding sample is recovered from the outlet of microfluidics. Collected fractions are 
subsequently submitted to protein assessment by mass spectrometry, being the last step of 
experimentation enabled within the framework of the collaboration with M. Jaquinod from 
EdyP laboratory. This group is renowned in the field of applied proteomics owing to a high 
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level expertise and technologically advanced equipment. Taking into account the final 
examination method, experimental conditions should be submitted to optimization from 
the point of view of the further analysis by mass spectrometry. Adaption of the overall 
method of operation is therefore desired.  
 
b) Keratins – an important issue for MS analysis 
In the scope of MS investigation, a basic and most important concern is the quality 
of final sample intended for analysis. The illustrated before approach appoints the need for 
meticulous proceeding in the preparation of samples devoted to downstream investigations. 
Substantially, we have to consider a few requirements aiming to avoid contaminations 
coming from the experimental environment which are mainly represented by keratins. 
These species are fibrous structural proteins abundantly existing in the surrounding 
medium. Indeed, a typical laboratory environment is in reality an important source of 
contamination by keratins transported by dust and principally coming from skin, hair and 
clothing. Their presence highly pollutes MS signal and disturbs efficient protein 
identification especially in case of low content of the target material. In order to reduce the 
risk of contamination, particular precautions should be undertaken, assuming that 
everything in the environment is a potential source of keratins. In the case of here 
developed experimentation, all used material is thus thoroughly cleaned and micro-tubing 
washed with detergent and sterile miliQ quality water before the experiment. Injected 
samples and buffers are also prepared in an accurate way by using sterile materials and 
chemicals. Finally, sample recovery is performed at the exit of possibly well separated and 
closed fluidic circuit. These steps have to be absolutely undertaken especially if small 
quantity of recovered protein is expected, which is actually the case in our approach. 
Although the precautions are taken, the realized experiment consists of many hand-
operated steps and it is extremely difficult to establish completely keratin-free conditions. 
As it will be discussed later on, this is a significant issue and appears problematic for the 
MS analysis of recovered samples. Nevertheless, the obtained results will enable us to 
draw pertinent conclusions and confirm target-specific out-of-biochip desorption.  
 
c) Optimization of the experimental buffer regarding MS assay 
Regarding downstream MS analysis of samples coming from specific target release 
experiment, the use of compatible buffer is an important concern. In such proceeding, mass 
spectrometer involves sample ionization step and thus the experimental buffer should not 
contain salt at considerable concentration. Typically, samples recovered in PBS buffer can 
not be directly put to examinations because ions provided by NaCl or KCl could interfere 
with formation of target ions and thus influence correct identification of species. In case of 
MS involving procedures, a commonly used basis for sample preparation is ammonium 
bicarbonate salt, otherwise ammonium hydrogen carbonate (NH4HCO3).239, 240 This reagent 
4.3 USE OF THE PHOTOTHERMAL EFFECT FOR PHYSICAL DESORPTION AT THE MOLECULAR LEVEL 
121 
 
provides a volatile aqueous solution that readily releases ammonia and CO2 (pH 7.8 at 
25°C). This property makes ammonium bicarbonate a good buffer for the applications 
associated to sample preparation by lyophilization. Lyophilization procedure of NH4HCO3-
based sample enables to obtain a material devoid of any salt residues which is highly 
applicable to MS ionization approach by MALDI or electrospray techniques. Therefore, 
here reported study makes use of ammonium bicarbonate solution as running buffer 
applied along the experiment.  
Although the aforementioned buffer is compatible with MS detection, the key point 
of here developed experimental approach is expressed by target addressing/release based 
on DNA chemistry. That is why, we have to take into account the fact that NH4HCO3 
dissolved in water is not typical a saline solution used in DNA studies.  
The electrostatic interactions play an essential role in double DNA helix formation. 
Deoxyribonucleic acid molecule is negatively charged owing to many phosphate moieties 
integrated in DNA backbone primary structure. Therefore, the hybridization process of 
complementary strands has to be assisted by an environment of sufficient salinity that 
ensures the presence of ions providing negative charge screening. Stabilization of the 
double strand is mainly generated by monovalent ions distributed in the surrounding 
medium. In NH4CO3 solution, the ion equilibrium is driven by ammonia-ammonium 
couple and carbonate chemistry that involves HCO3- to CO3-2 transformation assisted by 
carbamate formation.241 None of particular studies treating of dsDNA stability in 
NH4HCO3 buffer are proposed in the literature.  
Thus, we here report on initial experiments realized in the ammonium bicarbonate 
buffer. This is to examine hybridization of DNA and protein-DNA molecules on the 
biochip surface in such unusual conditions. Obtained hereby SPRi signals show good 
responses in 200 and 300 mM solutions of NH4HCO3 (cf. Fig. 4.9). These results are 
consistent with those observed in standard saline solutions containing NaCl (e.g. PBS). We 
have thus decided to introduce 200 mM ammonium bicarbonate solution as a running 
buffer in protocol of the present capture-release experiment.  
 
 
Figure 4.9 SPRi monitoring of DNA hybridization realized in buffers of different salinity. The former 
reflectivity shift (~15 min) corresponds to hybridization of Zip2*-PvuII on Zip2 probe. The latter one is 
consistent with immobilization of rab-IgG-PvuII* conjugate.   
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4.3.3 Thermodynamic stability of the DNA substrate 
The key element of the following study is not only to provide an efficient target 
addressing by DNA hybridization, but above all, to enable an effective target release based 
on DNA dissociation induced by the photothermal effect. The preliminary tests realized 
with available DNA oligomers and protein-DNA conjugates did not result in desired 
desorption of immobilized material. None of expected desorption events was observed, 
even at the highest laser intensity practicable in our set-up. We may thus speculate that the 
employed optical configuration and laser powers are not qualified to generate a sufficient 
temperature increase, required for the experiment. The use of more powerful light source 
would be probably a good solution but such instrumentation is not available for the present 
project. We must however take into account that more efficient heating could generate 
inadvisable secondary effects such as perturbation of biomolecular stability or creation of 
vapor bubble. Further, if we assume the final application of the biochip system to living 
cells, such phenomena could be a significant factor of physiological stress and should be 
thus avoided. To overcome the problem of the insufficient laser power, we need to make 
deeper insight into thermodynamic stability of the DNA strands employed in the present 
work. 
In order to estimate thermal conditions required to produce efficient target release 
from the biochip surface, it is useful to characterize melting temperature of the 
oligonucleotides used in the molecular constructs. To do so, we make use of a 
computational method for nucleic acid thermodynamics, available on-line.242 This 
simulation tool is based on two-state melting model of DNA (double strand and random 
coil) and enables approximation of Tm which can be safely applied to short oligonucleotide 
sequences.243 The thermodynamic parameters characterizing melting process of dsDNA are 
determined by using the nearest-neighbor method and as it was demonstrated by 
SantaLucia fit well the experimental data.231 These calculations concern however DNA 
melting and hybridization observed in solution but are fairly accurate to evaluate short 
duplex thermodynamics in the microarray format.  
 
Table 4.1 Melting temperature predictions for the oligonucleotides employed in biochip molecular assembly. 
Theoretical Tm values are calculated by using The DINAMelt Web Server242 and obtained for the relevant 
hybridization conditions: 0.25 µM of DNA, 25°C, PBS buffer.  
double strand Tm 
Zip1-Zip1* 68.2°C 
Zip2-Zip2* 67.3°C 
Zip3-Zip3* 69.0°C 
EcoRI-EcoRI* 62.7°C 
PvuII-PvuII* 62.1°C 
NcoI-NcoI* 64.1°C 
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According to the aforementioned numerical simulation, melting temperatures are 
estimated for Zip and restriction site-containing sequences deployed in the biochip 
molecular assembly (cf. Table 4.1) The values hereby established provide information on 
the thermal energy that should be delivered to realize dissociation of the oligonucleotides – 
a phenomenon that lays a foundation of here explored photothermal release of molecular 
targets from the microarray surface. Willing to achieve this final goal, it is actually not 
necessary to attain the melting point which essentially serves to determine conditions 
where statistically half of available nucleic acid strands still remains as double helices. We 
expect that thermal energy represented by lower temperatures, sufficiently influences DNA 
dissociation constant (Koff) and may produce individual dehybridization events. One may 
observe that Tm values approximated for the oligonucleotides in question are however quite 
high and may thus explain the lack of satisfactory results in the preliminarily realized tests. 
Indeed, we deduce that the optical configuration originally conceived probably does not 
provide sufficient level of heating and dissociation kinetics is still very slow. That is why a 
useful solution is to provide supplementary destabilization of DNA thermodynamic 
equilibrium regardless to lasing conditions available in the present study. 
In literature, thermodynamic stability of DNA duplex is widely studied in terms of 
various factors: salt concentration,244 temperature,245 base pair mismatches246 or presence 
of organic compounds.247 Non-equilibrium DNA state can considerably decrease DNA 
melting temperature and thus facilitate double strand dissociation. To do so, among 
different solutions, we can mention for instance destabilization of dsDNA by introducing 
point mutations into base pair sequence or by modifying the surrounding medium with 
denaturing agents. The second alternative seems more straightforward and is applied for 
the need of the study here reported. 
 Among DNA denaturing agents, we can enumerate several chemical compounds 
like for example formamide,247 urea and its derivatives,248 guanidinium hydrochloride249 
and other chaotropic salts. According to J. Fuchs (CREAB), a buffer supplemented with 20 
% of formamide (v/v) enables hybridization of oligonucleotides on microarray and 
noticeably decreases the DNA melting temperature.122 In the present study, it is decided to 
make use of N,N-dimethylformamide (DMF) also reported to influence DNA duplex 
stability and to induce measurable drop of melting temperature while introduced to a 
solution.250 We thus apply the analogous 20 % DMF content which seems to be correct 
since formamide and N,N-dimethylformamide are closely related chemical compounds and 
act on the dsDNA stability in a similar way.251 Therefore, we may consider further J. 
Fuchs’s statement assuming that every percent of formamide added to the buffer induces 
~0.6°C decrease of Tm. Taking into account the presence of the denaturing agent, the 
consequent melting temperature ascribed to our experimental conditions may be 
approximated to about 55°C. However, we hopefully think that local heating generated by 
the photothermal effect in our configuration does not rich this melting temperature level 
since it would certainly perturb the condition of biomolecular or/and cellular entities. 
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Detailed insight into thermal effects generated in the employed optical strategy does not in 
fact make object of the present PhD thesis and none of measurable temperature is given. 
Nevertheless, we speculate that employment of the buffer supplemented by DMF provides 
an ample shift of thermodynamic equilibrium to single stranded DNA and thus ensures 
efficient target release which is demonstrated by the following findings. 
 
4.3.4 Photothermally driven protein release from the DNA-based matrix 
After the necessary optimization elements have been discussed, we may now 
proceed to demonstrate a case study of photothermally driven release observed for 
independent molecular targets. For this purpose, a DNA functionalized biochip (Zip1 and 
Zip2) is shown to specifically address two molecular targets: CKBB-EcoRI* and CKMM-
PvuII* by means of the corresponding intermediate strands. All building blocks of the 
molecular architecture are introduced in the flow cell in 200 mM ammonium bicarbonate 
buffer, supplemented with 20 % of DMF (v/v). SPR imaging allows monitoring of the on-
chip construction steps in real time and in the absence of labeling (Fig. 4.10). From the 
obtained results, we notice that registered reflectivity shift is higher for the complementary 
DNA than for the protein-DNA conjugate. This result might be explained by the fact that 
creatine kinase is a smaller protein in comparison to an IgG for example. Here addressed 
targets are probably composed of chemically modified CK subunits (brain or muscle 
fraction of nearly 40 kDa), which gives almost fourfold difference of the molecular weight 
comparing to the IgG molecule (150 kDa). Moreover, as it was evidenced before, the 
corresponding partners at intermediate (i.e. Zip1-EcoRI) and final level of the molecular 
construction (i.e. rab-IgG–EcoRI*) do not hybridize in equivalent proportion. SPR data 
revealed previously that one protein-DNA molecule hybridizes to one of about 4 
complementary strands available. The unequal hybridization ration is probably the case in 
here demonstrated experiment.  
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Subsequently to the immobilization of proteins, we perform their photothermally 
induced desorption. Local heating provided by the laser beam is realized in two separate 
steps. To do so, laser tracing is performed in parallel lines along the y axis as depicted on 
the Figure 4.10 a). The DNA matrix is conceived in such manner that desorption of target 
material is sequentially executed for each family of spots. Probes are grafted on the biochip 
in several copies of large spots (~1.2 mm in diameter) in order to increase the amount of 
eventually desorbed proteins which is almost at the MS detection limit. At first, laser 
tracing is executed on Zip1 family of spots situated on the left side of the prism (in the y 
direction) and then on the second Zip2 probe placed on the right side. After each probe-
specific desorption, the SPR signal is registered in order to visualize the relevant 
reflectivity shifts.  
Processed data evidence specific release of the concerned targets. Following each 
laser tracing step, we can indeed observe negative reflectivity shifts corresponding to the 
following probes: Zip1 in the first step and Zip2 afterwards. As clearly seen, the registered 
signal drops do not completely attain starting level (before construction of the molecular 
assembly) and represent about a half of the original signal. This fact can have one simple 
explanation. Namely, the monitored reflectivity signals are for each probe averaged over 
Figure 4.10 Photothermally driven release of CKBB and CKMM proteins immobilized on the DNA matrix 
a) schematic representation of laser tracing on a gold prism; b) DNA  matrix composed of Zip1 and Zip2 
spots (1.2 mm in diameter); c) SPR monitoring of the experimental steps: molecular assembly (Zip1 + 
Zip1*–EcoRI + CKBB–EcoRI* and Zip2 + Zip2*–PvuII + CKMM–PvuII*), controlled release from Zip1 
then Zip2, re-hybridization (Zip1*–EcoRI and Zip2*–PvuII) ∆; SPRi difference image captions: 1) laser 
tracing on the Zip1 family of spots, 2) laser tracing on the Zip2 family of spots, 3) re-hybridization of 
Zip1*–EcoRI, 4) re-hybridization of Zip2*-PvuII.  
∆ registered Zip1 and Zip2 signals are relative one to each other because no reference probe signal is 
present and considerable refractive index are generated in the bulk solution. 
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all pixels on the corresponding spot surface image. From the other hand, these spots are not 
integrally covered by desorption effect and thus the signal drops are not total. Indeed, the 
SPR differential images expose the exact zones from which the material has been removed. 
We can thus clearly identify the lasing lines that are revealed by a lower level of the 
grayscale [cf. Fig.4.10 1)-2)]. We can also notice some difference in thickness of the 
observed lines that reflect the size of the laser spot. It is because in reality, when displacing 
the laser in the x direction, its on-surface focalization is slightly changed and therefore the 
laser spot size modified. In the here presented configuration, it may vary from about 50 to 
150 µm which corresponds to an approximate value of laser intensity of about 1.9 µW/µm2 
(cf. Fig. 4.6).  
The reported experiment involves laser tracing at a controlled displacement rate 
which provides instantaneous heating confined to the local environment where thermal 
energy is consequently dissipated. As a result, we produce local DNA dissociation and 
specific target liberation, keeping primary DNA probe intact. It is confirmed by the last 
step of the experiment monitored by SPRi [Fig 4.10 3)-4)] where complementary strands 
are re-introduced on the biochip surface. An efficient step-by-step re-hybridization is thus 
registered specifically for Zip1 and then for Zip2 probe. This finding is unequivocally 
confirmed by the associated differential images where the reflectivity signal is retrieved 
exactly in the same zone from where the material has been previously desorbed. It means 
that the applied conditions of local heating do not destroy the original probes that remain 
functional. Noteworthy is the fact that we are able not only to realize a localized desorption 
of the immobilized targets but also to restore the molecular architecture. Therefore, one 
advantage of using DNA matrix is that it can be completely regenerated once the 
experiment is finished. Regeneration is provided by a short washing with 100 mM solution 
of NaOH. Rinsed in miliQ water and dried under argon stream, such DNA biochip may be 
used for further experiments within a few months if properly stored.   
 
4.3.5 Mass spectrometry assay of the recovered samples 
Taking into account the obtained data represented by images issued from SPRi as 
well as the SPR kinetics signal, we have thus demonstrated the efficient method for target-
specific and localized removal of biological materials previously immobilized on a solid 
support. In order to confirm the results obtained from SPRi, samples recovered from the 
experiment were assayed by mass spectrometry to investigate presence of the released 
proteins (CKBB or CKMM). Therefore three consequent fractions were collected from the 
outlet of fluidics: “0” as blank sample before laser desorption, “1” during Zip1 probe laser 
tracing and “2” when desorption was performed on the Zip2 spot family. All three samples 
were given to M. Jaquinod for protein assay on OrbiTRAP mass spectrometer.   
The MS analysis has unfortunately revealed an important amount of impurities in 
the given samples. Though necessary precautions were undertaken, a certain level of 
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contamination was possible taking into account the manual character of several steps. 
Therefore, the MS signal has confirmed considerable pollution by keratins and other non-
relevant proteins in all three samples. Tests “0” and “1” have not evidenced any trace of 
proteins corresponding to the experiment. Nevertheless, thorough analysis of “2” sample 
has resulted positively in the presence of the creatine kinase M fraction. Although, the 
amount of the indentified protein was minor and covered by many other signals, the test 
has approved the existence of right protein in its specific sample. Effectively, CKMM (or 
more exactly CKMM-PvuII*) was desorbed from Zip2-based spots and subsequently 
recovered in the “2” sample. The quantity of the released protein has been estimated to 
about 100 fmol which makes it extremely challenging to detect especially if impurities are 
present. Although the amount of protein material was weak and efficient analysis 
hampered by polluting proteins, we may consider these partial results as concluding. We 
deduce that desorption from specific spots in reality happens and does not come about 
spontaneously. If it was the case, CKMM (and also CKBB) would be found in other 
samples since they were  injected to fluidics in more important quantities than effectively 
immobilized on spots.  
 
4.3.6 Conclusions 
We hereby demonstrated a simplified example of the ligand fishing approach (SPRi 
detection + MS analysis) which may be potentially applied complex protein mixtures. 
Instrumental improvement shall become an object for future system development in order 
to conceive high-performance automated operation. The great advantage of such device, 
comparing to the original ligand fishing approach, would be the possibility to “fish” 
several targets through specific biomolecular interactions in one single experiment. We 
demonstrate that protein-DNA chemistry provides high specific target addressing (DNA 
hybridization, specific antibodies) followed by spatially controlled desorption of at least 
two different targets. The present biochip system may be thus potentially employed to 
investigate complex biological mixtures with high throughput and for advanced 
applications in proteomics. 
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4.4 Application of the photothermal effect to the micro-object release 
 
Having the proof of controlled release at a molecular lever by using the 
photothermal effect in the SPR configuration, we may proceed to explore the efficiency of 
such strategy on more developed on-chip assemblies amenable to capturing objects of a 
micrometric size. The essential objective behind that is to realize a specific immobilization 
of living cells followed by their subsequent release from the surface by local heating. But 
before starting to work with living biological objects, an important development step 
intends to realize preliminary studies in order to validate the system functionality on less 
vulnerable targets. Indeed, living cells are of complex nature that makes them susceptible 
to even slight variation of external parameters in the surrounding medium (temperature, 
electric field intensity, buffer content). Therefore, this section investigates the laser-
induced desorption executed on proper molecular assembly capable of the immobilization 
of synthetic microbeads. Polystyrene (PS) microspheres are used as target objects that 
imitate cell specific capture based on a membranar marker and its specific interaction with 
an antibody (Fig. 4.11).   
 
 
4.4.1 Photothermally driven release from the IgG–DNA based construction 
As a preliminary study to micro-object release assays, we realize an experiment of 
the laser-induced desorption on IgG–DNA constructs, analogously to the tests with 
protein-DNA conjugates described before. For this purpose, rab-IgG–PvuII* and rab-IgG–
EcoRI* are introduced on the corresponding Zip1 and Zip2 probes (via intermediate 
strands) and subsequently released by the laser irradiation. This approach constitutes the 
first step to more sophisticated applications based on cell-directed antibodies and leading 
Figure 4.11 Schematic representation of the laser-induced 
release of polystyrene µbeads from the biochip surface. 
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to controlled release of specific cell fractions. For this purpose, we show efficient 
desorption of rabbit antibody from DNA-based biochip which relies on double strand 
dissociation provided by the local heating. SPRi kinetics proves accurate addressing of a 
rab-IgG–DNA target realized in PBS buffer supplemented with 20 % of DMF (Fig. 4.12). 
These results are consistent with the former ones obtained in the enzymatic cleavage 
approach. Target capture is therefore specific to the corresponding probes and triggers 
analogous responses as previously observed: the IgG–DNA signals are 3 to 5 times higher 
than those of the intermediate oligomers. This confirms that hybridization is correct despite 
the presence of the denaturing agent. Moreover, the laser-induced desorption proves to be 
probe-specific and reveals accurate reflectivity drops that can be eventually retrieved if the 
relevant building blocks are injected again. Hence, the biochip system validates the 
concept of the photothermally driven antibody release from a DNA microarray and gives 
thus an opportunity of extension to more advanced applications. If antibodies directed to 
specific target are used, this approach may be furthermore explored in terms of micro-
object release which makes the object of the following sections.  
 
 
 
 
 
 
 
Figure 4.12 Surface Plasmon Resonance (SPR) monitoring of the biochip molecular construction and the 
photothermal desorption induced by laser beam. (t0) Zip2 and Zip3 probes grafted on the gold surface; (t1) 
intermediate strand hybridizations (Zip2*–PvuII and Zip3*–NcoI); (t2) immobilization of IgG–DNA 
conjugates (rab-IgG–PvuII* and rab-IgG–NcoI*); (t3) laser tracing on Zip2; (t4) laser tracing on Zip3; (t5), 
(t6) reconstruction of molecular assembly. Zip2 and Zip3 signals are averaged and rectified by subtraction 
of NC signal (reference probe). 
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4.4.2 Molecular assembly capable of microbead immobilization 
The present experimentation employs streptavidin-coated polystyrene (PS) 
microspheres. Polystyrene-based microparticles exemplify an easy to functionalize 
material which can be deployed for many applications. Chemical engineering of this 
polymer enables efficient conjugation with various biomolecules (DNA,252 protein253) and 
generation of functional conjugates as potential tool for biosensing254, 255 or development 
of immunoassay techniques.253, 256 Wilson et al. report on the use of streptavidin-coated 
microspheres as a primitive model of cell or bacterium system. Interaction between 
streptavidin (STV) and biotin-modified target is thus supposed to mimic an interaction 
with the cell surface. In such case, it is a much simplified model of cell surface marker and 
antibody interaction since any antibody-antigen interaction is involved. Nevertheless, the 
STV-biotin, as having the highest dissociation constant among naturally occurring 
biological complexes, is a desirable couple for molecular biology assays. Therefore, 
streptavidin-coated polystyrene microbeads are chosen as target destined to test the 
developed capture-release strategy.  
 
 
 
Because the photothermally driven target desorption from the gold surface is based 
on dsDNA dissociation, the on-chip immobilization of STV-PS microbeads has to involve 
hybridization process on DNA-based biochip. From the other hand, primary amine-
modified oligonucleotides or antibodies can be easily coupled to biotin via biotin-NHS. 
Therefore, two molecular assemblies are employed for specific capture of the microspheres 
provided by STV-to-biotin affinity (Fig. 4.13). The former one is based on direct 
hybridization of a complementary biotin-modified oligonucleotide (Zip1). As to the latter 
one, microbead capture involves the interaction between an immobilized antibody (via 
antibody-DNA conjugate) and a biotin-conjugated secondary antibody assembled on the 
PS microbead (Zip2). The second case closely reproduces the molecular assembly which is 
here deployed as cell capturing construction. In this study, we use commercially available 
streptavidin-coated microspheres made of polystyrene and of 6 µm in diameter. SPR 
 
STV 
PS µbead 
STV 
PS µbead 
Zip1 Zip2 
Figure 4.13 Schematic representation of molecular 
assemblies on Zip1 (Zip1*-biotin + STV-µbead) 
and Zip2 (Zip2*-PvuII + rab-IgG-PvuII* + IgG-
anti-(rab-IgG)IgG-biotin + STV-µbead). 
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imaging system enables detection of phenomena at a molecular level occurring on the gold 
surface. The microbead capture and desorption steps are evidenced by direct visualization 
under microscopy.  
 
4.4.3 PS µsphere immobilization and release followed in SPRi and microscopy 
As explained above, microbeads are captured on the gold surface functionalized 
with Zip1 and Zip2 probes, and according to two different molecular architectures. Thus, 
microbeads conjugated to Zip1*-biotin are immobilized on the Zip1 spots, while the Zip2 
spots, previously assembled with intermediate Zip2*-PvuII strand and rab-IgG–PvuII* 
conjugate, are designed to capture microbeads coupled to biotinylated anti-(rab-IgG) 
antibody.  The phenomena of target microbead immobilization and photothermally driven 
release are directly observed thanks to a transparent flow cell (cf. 4.2.1). As it turns out, the 
hydrodynamic conditions are crucial for the efficient capture and release of micro-objects. 
Significant non-specific (out-of-spot) adsorption of microspheres on gold surface is 
observed if the flow rate is too slow during injections. Therefore, when flow cell depth is 
quite big (e.g. PDMS flow cell of 1 mm depth), the buffer flux has to be decelerated to 
enable microbead sedimentation which results in a considerable side adsorption [cf. Fig. 
4.14 c)]. Once the µbeads have been non-specifically adsorbed on the gold surface, they 
can not be removed even by a flow rate instantly increased (up to 500 µL/min which 
actually corresponds to a weak linear flow of 0.83 mm/s).  
 
 
Figure 4.14 Polystyrene microsphere immobilization on the DNA-based biochip according to proper 
molecular assemblies. a) Zip1 spot centre; b) Zip2 spot centre; c) Zip1 spot boundary. PS µbeads are injected 
at 0.3 % (w/v) in PBS supplemented with 0.5 % of BSA. Self-aggregation is observed in the case of µbeads 
conjugated to biotinylated IgG (Zip2-based assembly). Tests are realized by using 1 mm PDMS flow cell. 
 
Concentration of microbeads in the injected sample is also an important concern. 
Indeed, more than 0.3 % (w/v) of PS microbeads in the injection preparation favors out-of-
spot µsphere immobilization despite surface blocking by 1% solution of BSA. Thus, higher 
content of PS microsphere should be avoided even if it facilitates direct observations of 
immobilization events - biochip spots are visible to the naked eye. Moreover, in the case of 
PS-STV microbeads conjugated to the biotinylated IgG (secondary anti-rab-IgG), high 
concentration of this antibody induces µsphere self-aggregation [cf. Fig. 4.14 b)]. 
Nevertheless, this phenomenon can not be entirely suppressed because several biotin 
moieties are potentially available to interact with their affinity sites placed on streptavidin 
a) 
100µm 
b) c) 
100µm 100µm 
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molecules and belonging to different µbeads. Taking into account all these concerns, 
optimal parameters are worked out in order to guarantee a specific on-chip µbead 
immobilization and restrain non-specific interactions.  
 
 
 
In order to drive the experiment in the optimal conditions, a flow cell of 150 µm in 
thickness is used in order to provide sufficient control of PS microbead immobilization on 
corresponding spots and limit non-specific interactions. The transparent flow cell is placed 
over DNA-functionalized gold surface in the SPRi configuration previously described. The 
biochip is prepared according to the electropolymerization method and provides DNA 
probe spots of 1.2 mm in diameter: Zip1, Zip2 and reference NC probe for background 
signal correction. As it was evidenced before, the running buffer has to be supplemented 
with the denaturing agent in order to facilitate DNA dissociation. Therefore PBS with 20 
% of DMF (v/v) is flowed over the biochip at 15-25 µL/min during sample injection steps 
(linear flow of 0.17-0.28 mm/s) and accelerated to 250 µL/min during laser tracing (2.78 
mm/s). The on-chip assembly is monitored under construction by SPR imaging system 
(Fig 4.15). Observations of kinetics result in an adequate signal as to DNA and IgG–DNA 
conjugate hybridization (Zip2) but registers only slight reflectivity shifts when microbead 
conjugates are captured (observed on both Zip1 and Zip2). In this case, the minor signal is 
probably due to microbead size which is not suitable for efficient detection in such SPRi 
configuration. It is because the SPRi detection is practically provided by the evanescent 
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Figure 4.15 SPR monitoring of PS microbead capture and release. The following experimental steps are 
observed: Zip2*-PvuII hybridization (3 min), rab-IgG-PvuII* injection (18 min), loading of PS-µbead 
assembled with Zip1*-biotin (40 min), injection of PS µbead assembled with IgG-anti-(rab-IgG)-biotin 
(68 min), laser tracing on Zip1 and Zip2 (90 min, 98 min). Zip1 and Zip2 signals are averaged and 
rectified by subtraction of NC signal (reference probe). Inset images evidence specific microbead 
immobilization on Zip1 and Zip2 spots.  
 
4.4 APPLICATION OF THE PHOTOTHERMAL EFFECT TO THE MICRO-OBJECT RELEASE 
133 
 
wave penetrating into contact medium up to about 100 nm of depth and thus can not attain 
micrometric objects. Nevertheless, SPR differential images issued over microbead 
injections, show correct response on Zip1 and Zip2, unlike the reference probe signal (NC) 
that remains negative. Microbead capture, even if barely detected, is therefore specific and 
additionally confirmed by direct microscopic observations. Indeed, registered images 
evidence proper PS-µbead immobilization where no significant side adsorption is 
observed. We notice the presence of auto-aggregated µbeads on the Zip2 spot but, as it was 
said, it can not be avoided since multivalent interactions between PS-STV microbead and 
multi-biotinylated antibody are possible. Following target capture step, one may proceed to 
test the efficiency of the photothermally driven controlled release. 
In the 4.3 section, we examined the first approach to the laser-induced photothermal 
desorption and confirmed the process specificity at molecular level. Subsequently, we use 
the analogous instrumental set-up to induce micro-object release by the local heating. A 
laser-diode of similar intensity range is thus deployed and PS µbead liberation evidenced 
by direct visualizations under a microscope objective. Subjected to plasmon resonance 
conditions, the laser beam is focalized on the biochip zone corresponding to immobilized 
target microbeads. Direct images are recorded by a camera along with laser displacement 
at 10 µm/s. In the demonstrated experiment (Fig. 4.15), the laser tracing is performed in 
two steps evidenced by SPR signal decreases registered on the both probes. The 
corresponding reflectivity shifts are mainly resulting from desorption of molecular entities. 
Therefore, it explains more significant decrease of Zip2 signal related to its more 
developed molecular architecture (involving IgG–DNA conjugate). Surprisingly, 
microscope visualizations reveal that microbead release does not take place on Zip1 spots 
at all and only in the slight extent in the case of Zip2 spots. In fact, a minor fraction of 
polystyrene microspheres immobilized on Zip2-based assembly is desorbed (Fig. 4.16). 
The observed phenomenon is instantaneous, being probably assisted by hydrodynamic 
forces provided by accelerated buffer flow (up to 500µL/min). The release efficiency has 
been estimated to less than 10 % within a few essays. Moreover, increase of DNA 
destabilizing agent content (DMF) to 40 % (v/v) does not generate more efficient 
microbead release. An extended irradiation by diode-laser (up to a few minutes) does not 
produce new microbead release events, neither.  
 
Figure 4.16 Sequences of images registered during laser-induced desorption of PS µbeads immobilized on 
Zip2 spot. Circles evidence zones of µbead release (before desorption in blue and after desorption in red). 
None of µbeads are desorbed from Zip1-based construction. 
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To explain different results observed on Zip1- and Zip2-based constructions as well 
as the low efficiency of the microbead release, we may consider this as an effect of 
different thermodynamic equilibrium attributed to the corresponding sequences. It is 
however difficult to point out an important contrast in the Tm values between Zip1-Zip1* 
and Zip2-Zip2* (or even PvuII-PvuII*) which can be estimated to less than 5°C. We must 
additionally take into account the fact that the microbeads are not directly attached to the 
support by simple DNA duplex. Therefore, in order to understand why the laser-induced 
microsphere release is not complete, we should look closer at molecular arrangement on 
the surface and consider contribution of more developed micro-object attachment than by 
simple double strand.   
4.4.4 Multivalent interactions 
In principle, microbead immobilization on the functionalized gold surface is 
enabled by the interaction between streptavidin and biotinylated intermediate molecules 
(oligonucleotide or antibody). As we know, the biotin molecule has a remarkably strong 
interaction with a homotetrameric protein STV which is characterized by an extremely 
high dissociation constant of ~10-15 M.151 This biomolecular interaction represents the 
strongest ligand-receptor couple currently known. One streptavidin protein has four 
subunits with identical recognition sites for biotin molecule. Taking into account the strong 
affinity of biotin to STV and quadruple possibility of such interaction, more realistic model 
of on-chip assembly with PS µbeads should be considered (Fig. 4.17). Therefore the 
micro-objects may be anchored on the surface by multiple interactions. Probably, one 
microsphere is engaged within several STV-biotin bridges and with a few DNA duplexes. 
In order to obtain an efficient liberation event, all of the anchoring double strands should 
dissociate in the same time. However, locally increased temperature produces DNA 
melting phenomena in a fairly statistic way. That is why, an individually dissociated 
oligonucleotide is staying close to the surface and may eventually find a new 
complementary strand before all other neighboring DNA duplexes participating in µbead 
anchoring will dissociate. Hence, the probability of an instantaneous multiple dsDNA 
dissociation leading to microbead liberation is weak.  
The aforementioned phenomenon finds reflection in DNA hybridization studies 
realized on a microarray and carried out with SPRi device equipped with temperature scan 
facility.122 In the cited work, J. Fuchs demonstrates that DNA amplification by biotinylated 
oligomer conjugated to streptavidin (or STV-coated gold NPs) results in increase of the 
melting temperature. Considerable difference in Tm is revealed and attains about 15°C in 
the particular example of short oligonucleotides (15 bp). This study confirms the difficulty 
to perform an efficient detachment of PS microbead by local heating in the case when 
target is bound by multiple STV-biotin interactions. Perhaps, incorporation of more 
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powerful laser source (e.g. fiber laser) would be more efficient but it is not tested in the 
present approach. 
 
 
 
 
Further tests could be carried out in the scope of enhancing micro-object release by 
the local heating. Improvement solutions could be mainly focused on limiting the multiple 
interactions: by using engineered streptavidin with only one binding site or by partially 
blocking the available sites for biotin recognition. It could reduce the potential multi-
interaction of target microsphere with the immobilized probe and drive to more oriented 
on-chip capture. However, this development is not of real significance here, since PS 
microbeads are supposed to imitate the cell interaction with antibody where biomolecular 
recognition is directed by the abundant presence of cell membrane domains. This study 
demonstrates that photothermally induced release of microspheres is possible by using the 
proper on-chip assembly. In the particular case of Zip2-based construction the microbead 
immobilization relies on the antibody-antigen recognition (rab-IgG immunorecognition by 
anti-(rab-IgG) IgG) which may be ascribed to interactions occurring between cell 
membranar markers and specific antibodies. Although it remains only a very approximate 
model of cell capture on the surface, in the following section we will make use of the 
experience here acquired and realize controlled release of living cells by the means of 
laser-induced local heating.  
 
 
 
Figure 4.17 Realistic model of PS-µbead multiple binding. Each microsphere is equipped 
with several STVs, having four sites of specific interaction with biotin. Multivalent binding 
may be also explained by the presence of several biotin moieties on anti-(rab-IgG) antibody 
molecules (µbead self-aggregation).  
 
 
PS µbead 
STV STV STV 
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4.5 Specific capture and controlled release of living cells  
The photothermally induced release of living objects such as blood cells is the 
culmination part of the study described in the present chapter. We have learnt from the 
previous experiments that the local heating generated on the metal surface plasmons by 
laser irradiation may produce a controlled release of the molecular components or 
polystyrene microbeads. Desorption events are generated in a localized way and thus may 
concern targets of interest specifically immobilized on the biochip surface. In the present 
section, we indeed report on an efficient addressing of lymphocytes onto the biochip 
surface and their sequential release by laser illuminations. In addition to the results 
obtained in the restriction enzyme-based strategy (chapter 3), we demonstrate specific 
capture of splenocytes by means of microscopic observations. The controlled release of 
cells founded upon dsDNA dissociation by local heating is then evidenced.  
 
 
 
 
4.5.1 The experimental conditions 
For the sake of the present work, we dispose of mouse splenocytes characterized by 
diameter of about 10 µm, which enables their direct observation in microscopy. Therefore, 
we benefit from the developed instrumental configuration where the biochip assembled 
with transparent flow cell is placed under a microscope objective (the configuration 
previously exploited by the occasion of PS microbead experiment). This set-up provides 
the possibility of real-time visualizations and follow cell capture and release happenings. 
Compared to microspheres, living cells are of more complex nature and various possible 
physicochemical interactions may be thus considered. As we have learnt before, an 
important issue is to create optimal conditions of the hydrodynamic flow in order to ensure 
Figure 4.18 Schematic representation of lymphocyte release from 
the biochip surface induced by the photothermal effect. The cell is 
captured through specific antibody tethered on DNA-based 
assembly. 
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correct immobilization of cells on the specific spots and to reduce their non-specific 
adsorption on the surface.  
The previously reported experiments driven with cells (the enzymatic release 
strategy) or microspheres evidenced that using a flow cell of an important thickness (1 
mm) demands application of low flow rates which provide the micro-object sedimentation 
(weak volume flow rate) and important non-specific immobilization. The injection of 
lymphocytes in such microfluidic conditions implies more or less uniform distribution of 
the cellular sample over the gold surface. In this situation, specific spots can not be 
accurately determined. As previously evidenced, an efficient on-spot capture may be 
enabled by imposing sufficient flow rate and using smaller reaction chamber volume. 
However, as experience shows, by using too thin flow cell (e.g. 50 µm) none of cell 
immobilization events are observed by microscopy (even at a very slow flow rate).We 
speculate that in this particular fluidic conditions cells are submitted to considerable shear 
forces which disable their efficient on-chip capture.70 Too small reaction chambers should 
be therefore avoided. In consequence, it is decided to use a flow cell of 200 µm thickness 
as described in section 4.2.1 and apply a flow rate of 30 µL/min at least. Linear velocity is 
therefore estimated to at least 0.25 mm/s at central cross-section of the reaction chamber.   
4.5.2 Buffer biocompatibility 
One of the major issues when working with living cells is to ensure 
biocompatibility of the experimental buffers. In this particular study, proper conditions 
need to be provided in order to trigger effective DNA dissociation and realize successful 
target desorption (live cell in our case). The former evaluation of the experimental 
parameters points out that the running buffer needs to be enriched with a denaturing agent 
(here 20 % of N,N-dimethylformamide) to enable sufficient destabilization of the DNA 
substrate. DMF is however an organic solvent which is not a standard component of cell 
culture media. Its polar nature may induce possible interactions with the cell surface and 
alter physicochemical properties of the cell membrane, e.g. microviscosity. DMF has been 
mainly considered in the terms of its toxicity in humans and animals but is not classifiable 
as a carcinogen by the International Agency for Research on Cancer (IARC).257 Some 
studies driven on cancer cell cultures report on DMF-induced inhibition of cell culture 
growth (within many hours of incubation) and induction of cell morphological changes 
(e.g. flattening, low density cells or cytoplasmatic extensions).258-260 In particular cases, 
loss of tumorigenicity or cells of more mature phenotype are observed.  Nevertheless, all 
these effects are demonstrated to be reversible if DMF is removed from the cell culture 
medium.  
Regarding to lymphocytes, DMF action has not been widely explored. It is however 
evidenced that DMF does not have mutagenic influence on human lymphocytes261 and 
induces inhibition of lymphocyte proliferation during a long-time incubation.262 Since the 
denaturing agent is crucial element of here used buffer that cells will get in contact with, it 
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has been decided to perform preliminary tests of splenocyte incubation in the presence of 
this reagent (cf. Fig. 4.19). It turns out that cell viability is sustained over 95 % within up to 
three hours of incubation in PBS supplemented with 20 % of DMF (v/v), independently if 
splenocyte growth is stimulated with ConA or not. In the particular case of our study, 
lymphocytes are suspended in the running buffer for a short time (lees than one hour). 
They get in contact with DMF only when injected to microfluidics and till laser-induced 
release. Once cells are released from the biosensor, they might be resuspended in a buffer 
devoid of DMF. Although DMF may alter cell morphology or growth, the effect is 
reversible as demonstrated by previous works. Such system may be thus successfully 
applied to cell sorting purposes.  
 
 
 
 
 
 
 
 
 
 
 
100 µm 100 µm 
culture medium PBS + DMF b) 
a) 
Figure 4.19 Incubation of the splenocyte sample in PBS supplemented with 20 % DMF (v/v).  
a) monitoring of cell viability within 3 hours of culture in PBS/DMF solution compared to  standard 
RPMI medium. b) visualisation of cellular sample upon 48 h of incubation. Cell cultures are incubated at 
37°C in the conditions of 95% humidity and 5% CO2. DMF content do not reveals particular influence on 
lymphocyte viability and morphological appearance.  
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4.5.3 Specific lymphocyte capture revealed by microscopic visualizations 
The developed strategy aspires to ensure controlled capture and photothermal 
release of primary lymphocytes, by basing on analogous molecular assembly as it was 
demonstrated for the enzymatically driven desorption. For this purpose, we use the 
previously exploited on-chip assembly relying on 3-component architectures. As 
mentioned above, the experiment is driven in PBS + 20 % DMF (v/v) and by using 200 µm 
flow cell assembled with DNA-biochip in the configuration of the home-made SPRi. A 
mixture of B- and T-type cells stimulated in 48 hour-incubation with ConA, is introduced 
and immobilized on the biosensor surface thanks to the specific immunorecognition. 
Therefore, B lymphocytes are directed to Zip1 spots assembled with anti-CD19 antibody 
whereas T lymphocytes are recognized on Zip2 spots where anti-CD90 antibody is tethered 
(both antibodies are immobilized through the relevant intermediate DNA strands and IgG–
DNA conjugates). Zip3 probe serves as negative control since it undergoes hybridization 
with non-relevant IgG–DNA conjugate (anti-HcB-NcoI* and through Zip3*-NcoI). The 
step-by-step molecular construction is controlled in real time by SPRi which triggers 
analogous reflectivity shifts as those previously obtained with rab-IgG–DNA conjugates.  
In addition to SPRi data, cell immobilization is monitored by direct observations 
under the microscope (Fig. 4.20). Following the injection of splenocytes, we notice their 
specific addressing on the corresponding spots (i.e. Zip1 and Zip2) and do not observe any 
of binding events on the negative spots (i.e. Zip3). Confined on-spot cell trapping and 
absence of significant non-specific adsorption validate the applied blocking protocol 
(BSA/cytochrome c) and the established hydrodynamic conditions.  Moreover, under 
sufficient magnification we can clearly observe morphological differences between the 
immobilized cells which might confirm specific on-chip immobilization of the 
lymphocytes. Microscopic examinations of the splenocytes captured on the biochip surface 
reveal indeed a considerable size contrast between cells observed on Zip1 spots (a priori B 
lymphocytes) and Zip2 spots (deduced as T lymphocytes). We tend to explain this result 
by the fact that prior to experiment, the splenocytes are cultured in the presence of 
concanavalin A (ConA) reported as T cell stimulation factor.  
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Concanavalin A is a homotetrameric lectin recognized as a mitogenic agent that 
provides preferential activation of large number of T-cells.179 It binds with high affinity to 
D-mannose and D-glucose sugar residues being a part of glycolipidic and glycoproteic 
structures of cell surface.263 Therefore, ConA presence in culture medium gives rise to cell 
agglutination which is also the case of the splenocyte culture here studied (a great number 
of floating cellular aggregates is observed starting from 24 hours of incubation). 
Concanavalin A induces proliferation of T-cells and enhances their energy metabolism by 
boosting ATP turnover.264 Upon stimulation by the mitogenic agent, T lymphocytes 
constantly divide from lymphoblasts grouped in the agglutinated cell aggregates.265 
According to Abbas et al.,  lymphoblasts are considered as large activated lymphocytes 
characterized by more important number of organelles and increased cellular metabolism 
reflecting a greater cytoplasmatic volume.10 Incubation of mouse lymphocytes in the 
presence of ConA reveals in fact ~2 µm cell diameter growth within 48 hours of culture. 
(Fig. 4.21) Since the influence of concanavalin A on stimulation of murine B-type cells has 
not been evidenced, we can speculate that increased cell size is mainly due to T-
lymphocyte growth. It seems to explain size differences observed for the lymphocytes 
Figure 4.20 Specific capture of B- and T-lymphocytes on the DNA functionalized biochip and via cell 
directed antibody-DNA conjugates. B-cells are captured on Zip1 probe by anti-CD19 IgG and T-cells on 
Zip2 probe – by anti-CD90 IgG. Zip3 probe is used as negative probe and assembled with non-relevant 
anti-HcB IgG. a) SPRi images of Zip1, Zip2 and Zip3 spots; b) microscopic visualizations of the relevant 
spots under × 10 magnification; c) schematic representation of the on-spot molecular assemblies and 
resulting cell capture; d) numerical magnification on the relevant spot areas.  
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captured on the biochip and thus may testify a successful immobilization of B-cells on 
Zip1 spots and T-cells on Zip2.  However, an independent test based on cell 
immunostaining by using fluorescence markers could be additionally envisaged in order to 
unequivocally confirm the specific cell capture.  
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4.5.4 Lymphocyte desorption by the local heating 
As we know, living cells are physiologically independent entities which 
equilibrium is prone to be destabilized in the presence of different environmental stimuli. 
Laser illumination is thus a potential source of cellular stress depending on its wavelength 
and intensity, optical focalization, irradiation time, etc. The beam of high-energetic 
photons may induce variations of thermal (temperature increase), electric or mechanical 
(e.g. cavitation bubble) parameters in the cell environment. The results of such 
modification can be harmful for the cell physiological condition. However, some studies 
show that laser-induced stress wave does not necessarily produce fatal-to-cell effects. 
Maezawa et al. elucidate similar influence on differentiation of cells when detached from a 
surface by laser-induced stress or by trypsin treatment.266 Some lasers have also been 
safely used in the field of photothermal therapy. Near-infrared laser generating 
photothermal effect on gold NPs is shown to be marginally absorbed by biological 
tissues.227, 267 Regarding to the single cell level, a red light laser is reported to produce 
some morphological changes268 and enhance lymphocyte proliferation.269 In these 
examples, laser biocompatibility is mainly discussed in terms of direct cell exposure to a 
laser beam. In the case of our study, cells are however introduced in the environment 
devoid of direct laser radiation (only small part of the laser energy is reflected on the glass-
gold interface). Namely, the photothermal effect induced on the gold surface plasmons 
generates a non-radiative dissipation of the energy to the cell surrounding medium by 
means of the electric field enhancement and the temperature increase. These two 
parameters should be in reality considered as potential source of cell stress. However, as 
we will see, the obtained results seem to prove biocompatibility of the developed strategy.  
The following experiments employ the optical configuration combined with the 
diode laser integrated with an optical fiber (Pin = 220 mW). Once the lymphocytes are 
specifically captured on the DNA-based molecular assembly, we proceed to their 
Figure 4.21 Lymphocyte diameter increase observed 
within 48h culture in the presence of ConA. Data 
retrieved from Cell Viability Analyser Vi-Cell  
(Beckman Coulter). 
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sequential liberation by the laser irradiation. The photothermally driven release is executed 
locally on each relevant spot and followed in real time by microscopic visualizations (Fig. 
4.22). The registered optical images evidence that surface lasing step induces the localized 
detachment of cells which occurs instantaneously. Since the laser tracing is remotely 
controlled, B- and T-type lymphocytes immobilized on the relevant spots (Zip1 and Zip2 
respectively) are subsequently released in independent spot-specific steps.  
 
 
 
Figure 4.22 Sequential release of B- and T-type cells by laser beam: a) laser tracing on Zip1 spot and release 
of B lymphocytes captured via anti CD19– EcoRI*; b) laser tracing on Zip2 spot and release of T 
lymphocytes captured via anti CD90–PvuII*. All images are obtained upon × 4 magnification. 
 
Willing to realize photothermally driven cell sorting from the biochip surface, an 
important concern is also to evidence the reusability of such system. As it was previously 
demonstrated at the molecular level, oligonucleotide probes retain their integrity over 
lasing step and proper biochip assembly may be restored. In addition to this, we hereby 
prove that cells introduced to reconstructed microarray are still specifically captured on the 
spots where material was previously removed (Fig. 4.23). 
 
 
 
Figure 4.23 Reusability of the developed biochip system. a) B- and T-type lymphocytes 
immobilized by proper antibodies tethered on Zip1 and Zip2 spot, respectively; b)  cell detachment 
by local heating; c) successful capture of splenocytes upon reconstruction of the relevant molecular 
assembly (Zip1*-EcoRI + anti-CD19–EcoRI* on Zip1 spot and Zip2*-PvuII + antii-CD90–PvuII* 
on Zip2 spot). All images are obtained upon × 4 magnification. 
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When performing microscopic observations during desorption step, the laser 
localization is identified as reddish spot barely observable because only inconsiderable 
percentage of the radiation is reflected (probably on the gold-glass interface defects) and 
may be directly observed. It confirms that a great part of the energy is involved in coupling 
with the surface plasmons and further transformation to the local heating. Considering 
single cell release events, we speculate that after the laser-induced DNA dissociation 
occurs, a liberated lymphocyte is orthogonally repulsed by convection currents and carried 
away in hydrodynamic buffer flow.  
In reality, the laser spot specific to the fiber-diode laser is bigger that the one 
obtained for simple diode laser previously employed (laser spot diameter of ~550 µm and 
~100 µm, respectively). This certainly results in better distribution of thermal energy to the 
local medium. Even if the level of energy consumed per surface unit is lower than for the 
diode-laser (0.3 compared to 1.9 µW/µm2), we opine that the observed here micro-object 
desorption is mainly enabled by more efficient distribution of the locally produced heat. 
Namely, the laser spot of greater size generates larger profile of the heat diffusion which 
covers more of the surrounding solution volume. Although the measurement of local 
temperature increase is not done and comparative study is disabled, an efficient release of 
the immobilized cells induced by the fiber-diode laser is here demonstrated. More detailed 
characterization of the thermal conditions generated by the photothermal effect near the 
surface need further investigations and will be the object of a future work.  
 
4.5.5 Laser-induced release observable at single cell level 
In another approach, we attempt to demonstrate the photothermally driven release 
by observations at the level of the individual lymphocytes. Namely, we use a DNA-biochip 
functionalized by microcantilever technique which enables to obtain probe spots of a few 
micrometer size. This polypyrrole-based spotting technology has been developed in 
LAAS-CNRS laboratory from Toulouse (France) and offers the possibility of biomaterial 
deposition in form of miniaturized spots.270-272 (Fig. 4.24) In a previous work, such high-
density matrix is reported to realize an organization of lymphocytes by dint of specific 
antibodies grafted on the surface.273 By using the relevant molecular assembly including 
IgG–oligonucleotide conjugates, DNA matrix is consequently transformed to the cell-
specific antibody microarray capable of capturing one cell per each microspot of ~7 µm in 
diameter. Although totality of microspot matrix is not occupied by properly immobilized 
lymphocytes, we do not observe any cell binding on negative spots (polypyrrole in this 
case) and thus consider cell recognition as specific.  
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Figure 4.24 Lymphocyte immobilization on the DNA-based biochip functionalized by microcantilever (left 
image) electrospotting technique. The obtained microspots have about 7 µm in diameter and enable to 
resolve cell immobilization to each individual spot. Specific capture of the splenocytes is realized on the 
molecular assembly based on the IgG–DNA architectures.  
 
One advantage when using the biochip of dense matrix composed of microspots is 
that we may focus on a smaller area of the local heating and observe release phenomena on 
the individual lymphocytes (Fig. 4.25). Cell liberation is in reality instantaneous and 
evidenced for single cells – optical magnification provides real time observation of 
individual lymphocytes released in the laser illumination spot and its subsequent carrying 
away in the buffer flow. From the registered images it is possible to conclude that 
lymphocytes keep their integrity since they are demonstrated as well-defined discrete 
objects withdrawn from the biochip surface by hydrodynamic flow. Although, any regular 
studies of morphological cell modification possibly produced in the photothermal effect 
are not carried out, we may consider the demonstrated results as sufficient to prove that 
such strategy may find an application to cell sorting purposes.  
 
 
 
Figure 4.25 Focus on release phenomena of B-type cells by laser-induced local heating. Primary 
lymphocytes are immobilized on Zip1 microspot matrix via an antibody-oligonucleotide conjugate (anti-
CD19–EcoRI*) and instantaneously desorbed by photothermal effect.    
Ppy 
100µm 
Zip1 
100µm 
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4.6 Conclusions 
Recapitulating the presented findings, we must underline that photothermal effect 
assisted by surface plasmons can efficiently release material immobilized on a biochip 
surface. The developed instrumentation enables to realize locally defined desorption of 
molecular targets, synthetic microbeads and biological cells as well. Further improvement 
of the experimental set-up can be however foreseen. The proposed configuration requires 
certain level of manual manipulations - mainly between each step of laser-induced 
desorption, when the laser source is momentarily removed and SPRi signal retrieved. 
Better solution would be therefore to employ a pulsed laser permanently installed with 
SPR imaging set-up where a remotely controlled shutter could cut the signal registration 
for short intervals during the lasing step. This would enable simultaneous detection of 
reflectivity variations accompanied by photothermally induced desorption.  
Further development may be also proposed in the matter of flow cell used in this 
study. Conception of new microfluidic modules may be foreseen in order to provide an 
oriented flow of micro-objects and to make their on-chip distribution more uniform. 
Pertinent solutions are given by advanced fabrication techniques based on lithography in 
polymers.274 Cyclic olefin copolymer (COC) is an example of transparent and resistant 
polymer which is of great interest for new applications. Its excellent properties make it a 
high-tech material for micro- and nanodevice development.275 The preliminary tests with 
COC-made microfluidic modules are currently carried out in the CREAB laboratory (L. 
Leroy, Y. Roupioz) and mainly focused on application to biochip systems based on living 
cells or bacteria. 
The presented in this study approach may open up to new perspectives founded 
upon controlled release of species from a DNA microarray. The strategy benefits from the 
intrinsic thermodynamic properties of DNA double strand which can undergo dissociation 
if local heating applied. The advantage of the proposed approach is that the experiment is 
driven in the absence of markers, i.e. on native cells, and followed in real time by SPR 
imaging and microscopic examination. Moreover, the particular on-chip assembly enables 
regeneration of the original matrix that can be employed for further biosensing 
investigations. Since the biochip is based on DNA chemistry, a future development may 
rely on the conception of tunable system by introducing DNA building blocks of a 
different thermodynamic equilibrium (e.g. by point mutations or various DNA length) on 
the same sensor surface. It could thus produce abrupt dissociation events at well-defined 
temperatures giving birth to more sophisticated release strategies. Since a DNA matrix 
may be easily transformed to cell specific micropattern (thanks to antibody-DNA 
conjugates), an efficient cell sorting from complex biological extracts could be thus 
enabled.  
Apart characterization of cellular suspensions, the developed methodology may 
find also other applications. As it has been demonstrated in our study, samples issued from 
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the experiment are assayed by mass spectrometry technique in terms of specific protein 
identification. In this particular case, such proceeding is a kind of proof-of-concept that 
confirms target-specificity of the developed release strategy. Nevertheless, the present 
methodology may become a powerful tool to analyze complex biological samples (e.g. 
plasma, cell culture supernatants), if further improvements are introduced. Integration of 
DNA biochips and protein-DNA conjugate chemistry into Surface Plasmon Resonance 
technique combined to MS analysis may give solid bases for construction of novel 
versatile device potentially explored in the field of proteomics. Automation of sample 
identification process, reduction of recovered sample volume192 and enabling investigation 
from weak quantities of analyte would thus open various applications for the ligand fishing 
from diverse biological materials.234  
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Concluding the present PhD thesis, I would like to recapitulate the overall findings 
here reported and put forward some perspectives that the developed biochip can open up 
to. By this work, we have shown the example of biochip performing in selective capture of 
several molecular and cellular targets as well as their subsequent release under spatio-
temporal control. DNA-based matrix has been therefore proposed as a miniaturized 
molecular platform, easy to fabricate and handle, making it a versatile tool for biosensing 
strategies. It was demonstrated that a DNA microarray can be readily turned into an 
antibody pattern with help of proper antibody-oligonucleotide conjugates. The developed 
synthetic approach permitted to obtain a monoconjugated IgG–DNA product with 
satisfactory yield and proven functionality in the three-component biochip assembly. 
Further, the proposed conjugation protocol might be applied to create a set of IgGs 
combined with exclusive DNA oligomers in order to realize multiplexed capture of several 
targets. By using antibodies directed to specific antigens (e.g. proteins, cells, bacteria), they 
can be properly addressed on the biochip surface and thus open up an opportunity of 
efficient “ligand fishing” or cell sorting from a heterogeneous mixture. Indeed, the reported 
study has evidenced a controlled sorting of B and T lymphocytes to well-defined spatial 
locations, characterized by cell-specific molecular assemblies.  
The main goal of the present project was to enable a specific sorting of cellular 
samples into individual fractions of cells. According to the announced objectives, we have 
demonstrated a DNA-based microarray performing selective capture and subsequent 
release of B and T lymphocytes characterized by specific phenotypes (CD19 and CD90, 
respectively). Living cells were addressed on the biochip with help of corresponding 
surface functionalization, resulting in great affinity to the defined cell type (anti-CD19 and 
anti-CD90 IgGs). Proper molecular assemblies allowed efficient immobilization of the 
lymphocyte subsets onto spatially confined areas: large spots (several hundreds of cellular 
entities per spot) or microspots (one cell per spot). Subsequently to the realized on-chip 
capture, cells were shown to be released by dint of two independent strategies.  
The former approach of cell release was provided by the enzymatic cleavage 
performed with help of endonucleases yielding a specific digestion of well-defined DNA 
sequences (restriction sites). The latter methodology relied on direct dissociation of 
dsDNA substrates enabled by local heating generated in the photothermal phenomenon. 
The main features of the both proposed strategies are grouped in Table 5.1. By the present 
work, we have demonstrated the performance of the proposed strategies by realizing a 
programmable sorting of two types of lymphocytes. Both developed approaches can be 
potentially extended to more multiplexed system, ensuring specific release of several 
cellular targets. On the one hand, it can be achieved by using different commercially 
available restriction enzymes which are prone to perform precise cleavage at different 
oligonucleotide sequences. On the other hand, laser-induced dissociation of double-
stranded DNA offers a possibility to use thermodynamically different substrates which 
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denaturation is achieved at a distinct level of the local heating (e.g. point mutations).122 In 
the first case, using several restriction enzymes in a single experiment incurs however a 
risk of star activity (relaxation or alternation of enzyme specificity) and considerably 
increases the cost of cell sorting strategy. The method based on photothermal desorption 
seems to be more straightforward and does not involve the use of costly reagents. The main 
issue of the second strategy is employment of sophisticated instrumentation which involves 
integration of optical elements (SPRi system, laser beam) and precise mechanical control 
system (positioning of the laser spot). Nevertheless, the both proposed capture-release 
systems benefit from a real-time and label-free detection by SPRi. Unlike FACS- or 
MACS-based methods, the developed approaches enable to conduct an assay on crude 
biological samples devoid of particular pre-processing step (i.e. labeling). Moreover, a 
great advantage of the DNA-based biochip is that it can be regenerated and the original 
matrix recovered, once an individual test has been accomplished. In the future, it could 
thus provide an opportunity for high-throughput studies of complex cellular samples in the 
scope of human immunology or for biomedical investigations.  
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ENZYMATIC  
CLEAVAGE 
LASER DRIVEN 
DESORPTION 
principle of cell 
release 
enzymatic digestion of DNA 
substrate 
dissociation of dsDNA by local 
heating 
desorption time span several minutes over seconds 
source of multiplexed 
analysis 
multitude of restriction sites 
large variety of synthetic 
oligomers (different sequence 
lengths, point mutations) 
weakness of cell 
sorting strategy 
consumption of additional reagents 
(enzymes) 
sophisticated instrumental set-up 
(SPRi combined with precisely 
controlled laser source) 
potential 
improvements 
- recovery of cell fraction 
- simultaneous microscopic 
observations 
- new flow cell design 
- introduction of a pulsed laser for 
simultaneous SPRi detection and 
laser desorption 
- recovery of released samples  
(cell sorting, ligand fishing) 
required conditions 
for successful release 
- temperature 37°C 
- buffer (Mg2+ content) 
- powerful laser source 
- destabilizing conditions (addition 
of DMF) 
advantages 
- highly-specific cell capture based on immunorecognition 
- robust biochip molecular assembly (DNA matrix, IgG–DNA 
monoconjugation) 
- reusability (regeneration of the original matrix) 
- label-free method (no sample pre-processing needed) 
- simultaneous monitoring of molecular and cellular events 
 
Table 5.1 Comparative table of both developed strategies of cell sorting 
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The hereby developed biochip system emerges therefore as a potential cell sorting 
tool prone to find an application in advanced studies on blood cells. The reported findings 
describe selective release of B and T lymphocytes from a functionalized surface into 
separate fractions that can be imaginably devoted to downstream analysis at different level 
(whole-cell functional assays, transcriptomics and proteomics). Thus, the established study 
provides an attractive element in the field of research on the undiscovered aspects of the 
human immunology. Indeed, thorough studies on a precise lymphocyte family could pave 
the way to better understanding of defense mechanisms against pathogenic infections, 
malignancies or particular reactions of auto- and allo-immunity. Apart from answering 
many questions of the immunological nature, profound examination of individual 
lymphocyte populations could drive to formulation of novel strategies to cure various 
diseases with immune foundations. Indeed, numerous infectious disorders still do not have 
an efficient treatment (e.g. HIV) and evaluation of new vaccines and biological drugs is of 
great interest. Bioassays carried out on specific lymphocyte units might provide a detailed 
screening of immune cell responses upon contact with antigen and thus enable essential 
information in the design of novel pharmaceutics. A special focus in the development of 
new vaccines is ascribed to cancer immunology. Currently employed methods examine 
lymphocytes on a large scale and thus only offer statistically meaningful results. 
Investigation of discriminated populations of the immune cells is a valuable approach that 
shall give a larger insight into immune responses involved in cancer. Further, 
comprehensive examination of individual subsets of lymphocytes is highly advantageous 
when assaying immunological responses against effectors originating from the same or 
foreign host organism. It could open up to rational treatment of autoimmunity disorders 
and rapid diagnostics in the field of clinical transplantation. 
  
 
Figure 5.1 Potential applications of the developed biochip in studies on several aspects of the human 
immunology.  
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In the matter of cell-based biosensors for research goals, an extremely challenging 
approach is to provide the design of such miniaturized systems that are capable of working 
at single cell level. Strategies of that kind are extremely attractive for various research 
purposes because they offer a great potential to discover particular features of a cell type of 
interest in terms of its proper functionality and physiology.276 Such approach is also 
interesting in regard to studies based on immune cells, aiming to reveal complex 
mechanisms of immunological responses.277  
Using the molecular tool developed in this work, an intriguing study is currently 
carried out on development of an original biosensor that may be potentially employed to 
explore lymphocytes at a single cell level. As a fruit of collaboration with J. Liu (CREAB), 
we demonstrated a specific trapping of individual immune cells inside pores of 
micrometric size (cf. Fig. 5.2). The inner wall of such micropore was originally 
functionalized by Zip sequences (using CLEF process)278 and a single lymphocyte was 
captured by dint of the cell-specific antibody combined with a corresponding DNA strand. 
Therefore, this study exemplifies the development of a single-cell biosensor that may give 
the opportunity of thorough studies driven on various cellular samples from the angle of 
individual cell metabolism (e.g. secretory activity), morphological changes, pathologic 
behavior, etc. In the field of assays at single-cell level, an extremely interesting approach is 
to give the insight into functionality of an exclusive immune cell unit (a lymphocyte 
characterized by a well-defined phenotype)33, 34 and further development will be continued 
in this direction. 
 
Isolation of well-defined cell samples emerges not only as a breakthrough in the 
fundamental research but in biomedical field as well. Even if the proposed microsystem is 
far from a real “point-of-care” device, such cell sorting methodology could be foreseen as 
a potential tool in medical diagnostics. It could therefore enable a rapid and label-free 
assessment of parameters based on blood cell sampling (e.g. cancer biomarkers, viral 
antibodies). Biomedical application demands however that a potential test fulfills several 
important criteria like precision of measurement, linearity and reproducibility of the 
generated data. Every diagnostic tool needs to answer to these requirements for a 
standardized performance before it really finds the application at the site of patient care. 
We consider the present work as development of a building block of potential diagnostic 
device that in the future may find the light of day.  
Figure 5.2 T lymphocyte captured inside a micropore. 
Inner wall of the µpore is functionalized by Zip2 and the 
cell is trapped by dint of adequate molecular assembly 
(Zip2*-PvuII + anti-CD90–PvuII*). 
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This chapter introduces all necessary elements concerning the experiments which 
results have been discussed in the previous parts of the present manuscript. At the 
beginning, an exhaustive list of the used materials is presented where following items are 
listed: chemical reagents, synthetic oligonucleotides, biomolecules (antibodies, proteins) 
and finally cells assayed within the framework of hereby reported studies. Subsequently, 
detailed protocols of the concerned experiments are described. A step-by-step description 
of these proceedings gives thus thorough insight into the developed experimentation and if 
needed may help to reproduce it in the future.  
6.1 Experimental supplies 
Chemicals  
→ NaCl, KCl, Dithiothreitol (DTT), NaOH, H2SO4 96%, H2O2, Dimethyl sulfoxide 
(DMSO), Sodium dodecyl sulfate (SDS), Tris(2-carboxyethyl) phosphine 
hydrochloride (TCEP), 1-dodecanethiol, Phosphate Buffer Saline (PBS), 
Ethylenediaminetetraacetic acid (EDTA), salmon DNA (10mg/mL), Denhart 50x, 
acetonitrile, RPMI-1640 culture medium, Sodium pyruvate, 2-Mercaptoethanol, 
Penicilin-Streptomicin stabilized solution, , MgCl2 (Sigma-Aldrich, France) 
→ NH4HCO3, LiClO4, N,N-Dimethylformamide (DMF), Tween20 (Fluka, France) 
→ Ethanol (96.2% and 99.9%) (Carlo Erba reagents) 
→ Tris-HCl (Tris(hydroxymethyl) aminomethane) (Interchim, France) 
→ Pyrrole (Tokyo Casei, Japan)  
→ Streptavidin conjugated polystyrene microspheres 6µm (Polysciences Europe 
GmbH, Germany)  
→ SM(PEG)12 (succinimidyl-[(N-maleimidopropionamido)-dodecaethyleneglycol), 
Succinimidyl-6-(biotinamido)-6-hexanamido hexanoate (biotin-NHS) (Thermo 
Fischer Scientific, France) 
 
Materials 
→ Glass prism (angle 60°) top-coated by double metallic layer: titanium 5nm and gold 
45nm of thickness (Horiba Scientific-GenOptics, France)  
→ Glass slide for microscopy coated by double layer: chromium (2nm) and gold 
(55nm) (Schott Swiss SA, Switzerland) 
→ HPLC column: HiTrapTM Q FF 1mL (GE Healthcare, UK) 
→ Spin filter membranes (500µL) 3kDa, 30kDa and 50 kDa MWCO (VivaScience, 
France) 
→ NAPTM 5 columns, SephadexTM G-25 (GE Healthcare, UK) 
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Oligonucleotides 
The oligonucleotide sequences were all purchased from Eurogentec (France). 
Probe sequences (oligonucleotide-NH2(3’)) were coupled to Py-NHS as previously 
described.279 Zip1*-NH2(3’) was conjugated to biotin-NHS as follows: biotin-NHS was 
added in 20 molar excess to  ~30 µM solution of the oligonucleotide (in PBS, pH 7.4) and 
reaction was maintained during 60 min in room temperature; the conjugation product was 
purified on NAPTM 5 column (elution with deionized water) and final concentration 
assigned by 260 nm absorbance measurement.  This and all further absorbance 
measurements were realized by using ND-1000 Spectrophotometer Nanodrop (Labtech 
International).  
 
Table 6.1 Oligonucleotide sequences employed in the present work. 
 
Name Sequence (5′→3′) 
 Probes 
Zip1 pyrrole-(T10)-GACCGGTATGCGACCTGGTATGCG 
Zip2 pyrrole-(T10)-GACCATCGTGCGGGTAGGTAGACC 
Zip3 pyrrole-(T10)-TGCGATCGCAGCGGTAACCTGACC 
NC pyrrole-(T10)-TGGAGCTGCTGGCGT 
 Intermediate strands 
Zip1*–EcoRI TACCTTCG-GAATTC-ACTCGCACCGCATACCAGGTCGCATACCGGTC 
Zip2*–PvuII GACAAGGT-CAGCTG-TAGGCAAGGGTCTACCTACCCGCACGATGGTC 
Zip3*–NcoI CACTCACT-CCATGG-GCACTTGCGGTCAGGTTACCGCTGCGATCGCA 
 Targets 
EcoRI* GTGCGAGT-GAATTC-CGAAGGTA-(T10)-SH 
PvuII* CTTGCCTA-CAGCTG-ACCTTGTC-(T10)-SH 
NcoI* GCAAGTGC-CCATGG-AGTGAGTG-(T10)-SH 
Zip2* HS-(T10)-GGTCTACCTACCCGCACGATGGTC 
Zip1*–biotin biotin-(T10)-CGCATACCAGGTCGCATACCGGTC 
Complementary target strands are pointed out by an asterisk (*). 
Restriction sites are expressed in bold type. 
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Antibodies 
→ IgG from rabbit serum (Sigma-Aldrich, France) 
→ Biotin-modified anti-rabbit IgG (whole molecule) antibody produced in goat 
(Sigma-Aldrich, France) 
→ Monoclonal rat anti-mouse CD19 (clone: 1D3) (BD Biosciences, France) 
→ Monoclonal rat anti-mouse CD90 (clone: G7) (BD Biosciences, France) 
→ Monoclonal mouse IgG anti-HcB domain kindly provided by L. Bellanger 
(CEA/IBEB, France) 
→ Rabbit anti-CbpE IgG was provided from the Institut de Biologie Structurale 
(Grenoble, France) 
 
Proteins 
→ Streptavidin-R-phycoerythrin (STV-PE) (Invitrogen, France) 
→ Concanavalin A (ConA) (Sigma-Aldrich, France) 
→ Creatine kinase brain and muscle fractions, human (CKBB and CKMM) (VWR, 
France).  
→ Bovine serum albumin (BSA) (Sigma-Aldrich, France) 
→ Foetal bovine serum (FBS) (Sigma-Aldrich, France) 
→ EcoRI enzyme 20,000U/mL (New England Biolabs, UK) 
→ PvuII enzyme 10,000U/mL (New Englands Biolabs, UK) 
 
Buffers 
→ Hybridization buffer H: NaCl 537mM, K2HPO4 10mM, KCl 2.7mM, Tween20 
0.1%, Denhart 50x 2%, Salmon DNA (10mg/ml) 0.1%, pH 7.4 
→ Rinsing buffer R: NaCl 537mM, K2HPO4 10mM, KCl 2.7mM, Tween20 0.1% 
→ Buffer GDALi: LiClO4 100mM, glycerol 1% (v/v), acetonitrile 30% (v/v), DMSO 
20% (v/v), prepared in 25mL of deionized water (18.2 MΩ.cm) 
→ PBE buffer: PBS, EDTA 5mM, pH 6.8 (IgG–DNA coupling reaction) 
→ Blocking solutions: 1% BSA (w/v) in PBS; 2µM cytochrome c in PBS; 10µM BSA 
+ 5µM cytochrome c in PBS 
→ Running buffer 1: PBS, MgCl2 10mM, pH 7.4 (enzymatically driven release assay) 
→ Running buffer 2A: PBS, DMF 20% (v/v), pH 7.4 (laser-induced desorption of 
microbeads and cells) 
→ Running buffer 2B: NH4HCO3 200mM, DMF 20% (v/v), pH 7.8 (laser-induced 
desorption of proteins for downstream MS analysis) 
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→ Buffer A: NaCl 137mM, Tris-HCl 20mM, pH 8.0 (HPLC purification) 
→ Buffer B: NaCl 1M, Tris-HCl 20mM, pH 8.0 (HPLC purification) 
 
Culture media 
→ RPMI-1640 culture medium (Sigma-Aldrich, France) 
→ DMEM culture medium (Invitrogen, France) 
→ TH liquid broth (BD Biosciences, France) 
 
Cells and bacteria 
→ LS-102.9 (B cell hybridoma) and 3A9 (T cell hybridoma), collaboration with P. 
Marche from Institut Albert Bonniot (IAB) in La Tronche (France). 
→ Mouse splenocytes (C57Bl/6), collaboration with IAB (La Tronche, France) 
→ Streptococcus pneumoniae bacteria (R6 strain), collaboration with T. Vernet from 
the Institut de Biologie Structurale (IBS) in Grenoble (France). 
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6.2 Experimental procedures  
 
6.2.1 DNA biochip fabrication by electrospotting 
 
DNA chips were prepared either on a gold-coated glass prism (SPRi experiments) 
or on a glass slide (fluorescence immunoassay). Prior to functionalization, the gold layer 
was cleaned from potentially adsorbed impurities by a piranha solution (2:1 H2SO4/H2O2 
mixture; Caution: piranha solution is exothermic and strongly reacts with organics). An 
alternative solution was to use physical cleaning by oxygen/argon (75%/25%) plasma 
stream (plasma cleaner by Electronic Diener GmbH, Germany) but this protocol was not 
regularly employed. The cleaned gold surface was then immersed in 20 mM solution of 1-
dodecanethiol (in 99.9 % ethanol) for ~30 min at room temperature. By means of SAMs, a 
hydrophobic layer was formed in order to enable better confinement of probe spots and 
avoid inter-spot contamination during the electrospotting process. After the hydrophobic 
treatment accomplished, the surface was rinsed through successive washes with ethanol 
(96.2 %) and deionised water (18.2 MΩ.cm). The DNA probe grafting was subsequently 
realized upon electropolymerization method by using a home-made spotting  device as 
previously described.121, 122  
Solutions of several oligonucleotide probes (cf. Table 6.1) were prepared in GDALi 
buffer and could be stored up to 24h before use (4°C). Each spotting sample contained 
20mM of pyrrole monomer and pyrrole-modified probe at 0.2 µM, 1 µM, 5 µM or 10 µM 
depending on the experiment. Subsequent concentrations of DNA oligomer were prepared 
by dilution in series with 20 mM pyrrole solution (in GDALi). Electrochemically directed 
copolymerization steps were achieved by using a micropipette tip (10 µL) with an opening 
diameter (φ) of around 400 µm, 800 µm or 1200 µm, equilibrated with the 20 mM pyrrole 
solution prior to use. The counter electrode (platinum wire inside the tip) and the working 
electrode (gold surface) were connected to an external potentiostat (SP-200, Bio-Logic 
Science Instruments or PGSTAT30, Autolab). The pipette tip was filled-up with a relevant 
probe sample and placed over gold by using a motor control device (ESP300, Newport). 
Probe-bearing Ppy spots were synthesized by 2V electric pulse of 100 ms (100 µA of 
current range). Size of thus obtained spots was reflected in a charge recorded during the 
deposition step: ~1.5 µC (φ = 400µm), ~2.8 µC (φ = 800 µm) and ~8.8 µC (φ = 1200µm). 
The registered charge values testified nanometric thickness of the grafted Ppy film which 
is crucial for SPRi detection sensitivity.123 Density of thus deposited oligonucleotide probe 
was estimated to around 10 pmol/cm2.  
Successive polymerizations were carried out upon the same process with different 
oligonucleotide probes. Between consecutive tip loadings, the microcell was abundantly 
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washed with 20 mM Py in GDALi buffer in order to reduce the cross-contamination risk. 
Zip probes as well as NC (negative control) were deposited in multiplets to control the 
reproducibility (3-10 spots per probe). In a special case of biochip devoted to the 
photothermal protein desorption and further MS analysis, large and more numerous spots 
were grafted (over a dozen of 1200µm in diameter). As soon as the deposition of DNA 
matrix has been accomplished, the prism (or slide) was disconnected from the system, 
rinsed abundantly with deionised water and after drying under an argon stream, stored at 
4˚C. Washing step was performed by dipping upside-down in a big volume of water in 
order to avoid “comet tail” effect (cf. Fig.3.12). Such biochip was used within a few days 
but yielded a good hybridization signal when used after several months of proper storage. 
Removal of the polypyrrole and complete regeneration of the gold surface could be 
achieved by incubation overnight with 10% solution of commercial bleach.  
 
 
6.2.2 DNA biochip fabrication using microcantilever system 
 
Willing to reduce the probe spot size, electropolymerization was performed by 
using microcantilever system developed at the LAAS-CNRS laboratory (Toulouse, 
France).280 This system based on electrochemically driven deposition of Ppy film, permits 
to obtain up to 250,000 spots per cm2 and of ~7 µm in diameter. Analogously to previously 
described method, spotting solutions used in the experiment (1: Zip1-Py 10 µM + Py 20 
mM; 2: Py 20 mM) were prepared in GDALi buffer (supplemented with 25% (v/v) of 
glycerol to avoid excessive evaporation). Successive electro-polymerization steps were 
done by using microcantilever set-up272 providing precise control of the cantilever position 
by an external step motor. Analogously to the electrospotting process described above, 
cantilevers were filled up with the relevant spotting solution and placed over the gold 
layer. A 2 V potential difference was then applied (100 ms) between gold surface (WE) 
and the gold canal of the silicon cantilever (CE). The microarray was produced by 
successive “touch and go” steps giving rise to a matrix composed of Zip1 probe spots (5 
µm or 15 µm of lateral interval) and negative control Ppy spots (15 µm of lateral 
distribution).  
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6.2.3 DNA and IgG coupling reaction 
 
An antibody coupling with a short DNA oligomer (thiolated target oligonucleotide) 
was performed by using the hetero-bifunctional cross-linker SM(PEG)12 according to the 
protocol represented on Fig.2.6 b). In the first step, an IgG molecule underwent covalent 
coupling with the cross-linking agent. An appropriate IgG was suspended at 10-20 µM in 
pH 7.4 PBS buffer, then 100 molar excess of the SM(PEG)12 (stock solution at 100 mM in 
DMSO) was added and the obtained solution gently stirred. The IgG activation reaction 
was carried out for 1 h at room temperature.  The reactive sample was consequently 
purified on a NAPTM 5 column previously equilibrated with PBE buffer (triple washing) in 
order to remove the excess of the cross-linker. Purification eluate was therefore 
concentrated by using 30 kDa MWCO spin filter membrane (15 min, 15000 g; single 
washing with PBE) and suspended in PBE at ~25 µM. The concentration of the activated 
antibody-maleimide was determined by 280 nm absorbance measurement (ε280 = 210000 
M–1.cm–1).  
In parallel to the antibody activation, a DNA oligomer suspended in deionised 
water (80-95 µM) was mixed with TCEP (5 mM of final concentration) and the solution 
was homogenized. The reductive agent was added to eradicate disulfide bonds possibly 
formed between thiolated DNA oligomers, prior to further coupling. The reduction 
reaction was run for 30 min at room temperature, followed by purification on a NAPTM 5 
column (elution with PBE). The obtained eluate was concentrated by using 3 kDa MWCO 
membranes (15 min, 15000 g; double washing with PBE). The final concentration in PBE 
was assayed by 260 nm absorbance measurement. 
The final conjugation was subsequently realized. For this purpose, solutions of 
reduced DNA oligomer and maleimide activated IgG were put into reaction. A 2-fold 
molar excess of the antibody was combined with the DNA strand, gently stirred by 
micropipetting and allowed to react overnight at room temperature. The reaction sample 
was then concentrated to less than 100 µL by using 30 kDa MWCO spin filter (15 min, 
15000 g). During the concentration, buffer was exchanged to PBS pH 7.4 and sample was 
consequently purified on anion exchange chromatography.  
The coupling protocol and purification method detailed below, were analogously 
used to conjugate creatine kinase with corresponding DNA oligomers used in the study (cf. 
4.4). Protein activated by the cross-linker (CKBB or CKMM) and reduced oligonucleotide 
(EcoRI*-SH or PvuII*-SH, respectively) were combined at 1 : 1.5 stoichiometric ratio 
(kinase : DNA). Estimated yield of the obtained monoconjugated products were ~25 % and 
further optimization was not done.  
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6.2.4 Purification of protein-DNA conjugate by anion exchange chromatography 
 
Chromatographic purification of the IgG–DNA conjugation sample was realized on 
HPLC system Agilent 1200 Infinity Series LC (Agilent Technologies, France). The 
employed apparatus comprised the following modules: a manual injector equipped with a 
200µL injection loop, a 4-channel vacuum degasser, a quaternary pump, a multiple 
wavelength detector (UV-Vis) and an automatic fraction collector. Effective separation of 
the unreacted substrates as well as the conjugation products were provided by an anion 
exchange column HiTrapTM Q FF (1mL) characterized by 45-165µm of bead size (6% 
highly cross-linked agarose modified by -N+(CH3)3). The described system was alimented 
with buffers A and B meticulously prepared (filtration at 0.22µm membrane) and properly 
stored (4°C, up to one month).  
Prior to injections, the HPLC system was purged with deionised water (3ml/min 
flow, at least 10 min), washed with 100% of buffer B for 3-5min and then equilibrated with 
the starting buffer A (at least 5 column volumes). The analyzed sample was consequently 
injected to sample loop in 80-100 µL of total volume (partial loop filling avoided the 
sample loss in laminar flow). Species were eluted from the column in adequate conditions: 
1ml/min flow rate, working pressure of around 20 bar and NaCl gradient from 137 mM (tR 
= 5 min) to 784 mM (tR = 30 min). In reality a two-step gradient was applied: 1) 5-10 min, 
~60 mM NaCl/min (up to 35% of buffer B) and 2) 10-30 min, ~17 mM NaCl/min (35% to 
75% of buffer B). The second slower gradient was employed in order to obtain better 
resolution of peaks corresponding to fractions F2 (monoconjugated IgG–DNA) and F3 
(multiconjugated products and/or free oligonucleotides). Purification products were 
followed by simultaneous absorbance measurements at 230 nm, 260 nm and 280 nm.  
Fractions corresponding to peaks registered on a chromatographic profile were 
collected, concentrated on 30 kDa MWCO spin filter membranes (15 min, 15000 g) and 
suspended in pH 7.4 PBS. Collected fractions were subsequently assayed by UV 
absorbance measurements at 260 nm and 280 nm. The IgG loading by DNA oligomers as 
well as concentration of the monoconjugated IgG–DNA were assessed by using the 
obtained 260 nm and 280 nm absorbance values.117  
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6.2.5 Immunofluorescence assay 
 
The immunofluorescence test was realized to assess fractions F1, F2 and F3 
obtained upon purification of products issued from the conjugation reaction of rabbit IgG 
and Zip2*-SH (rab-IgG–Zip2*). For this study, a gold-covered glass slide was 
functionalized with Zip1, Zip2 and NC sequences (in triplets) according to the 
electrospotting protocol. Such DNA biochip was firstly incubated with blocking solution of 
1% BSA in PBS (room temperature, 10 min). In three independent assays, the probe matrix 
was incubated for 15 min (45°C) with a hybridization sample containing one of the 
relevant fractions (F1, F2 or F3) suspended in the hybridization buffer H. Each solution 
was supplemented with 0.1µM Zip1*–biotin for positive control. After hybridization, the 
biochip surface was abundantly washed with rinsing buffer R and incubated with biotin-
conjugated anti-rabbit IgG (1/1000 dilution in PBS) during 30 min at 37°C. The biochip 
was then washed with PBS and treated by 5% STV-PE (v/v) in PBS for 10 min in the dark 
(room temperature). After abundant rinsing with PBS, fluorescence signal read-out was 
directly observed by using optical microscope (BX60F-3 furnished by Olympus Optical) 
equipped with × 4 microscope objective WIG filter. Images were registered by 8-bit CCD 
camera (Hamamatsu) and proper software Image ProPlus (Media Cybernetics). Between 
each fraction assay, the biochip was regenerated with 0.1M NaOH (2-3 min incubation) 
and equilibrated with the R buffer prior to subsequent hybridizations.  
 
 
6.2.6 PS microbead sample preparation  
 
Streptavidin-coated polystyrene microbeads were combined with biotinylated 
species (anti-(rab-IgG) IgG-biotin or Zip1*-biot) prior to injection. 150 µL of microbead-
STV at 1.38 % (w/v) was submitted to triple washing in 0.5% BSA solution in PBS (6 min, 
10000 g) and re-suspended in the same volume (in PBS with 0.5% BSA). 100 µL of 
washed microbeads were mixed with 10 µL of Zip1*-biotin (at 100 µM). 50 µL of 
microbead solution was combined with 20 µL of ant-rabbit IgG-biotin (1/1000 dilution in 
PBS + 0.5% BSA).  Both solutions were incubated at 4°C during 30-40 min. After the 
incubation, samples were washed three times (6 min, 10000 g) and functionalized 
microbeads were re-suspended in PBS + 0.5% BSA solution to the following final 
concentrations: µbead-STV-biotin-Zip1* at 0.07 % (w/v) and µbead-STV-biotin-IgG at 
0.14 % (w/v). Loss of the microbeads during washing steps was neglected.  
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6.2.7 Preparation of cell sample 
 
Hybridoma cell lines LS-102.9 (B cells) and 3A9 (T cells) were kindly provided 
by P. Marche from Institut Albert Bonniot (IAB) in La Tronche (France). Frozen (-70°C) 
cell suspensions were thawed and incubated in standard conditions for mammalian cell 
culture (37°C, 95% humidity, 5% CO2). Hybridoma cells were grown in DMEM culture 
medium supplemented with 10% FBS, non-essential amino acids (0.1 mM), sodium 
pyruvate (1 mM), 2-mercaptoethanol (50 µM), penicillin (50 U/mL) and streptomycin (50 
µg/mL). Culture was driven during a few weeks and cells were regularly splitted to a fresh 
medium. Prior to use in the experiment (capture and release by enzymatic cleavage), LS-
102.9 and 3A9 were centrifuged (5 min, 300 g) and suspended in the PBS buffer 
supplemented with 10 mM of MgCl2 (running buffer 1) at 0.5 - 1.0 × 106 cells per mL. 
Number of cells in a sample was estimated on Cell Viability Analyser Vi-Cell (Beckman 
Coulter). 
 
Primary splenocytes were collected from an adult C57Bl/6 mouse (female). 
Directly after removal of the spleen, cells were separated on a grid mesh and suspended in 
cell culture medium (RPMI). The cellular suspension was then centrifuged (5 min, 300 g) 
and incubated with a lysis buffer (8.3 g/L NH4Cl, 0.8 g/L NaHCO3, 0.04 g/L EDTA) 
during 5 min in order to eliminate red blood cells. B and T lymphocyte mixture was 
washed in PBS and centrifuged again (5 min, 300 g). Cell pellet was subsequently re-
suspended in a complete medium: RPMI supplemented with 10 % FBS, penicillin (50 
U/mL) and streptomycin (50 µg/mL). Concanavalin A was added (at 2 µg/mL of final 
concentration) in order to stimulate T lymphocyte proliferation. Cells were cultured for 24 
to 72 h at 37 °C in the environment of 95% humidity and 5% CO2 (Forma Steri-Cycle CO2 
Incubator, Thermo Scientific). Prior to injection into the SPRi microfluidics, mouse 
splenocytes were centrifuged (5 min, 300 g) and suspended in the adequate experimental 
buffer at 3.0 - 5.0 × 106 cells per mL. In the enzymatic cleavage experiment, cells were 
injected in running buffer 1. For the photothermal desorption test, lymphocytes were 
suspended in running buffer 2A or the complete culture medium.  
 
Streptococcus pneumoniae (R6 strain) used for the bacterial study was a non-
encapsulated derivative of strain R36A (gift from the Rockefeller University, New York, 
USA). Bacterial culture was kindly performed by S. Bouguelia (CREAB), in TH liquid 
broth (composed of bacteriological peptone, heart infusion, dextrose, NaCO3, NaCl and 
Na2CO3). For the SPRi experiment, bacteria were retrieved from mid-exponentially grown 
cultures (OD600nm = 0.4). The given optical density (OD) corresponded to 108 colony 
forming unit per milliliter (cfu/ml), calculated by counting the colonies grown on solid 
support. Prior to injection, S.pneumoniae culture was extensively washed in PBS by two 
consecutive centrifugations (20 min, 1500 g). The bacterial pellet was eventually re-
suspended in running buffer 1 at final 109 cfu/mL concentration. 
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6.2.8 Target release from the biochip by enzymatic cleavage 
 
The molecular phenomena (hybridization and enzymatic cleavage) as well as cell-
involving events (capture and release from biochip surface) were monitored by a 
commercial SPRi apparatus (Horiba Scientific-GenOptics). The optical set-up was 
equipped with a 660nm LED and a 16-bit CCD camera (Pike F-145B or Dolphin F-145B 
by Allied Vision Technologies GmbH) as well as a TM/TE polarizer, a rotary mirror and a 
set of biconvex lenses. Adapted microfluidics was composed of a syringe pump (1 or 2.5 
mL Cavro XLP 6000 Pump by Tecan Systems, Inc), a degassing system (EliteTM Degassing 
System by Alltech) and a 6-channel injection valve. The main tubing (250 µm or 760 µm 
of ID) as well as the flow cells (~15µL of reaction chamber volume) employed here, were 
integrally made of PEEK. In a particular case of cellular sample injections, a transparent 
polyethylene-based tubing (760 µm of ID) was used (Fig.3.7). The running buffer 1 (PBS 
+ 10 mM MgCl2) was delivered at a flow rate depending on the experimental step: 20 
µL/min during biochip molecular assembly (intermediate DNA strands and IgG–DNA 
conjugates), 7-10 µL/min within the enzymatic digestion step, 15-20 µL/min during 
bacteria injections and higher values when lymphocytes were injected (50-100 µL/min for 
hybridomas and 20-60 µL/min for splenocytes). 
A functionalized DNA biochip (Zip1, Zip2, Zip3 and NC) was set up with a flow 
cell and housed in an incubator (IPP400, Memmert) at 37°C during the whole experiment. 
Prior to assay, the biochip surface was submitted to ultrasonication (1-2 min) and then 
incubated with blocking solution: 1% BSA in PBS (~15 min) or a mixture of 10 µM BSA 
and 5 µM cytochrome c in PBS (45-60 min) which was preferential for cell-based assays. 
The main experiment was followed in real time by SPRi (reflectivity signal monitoring), 
once the initial adjustments had been accomplished (equilibration with buffer, choice of 
the working angle). Molecular as well as bacterial and cellular samples prepared in the 
running buffer 1 were manually injected by using 200µL injection loops. Firstly, the 
intermediate DNA oligomers were independently introduced to the bioreactor (150 nM). 
Subsequently to that, injections of corresponding IgG–DNA monoconjugates at 50-60 nM 
(as calculated concentration of the relevant antibody) were performed. Following the 
molecular construction, lymphocytes or bacteria were loaded on the biochip within 2-3 
repeated injections at an adequate concentration detailed above. After cell-specific capture 
has been done, the restriction enzymes were injected in two subsequent digestion steps 
(200 U each). EcoRI and PvuII enzyme samples were prepared directly before the injection 
and remained for 20-30 min in the reaction chamber (total duration of the enzyme 
injection). During the enzymatic cleavage steps, fractions were recovered from the outlet 
of microfluidics directly into a 1.5 mL eppendorf tube and could be devoted to further 
characterization.  
The employed biochip was regenerated by 0.1 M NaOH solution (2-3 min), washed 
by water and dried under an argon stream. Such prism was stored at 4°C and could be 
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potentially used in subsequent experimentation. After the experiment, the microfluidic 
system was cleaned by 2% solution of the commercial bleach (at least 30min), then washed 
by 1% solution of SDS and finally deionised water. Registered SPRi data (proper software 
by Genoptics) were subsequently treated as described in the Appendices.  
 
 
6.2.9 Controlled target desorption by photothermal effect 
 
The experiments of photothermally induced desorption of biomolecules and micro-
objects were realized on a home-made system detailed in Chapter 4. Running buffer 2A or 
2B was delivered by a 50 mL syringe pump (A-99, Razel Scientific Instruments Inc.) at 20 
µL/min within whole assay (unless specified) and through PEEK/polyethylene tubing (ID 
= 760 µm). DNA biochips were prepared according to the electrochemical deposition 
process resulting in probe matrix composed of spots of diameter depending on the 
experiment: 7 µm or 800 µm for cell-based assay and 1200 µm in µbead and protein assay 
(in order to enable high level of material immobilization which is eventually desorbed for 
downstream MS analysis).  
Prior to the assay, a DNA biochip was cleaned in an ultrasonic bath (1-2 min) 
followed by incubation in a blocking solution depending on the experiment: 15 min with 
2µM cytochrome c (in PBS) for assay at molecular level, 15 min with 1% BSA (in PBS) 
for PS-µbead assay and 45-60 min with a mixture of 10µM BSA and 5µM cytochrome c 
(in PBS) for cell capture-release experiment. Once the biochip assembled with an adequate 
flow cell (detailed by the occasion of each experiment) has been placed into the optical 
system and the initial settings have been accomplished (manual adjustment of the working 
angle), injections of relevant specimens could start.  
Molecular samples were prepared in buffer 2A for microbead- and cell-based 
experiment, and in buffer 2B in protein assay for further MS analysis. They were manually 
injected by using an injection valve equipped with 200 µL or 500 µL (exclusively for the 
assay of “ligand fishing” type) injection loop. A dead volume between the injector and the 
biochip was estimated to around 30 µL and injections arrived into the reaction chamber in 
less then 2 min. Firstly, the complementary DNA strands were introduced at an appropriate 
concentration: 200 nM (cell-based experiment), 250 nM (µbead capture-release) or 300-
400 nM (protein assay). Hybridization of the intermediate strands was followed by 
injections of protein-DNA conjugates (exceptionally IgG–DNA) at 50-60 nM, 70 nM or 
150 nM, respectively. Subsequently to the molecular construction, functionalized 
microbead or cell sample (both detailed above) were loaded into reactor by injections at 
15-25 µL/min (microbeads) or 30-50 µL/min (splenocytes) flow rate. Specific capture of 
the micro-objects was followed by a microscope under × 4 or × 10 magnification (Olympus 
Optical) and registered by a proper camera (Infinity2-3C, Lumenera).  
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Consequently to the target capture on the functionalized biochip surface, controlled 
desorption was realized in independent lasing steps specific to each probe. Initial settings 
as well as the laser tracing phase were detailed in Chapter 4. In the proposed configuration, 
laser source was manually introduced between camera and prism (cf. Fig. 4.5). Therefore, 
the laser source was momentarily removed between each step of the photothermal 
desorption and SPRi signal retrieved. In this case, prism-LED-camera set-up could be 
slightly perturbed and the initial SPRi position restored manually (with the help of 
supplementary micrometric screws). During similar adjustments, SPRi signal remained 
unsettled and was not taken into consideration.  
An important issue when realizing out-of-support release by laser beam is the level 
of energy consumed to generate photothermal effect. As it was stressed out before, the 
dimension of local heating produced by the photothermal effect strongly depends on the 
irradiation time and the incoming laser intensity.214, 215 Okano’s group showed that local 
heating generated on a metal surface may induce partial destruction of solid support if the 
laser intensity is high enough.99 Characterization of the optical configuration used in our 
study has evidenced moderate level of surface energy generated on gold covered prism. 
However, if longer irradiation was realized (more than 5 min) thermal energy was 
accumulated in time and we could effectively observe some damages on the gold layer 
(black spot of probably carbonized material deposited on surface). Nevertheless, the 
experiments here reported, provided instantaneous contact of focused laser beam on 
surface (laser spot was displaced at 10-200 µm/s rate) which excluded material destruction 
phenomena. 
In the course of the experiment of the laser-induced desorption of creatine kinases 
(CKMM and CKBB), three fractions were recovered in the outlet of microfluidics (cf. 
4.3):”0” as blank sample before the lasing step, “1” and “2” samples within laser-assisted 
desorption on Zip1 and Zip2 spot family, respectively. The samples meticulously 
recovered into low-adsorption tubes (500-1000 µL) were then frozen and assigned to MS 
analysis. Cell or microbead recovery was not attempted in this experimentation. Biochip 
was regenerated and microfluidic system cleaned according to the protocol detailed in 
section 6.2.8.  
The developed instrumentation is an example of home-made experimental set-up. 
Entire system is a free-standing device placed in a dark room. Therefore, the whole 
experiment temperature control was disabled and could not be precisely regulated. Room 
temperature was thus considered as working condition, although it could be higher in the 
reality because most of the experiments have been carried out in summer (over 30°C). 
SPRi signal remained stable within many hours of experiment while only buffer was 
flowed through the system. Influence of the external temperature on detected signal may be 
therefore neglected. Although regular temperature measurements were not done, we 
speculate that heating of bulk solution generated by the photothermal effect may be 
disregarded as well. This statement is founded upon a few reasons such as local 
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confinement of the photothermal phenomenon, laser tracing accomplished in several 
minutes and finally considerable flow rate during desorption step.  
 
 
6.2.10 Mass Spectrometry analysis 
 
Samples recovered from the protein photothermal desorption experiment (samples 
“0”, “1” and “2”) were assayed by mass spectrometry kindly realized by M. Jaquinod 
(IRTSV, CEA Grenoble). The tested solutions were firstly dried under speed vacuum to 
evaporate ammonium bicarbonate. They were subsequently re-dissolved in 100 µL of 10% 
(v/v) acetonitrile (in 100 mM NH4HCO3, pH 7.9) and incubated at room temperature for 15 
min. Samples were then submitted to reductive conditions by addition of 2 µL of 500 mM 
TCEP and incubation during 30 min (RT). In further step of sample pre-processing, 
alkylation of cysteine residues was performed by addition of 10 µL of 100 mM 
iodoacetamide and followed by incubation for 30 min (RT). Samples consequently 
underwent protein digestion induced by trypsin (Promega Corp) – 0.5 µg was added and 
followed by incubation for 4 h at 37°C.  The digestion solutions were then dried under 
speed vacuum and the obtained peptide mixtures re-suspended in 25 µl of chromatographic 
purification liquid phase: H2O/acetonitrile 95%/5% (v/v) containing 0.2 % of formic acid 
(FA). The trypsin-digested samples were finally submitted to LC-MS/MS analysis. The 
samples were firstly separated on a nano-LC system, subsequently coupled to an 
OrbiTRAP mass spectrometer (ThermoFinnigan). The chromatographic analysis was 
enabled on 300 µm × 5 mm PepMap C18 pre-column and 75 µm × 150 mm C18 column 
(Gemini C18 phase). The employed method consisted in a 60-minute gradient flow (300 
nL/min) based on two buffers: I (5% acetonitrile and 0.2% formic acid in water) and II 
(80% acetonitrile and 0.08% formic acid in water). MS/MS data were acquired using 
Xcalibur (Thermo Fischer Scientific) and processed automatically using Mascot Daemon 
software (Matrix Science). 
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Appendix  A: MS analysis of the sample recovered upon EcoRI*-
NH2 conjugation with DSS 
EcoRI*-NH2 was coupled to DSS (100 molar equivalent) according to the protocol 
previously reported.146 After purification on NAPTM 5 column (elution with water), the 
sample was lyophilized and transferred to MS analysis kindly realized by C. Saint-Pierre 
from LAN laboratory (CEA Grenoble). 
 
 
 
 
The obtained results confirmed presence of hydrolyzed products in the analyzed 
sample (EcoRI*-COOH). The activated DNA-NHS was not evidenced which may indicate 
that NHS ester is susceptible to destruction before subsequent step of the conjugation 
protocol. 
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Appendix  B: Calculations of the IgG loading with DNA 
Willing to estimate the number of DNA strands coupled with a single IgG 
molecule, we make use of the absorbance law. Considering the absorbance of the 
conjugated product, we benefit from additivity of the Lambert-Beer law of absorbance. By 
assuming that conjugation of IgG and DNA does not influence their ε values, we have:  
 
where: A260 and A280  – absorbance values measured on the IgG–DNA conjugate at 260 nm and 280 nm; 
 l – length of optical pathway [cm]; 
 ε260 and ε280  – extinction coefficients at 260 nm and 280 nm [M-1cm-1]; 
 n – number of moles in a given volume [M].  
 
For the product fractions obtained upon conjugation of an IgG with an 
oligonucleotide, the measured absorbances (A260 and A280) permit to estimate Z:  
 
where:  Z – theoretical number of DNA strands conjugated with single IgG molecule; 
 R – ratio of extinction coefficients (ε260/ε280) 
 A260/280 – ratio of the measured absorbance values 
 
 
Estimation of antibody loading with DNA molecules is therefore enabled and 
accordingly assigned to the fractions issued from antibody coupling to three independent 
DNA sequences (EcoRI*, PvuII* and NcoI*): 
 
 
 IgG–EcoRI* IgG–PvuII* IgG–NcoI* 
fraction A260/A280 Z A260/A280 Z A260/A280 Z 
F1 0.64 0.0 0.64 0.0 0.65 0.0 
F2 0.98 0.6 0.94 0.6 0.98 0.6 
F3 1.5 3.8 1.37 4.7 1.36 2.4 
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Appendix  C: Assessment of IgG–DNA concentration in the 
fraction of monoconjugated product 
Fractions obtained upon chromatographic purification are concentrated, re-
suspended in PBS (pH 7.4) and their absorbance is measured (example of rab-IgG coupling 
to EcoRI*-SH): 
 
Appendix  D: Theoretical value of restriction enzyme units (U) 
needed to digest the microarrayed DNA 
This appendix serves to establish an approximate theoretical value of U (restriction 
enzyme units) which is optimal to perform digestion of immobilized DNA substrate. 
Following calculations were done for EcoRI enzyme according to data taken from Fuchs et 
al.177  
 
In the present study, DNA duplexes assembled on the biochip surface are of 46 bp 
length (e.g. Zip1*-EcoRI). According to the illustrated above table, each microgram of 
such substrate (33 pmol) needs 208 U of the restriction enzyme. When considering a DNA 
matrix composed of ~40 spots of 800 µm in diameter, we obtain 0.2 cm2 of surface 
coverage by probe-modified Ppy. It corresponds to around 2 pmoles of the immobilized 
oligonucleotide (10 pmol/cm2 according to previous studies),123 finally giving 12.6 U of 
EcoRI which approximates the optimal quantity of enzyme required to digest the adequate 
amount of the substrate.  
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Appendix  E: SPRi data treatment 
The SPRi data were acquired using proper software furnished by Horiba Scientific-
GenOptics (SPRiViewlt). It permitted to follow changes in reflectivity on the available 
biochip area through defined zones (so-called masks) corresponding to the spots of 
interest. Registered spot-specific reflectivity signals (R) were normalized to the luminosity 
observed in conditions devoid of SPR phenomenon (TE mode) and expressed in %. The 
SPRi system automatically subtracted background noise registered at the beginning of each 
experiment. Recording of the reflectivity signal was enabled by a 16-bit camera and plotted 
upon time during the whole assay (reflectivity kinetics curves).  
The obtained raw data were pre-processed in order to improve the clarity of their 
presentation. In the first step of the data treatment, all recovered signals (generally 35% - 
45% of R) were zeroed to the baseline, by subtraction of the average reflectivity registered 
for each spot at the beginning of the experiment or just before the injection. Further, the 
obtained curves corresponding to the same species were averaged and traced in time 
(starting injection of the blocking solution was omitted).  
 
 
 
As the final operation, the averaged reflectivity signals were corrected by a 
negative control (signal observed for NC probe). Subtraction of the NC signal aimed to 
eliminate the background reflectivity changes generated by global variations of the bulk 
solution refractive index. Such proceeding was particularly required during injections of 
enzymatic and cellular samples. The definitive curves were therefore plotted as relative 
reflectivity shift in function of time.  
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In fact, kinetics of enzymatic reaction was a parameter that, in the case of here 
proposed biochip system, could not be properly studied. It was because injection of 
enzyme solution generated global refractive index change observed by SPR imaging as an 
abrupt reflectivity rise (cf. figure above). Such effect was induced by introduction to the 
reaction chamber of high protein content in abundant buffer. Indeed, injected enzyme 
samples were based on commercially available solutions stored at -20°C. Such storage 
conditions required presence of glycerol at high levels (30-50 %) in order to keep the 
proteins properly folded. Samples of EcoRI and PvuII enzymes were prepared directly 
before injection and eventually contained up to 5% of glycerol. Similar preparation loaded 
to biochip system, strongly affected optical properties of the reaction medium and 
produced momentary variation of global reflectivity. Subtraction of the negative control 
(NC signal) resulted in SPRi signal over-correction mainly due to the lack of linearity of 
the reflectivity signal in the conditions of considerable refractive index change (signal 
saturation). Thus, a straightforward interpretation was disabled during the enzymatic 
incubations and enzyme functionality could not be assigned as long as it was not washed 
off the reactor. 
Simultaneously to the real-time monitoring of reflectivity signal proper to each of 
the defined spots, GenOptics program acquired images of the whole biochip area along the 
experiment (~2 images per minute). Thus, a useful tool to follow the biomolecular and 
cellular phenomena was to observe SPR differential images. A differential image resulted 
from subtraction of the reference image to the currently acquired one. Reference images 
were often taken at the beginning of an injection in order to highlight each step of the 
experiment (hybridization of DNA or IgG–DNA, cell immobilization, specific release). 
However during cellular and enzymatic injections, global variation of the refractive index 
influenced the registered differential images resulting in their poor contrast. In these cases, 
SPR images were processed by using image treatment software (ImageJ v1.43u, National 
Institutes of Health, USA) where final contrast was improved and proper phenomena 
revealed.   
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Appendix  F: PEEK-made flow cells used in the experiments 
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Appendix  G: Visualizations of splenocytes in SPR imaging 
 
 
 
 
Primary lymphocytes from mouse spleen (C57Bl/6) were straightforwardly loaded 
onto the gold surface devoid of particular treatment and functionalization. SPR images 
were sequentially registered at different focalization distances (from a) to n) ~1.5 mm of 
focalization distance shift). In function of the focalization, cells were visualized as oval to 
star-shaped discrete objects.  
APPENDICES 
181 
 
Appendix  H: Characteristics of the laser configurations 
 
 
 
Laser light spectra were registered with help of CCS100 Compact Fiber 
Spectrometer (Thorlabs GmbH, Germany). Measurements of the laser intensity were 
provided by a portable laser power meter LaserCheck (Coherent, France). 
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Appendix  I: Capture of single lymphocyte inside a micropore 
The present appendix describes the study realized in collaboration with J. Liu 
(CREAB), where we have demonstrated the specific capture of primary B and T 
lymphocytes inside micropores. For this purpose, we used a set of 9 pores of 15 µm in 
diameter etched in a silicon substrate and thermally covered by 4 µm-thick silica. The 
micropores were functionalized with DNA according to the CLEF technique previously 
described.278 Briefly, probes of interest (Zip1 and Zip2) were introduced to each micropore 
by electrochemically driven deposition of a polypyrrole film. As result of the 
electropolymerization, the generated oligonucleotide-bearing polypyrrole film was 
regularly distributed on the inner wall of a single micropore and demonstrated high level of 
attachment.  
 
 
 
Subsequently to the functionalization, the obtained chip was assigned to an 
experiment with mouse splenocytes. Within whole assay, the system was housed in a 
home-made support and integrally immerged in buffer volume (firstly hybridization buffer 
H and then pH 7.4 PBS). Prior to incubation with target samples, the biochip was saturated 
with 1% solution of BSA (in PBS). Stepwise hybridizations were consequently performed 
in order to provide three-component molecular assembly capable of specific cell capture. 
Namely, Zip1-based micropores were assembled with complementary Zip1*-EcoRI strand 
and eventually functionalized by anti-CD19–EcoRI* whereas Zip2 sequence hybridized 
with anti-CD90–PvuII* through the intermediate Zip2*-PvuII oligonucleotide. Following 
the molecular construction, the hybridization buffer H was exchanged to PBS and the 
cellular sample was then introduced to the biosensor. 
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A suspension of B- and T-type primary lymphocytes issued from mouse spleen was 
loaded on the biochip and cells were directly observed under microscope. Over a few 
minutes upon the deposition of the cellular sample allowing cell sedimentation in the 
buffer volume, lymphocytes could be observed when approaching to micropore locations. 
Most of cell units rolled over membrane and adsorbed non-specifically before reaching the 
micropore lumen. Several lymphocytes attained bottom of the membrane pyramidal 
openings and penetrated inside a micropore. Therefore, two different phenomena were 
registered: a single cell was translocated through the encountered micrometric hole or 
trapped inside the pore if specific interactions were ensured. The introduced lymphocytes 
became tethered in biochip locations decorated with anti-CD19 (Zip1 µpore) and anti-
CD90 (Zip2 µpore) antibodies in contrast to negative Ppy micropores where no cell 
capture was observed. Nevertheless, an efficient immobilization of splenocytes rarely took 
place since in reality, only a small fraction of the cellular sample got into contact with the 
functionalized surfaces. Furthermore, despite reliable functional coverage of micropore 
inner wall, lymphocyte immobilization was not a long-lasting event, probably due to 
characteristic hydrodynamic constraints. Indeed, once the buffer solution was actuated by 
rinsing in fresh PBS or even by a simple chip displacement, trapped lymphocytes were 
washed off from the micropores. We speculated that living cells remaining in such small 
diameter of the order of cell size, incurred considerable shear forces generated by 
surrounding liquid flow conditions. This conclusion was confirmed by the fact that once 
cells approached a single micropore border, they were rapidly translocated through the 
hole probably by a rapid liquid stream. It additionally explained why the quantity of 
effectively captured lymphocytes was so poor.  
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Despite the aforementioned difficulties and low rate of cell immobilization inside 
micropores, the realized study may be considered as promising approach to a single-cell 
level biosensor. The reported above experiment demonstrated phenomena of individual 
cell capture in well-defined biochip locations. Precise immobilization of lymphocytes 
loaded onto biochip in a mixed population of immune cells was ascribed to their specific 
recognition by molecular assembly based on antibody-DNA conjugates. Further studies 
will be carried out in order to improve the performance of the proposed single-cell assay. 
In this matter, the DNA involving molecular architecture may be potentially exploited to 
enzymatically driven release of an individual cell for its downstream examination. An 
important development would be to design more sophisticated microfluidic set-up to 
eventually meet the requirements of a lab-on-a-chip system. Rheological parameters inside 
a micropore should be therefore considered to ensure proper environment devoid of 
excessive shear stress regarding to cellular sample. An example of such microdevice 
should provide well guided flow of cell-containing solution to precise biosensing locations 
represented by functionalized micropore positions.   
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Développement de biopuces dédiées au tri d’échantillons cellulaires 
Le présent travail de thèse repose sur la conception d’un système miniaturisé de type 
biopuce capable d’assurer la capture et le relargage contrôlé de différentes populations des cellules 
sanguines (e.g. lymphocytes). Ce projet a pour objectif la construction d’un outil potentiel de 
recherche dans le domaine de l’immunologie ainsi que du diagnostic qui permettrait non seulement 
de réaliser des essais à partir d’une faible quantité d’échantillon, mais aussi de réduire le temps 
d’analyse. L’approche consiste plus précisément en la fabrication d’une matrice d’oligonucléotides 
et l’immobilisation de cellules via une molécule hybride composée d’un anticorps IgG couplé à une 
séquence d’oligonucléotide complémentaire. La synthèse du produit conjugué est mise en place et 
conduit à l’assemblage fonctionnel sur biopuce. Une fois les cellules spécifiquement capturées sur 
la surface, deux voies de relargage contrôlé sont explorées. Ainsi, les lymphocytes sont libérés de 
façon contrôlée et séquentielle par clivage enzymatique d’ADN ou alors par désorption physique 
possible grâce au chauffage localisé. La détection se fait en temps réel par l’imagerie de la 
résonance plasmonique de surface (Surface Plasmon Resonance Imaging, SPRi) qui présente 
l’avantage de pouvoir suivre les phénomènes biomoléculaires en absence de marquage et 
d’apporter une réponse simultanée d’un échantillon biologique sur un grand nombre de sondes. 
Accessoirement, une approche instrumentale particulière nous permet d’observer les étapes de 
capture/relargage par microscopie optique classique. La construction de la biopuce permet 
également l’élargissement à plusieurs cibles et ouvre ainsi la voie à de nombreuses possibilités 
d’exploration en termes d’application pour l’analyse d’échantillons biologiques plus complexes tels 
que du sang.  
Mots clés : biopuce, tri cellulaire, imagerie SPR, biomolécules conjuguées, enzyme de 
restriction, effet photothermique 
 
 
Development of biochips for blood cell sorting 
This PhD thesis is devoted to conception of a miniaturized system of biochip type able to 
perform a controlled capture and release of different populations of the blood cells (e.g. 
lymphocytes). The main objective of the project is to create a potential tool of research, especially 
in the field of immunology, and medical diagnostics as well, that could perform short-time analyses 
by using a small sample amount. The approach relies more precisely on fabrication of a DNA 
matrix and further immobilization of cells through a hybrid molecule composed of an IgG antibody 
covalently coupled with short oligonucleotide sequence. Synthesis of the conjugated product is 
developed and demonstrates functional assembly on the micro-platform. Lymphocytes are 
specifically addressed onto biochip surface and once they are captured, two independent strategies 
of selective release are proposed.  Therefore, immobilized cells are specifically detached either 
upon enzymatic cleavage of oligonucleotide substrate or physically desorbed by local heating and 
denaturation of double stranded DNA. The system makes use of Surface Plasmon Resonance 
Imaging (SPRi) to enable real time detection of different biomolecular phenomena in a label-free 
and high-throughput manner. Accessorily, a particular instrumental approach is developed in order 
to observe cell capture-release steps directly under optical microscopy. The biochip construction 
permits to extend its performance to many targets and may be further explored in terms of 
application to analysis of complex biological samples such as blood.  
Keywords: biochip, cell sorting, SPR imaging, biomolecule conjugation, restriction enzyme, 
photothermal effect 
